Living well with dementia: a systematic review and correlational meta-analysis of factors associated with quality of life, well-being, and life satisfaction in people with dementia by Martyr, A et al.
1 
 
Living well with dementia: a systematic review and correlational meta-analysis of factors 
associated with quality of life, well-being, and life satisfaction in people with dementia 
 
Anthony Martyr1,2, Sharon M. Nelis1,2, Catherine Quinn1,2, Yu-Tzu Wu1,2, Ruth A. Lamont1,2, 
Catherine Henderson3, Rachel Clarke4,5, John V. Hindle6,7, Jeanette M. Thom8, Ian Rees Jones9, 
Robin G. Morris10, Jennifer M. Rusted4, Christina R. Victor11 & Linda Clare1,2,12* 
 
*Correspondence to: Professor Linda Clare, Centre for Research in Ageing and Cognitive Health, 
School of Psychology, University of Exeter, Exeter, EX4 4QG, UK l.clare@exeter.ac.uk 
 
1. School of Psychology, University of Exeter, EX4 4QG UK 
2. PenCLAHRC, Institute of Health Research, University of Exeter Medical School, EX1 2LU UK 
3. Personal Social Services Research Unit, London School of Economics and Political Science, 
WC2A 2AE UK 
4. School of Psychology, University of Sussex, BN1 9RH UK 
5. School of Education and Social Work, University of Sussex, BN1 9RH UK 
6. School of Psychology, Bangor University, LL57 2AS UK 
7. Department of Care for the Elderly, Betsi Cadwaladr University Health Board, Llandudno, LL30 
1LB UK  
8. School of Medical Sciences, University of New South Wales, NSW 2052 Australia 
9. Wales Institute of Social and Economic Research, Data and Methods, Cardiff University, CF10 
3BB UK 
10. Department of Psychology, King’s College London Institute of Psychiatry, Psychology and 
Neuroscience, London, SE5 8AF UK 
11. Department of Clinical Sciences, Brunel University, UB8 3PH UK 
12. Wellcome Centre for Cultures and Environments of Health, University of Exeter, Exeter, UK 
2 
 
 
Word count: 4496 
 
Funding: The IDEAL study is funded by the Economic and Social Research Council (UK) and the 
National Institute for Health Research (UK) through grant ES/L001853/2 ‘Improving the experience 
of dementia and enhancing active life: living well with dementia’ (Investigators: L. Clare, I.R. Jones, 
C. Victor, J.V. Hindle, R.W. Jones, M. Knapp, M. Kopelman, R. Litherland, A. Martyr, F. Matthews, 
R.G. Morris, S.M. Nelis, J. Pickett, C. Quinn, J. Rusted, J. Thom). The funders had no role in the 
study design, data collection, data analysis and interpretation, writing of the report, or the decision to 
submit the article for publication.   
 
Keywords: Alzheimer’s disease; dementia; quality of life; depression; neuropsychiatric symptoms 
 
Running title: Living well with dementia  
 
  
3 
 
Abstract 
 
Current policy emphasises the importance of ‘living well’ with dementia, but there has been no 
comprehensive synthesis of the factors related to quality of life (QoL), subjective well-being or life 
satisfaction in people with dementia. We examined the available evidence in a systematic review and 
meta-analysis. We searched electronic databases to January 7th 2016 for observational studies 
investigating factors associated with QoL, well-being and life satisfaction in people with dementia. 
Articles had to provide quantitative data and include ≥75% people with dementia of any type or 
severity. We included 198 QoL studies taken from 272 articles in the meta-analysis. The analysis 
focused on 43 factors with sufficient data, relating to 37,639 people with dementia. Generally, these 
factors were significantly associated with QoL, but effect sizes were often small (0.1-0.29) or 
negligible (<0.09). Factors reflecting relationships, social engagement and functional ability were 
associated with better QoL. Factors indicative of poorer physical and mental health (including 
depression and other neuropsychiatric symptoms) and poorer carer well-being were associated with 
poorer QoL. Longitudinal evidence about predictors of QoL was limited. There was considerable 
between-study heterogeneity. The pattern of numerous predominantly small associations with QoL 
suggests a need to reconsider approaches to understanding and assessing living well with dementia. 
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Introduction 
 
Dementia refers to a group of progressive brain disorders which result in multiple cognitive and 
behavioural impairments (Ballard et al., 2011). Enabling people with dementia to ‘live well’ with the 
condition is a priority for policy and practice (Department of Health, 2009). Living well with chronic 
illness and disability is viewed by the Institute Of Medicine (2012) as ‘the best achievable state of 
health that encompasses all dimensions of physical, mental and social well-being' such that 'to live 
well takes on a unique and equally important personal meaning, which is defined by a self-perceived 
level of comfort, function and contentment with life’ (pg. 32). It is important to gain a clear 
understanding of the extensive range of factors that may influence ability to live well with dementia 
in order to identify potential targets for intervention. 
 
In instances where it has been discussed explicitly (e.g. Small, 2007), the concept of ‘living well’ 
with dementia has been equated with experiencing a good quality of life (QoL). Living well can 
however mean more to an individual than current QoL. A sense of subjective well-being can be also 
associated with living well. Likewise, living well can encompass the experience of a life that is and 
has been lived well – life satisfaction. The constructs of QoL, subjective well-being and life-
satisfaction are inter-related but encompass distinct elements (Clare et al., 2014a).  
 
Subjective well-being refers to both a positive cognitive appraisal of one’s current situation and the 
experience of an appropriate balance of positive and negative emotions (Diener and Chan, 2011). In 
line with this definition, Kitwood’s model of personhood (1997) emphasises the way in which 
interactions and environments contribute to enhancing or detracting from well-being for people with 
dementia. Subjective perceptions of satisfaction with life reflect the experience of meaning and 
purpose, the ability to experience continued personal growth, a sense of being in control of one’s life, 
active social participation, and happiness (St. John and Montgomery, 2010).  
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QoL is sometimes conceptualised specifically in relation to health (health-related QoL, HRQoL) 
(Albert et al., 2001). This is a narrow formulation, however, and given the pervasive effects of 
dementia there is likely to be considerable overlap between specific health-related and more generic 
elements of QoL (Wilson and Cleary, 1995). The World Health Organisation defines QoL much 
more broadly as ‘an individual’s perceptions of their position in life in the context of the culture and 
values systems in which they live and in relation to their goals, expectations, standards and concerns. 
It is a broad ranging concept, affected in a complex way by a person’s physical health, psychological 
state, personal beliefs, social relationships and their relationship to their environment’ (pg. 1) (World 
Health Organization, 1995). There is no single accepted theoretical model underlying the 
conceptualisation and assessment of QoL in dementia, but the most influential formulation is 
Lawton’s dementia-specific framework (1994), which recognizes that adequate measurement of QoL 
requires evaluation of multiple dimensions of a person’s life, presenting a broad conceptualisation 
that accords well with the WHO definition. 
 
Life satisfaction and subjective well-being have not been studied in depth in people with dementia, 
with a few important exceptions (Zank and Leipold, 2001). QoL has been investigated more 
substantially, but it has been argued that nevertheless little is known about the QoL of people with 
dementia, particularly those with more severe conditions (Kane et al., 2003, Banerjee et al., 2009, 
Cordner et al., 2010), or about whether QoL changes over time as dementia severity increases. In 
contrast, QoL can be assessed using either generic or dementia-specific measures, of which there are 
several available (Ready and Ott, 2003, Ettema et al., 2005, Bowling et al., 2015, Algar et al., 2016, 
Missotten et al., 2016). Although many of these measures share content themes and conceptual 
underpinnings (Missotten et al., 2016), different measures may yield different results. These 
methodological limitations and complexities make it difficult to draw clear conclusions about factors 
associated with aspects of living well with dementia.  
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While life satisfaction is typically assessed by self-report and well-being is typically assessed by 
informant ratings, QoL in contrast may be assessed either directly by self-report or by means of 
informant or proxy ratings made by family or health care professionals. Self-report by people with 
mild (Woods et al., 2014) and moderate to severe dementia (Hoe et al., 2005) has been shown to be 
reliable, though reliability may depend on which measure is used (Ready and Ott, 2003) and 
dementia severity. Comparison of self- and informant ratings in situations where both can be 
obtained indicates that informant ratings are typically more negative than self-ratings (Beer et al., 
2010, Moyle and O'Dwyer, 2012, Crespo et al., 2013), and this has implications for how we evaluate 
informant reports of QoL in people with very severe dementia where only informant or proxy ratings 
are possible. Furthermore, different informants may have different perspectives; for example, ratings 
made by family carers and paid/professional carers appear to be associated with different factors 
(Edelman et al., 2005, Clare et al., 2014b).  
 
Previous reviews have focussed on specific aspects of QoL in dementia, including dementia-specific 
HRQoL (Banerjee et al., 2009), measurement (Ready and Ott, 2003, Ettema et al., 2005, Bowling et 
al., 2015, Algar et al., 2016, Missotten et al., 2016), residential care (Lawrence et al., 2012, Moyle 
and O'Dwyer, 2012, Beerens et al., 2013, Robertson et al., 2017), qualitative accounts (O'Rourke et 
al., 2015a), and a recent narrative overview (Jing et al., 2016). To date, however, there has been no 
comprehensive systematic review and meta-analysis of factors associated with QoL, well-being and 
life satisfaction for people with dementia. A careful and comprehensive review is needed to 
summarise the evidence. In this systematic review and meta-analysis we examined evidence from 
quantitative observational studies in order to identify factors associated with QoL, well-being and life 
satisfaction in people with dementia. 
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Method  
 
Search strategy 
We searched Pubmed, CINAHL, Web of Science, PsycNET, AgeInfo, Zetoc, Social Care Online, 
and OpenGrey for English-language publications to 7th January 2016. The search comprised two 
strings. The first string comprised: (well-being OR wellbeing OR life satisfaction OR quality of life 
OR *QoL* OR Health Status OR ADRQL OR Apparent Emotion Scale OR BASQID OR CDQLP 
OR Discomfort Scale OR Duke Health Profile OR DHP OR EQ-5D OR Health Utilities Index OR 
HUI* OR Nottingham Health Profile OR NHP OR Pleasant Events Schedule-AD OR Progressive 
Deterioration Scale OR PWB-CIP OR SF-12 OR SF-36 OR ICECAP OR QUALIDEM OR 
QUALID) AND (dementia OR Alzheimer* OR Parkinson* OR Lewy OR Fronto). The second 
search string was designed to identify articles in residential care settings that may not mention 
dementia in the title or abstract and comprised: (well-being OR wellbeing OR life satisfaction OR 
quality of life OR *QoL* OR health status) AND (nursing home OR long term care OR assisted 
living OR residential living OR care home OR respite OR day care). Names of specific measures 
used in the searches were derived from two previous reviews (Ready and Ott, 2003, Ettema et al., 
2005). No date restrictions were imposed. We examined reference lists of review articles identified in 
the searches and searched online for additional publications by first authors of included studies. The 
review protocol was registered with PROSPERO: CRD42014013633. 
 
Inclusion and exclusion criteria 
The population of interest was people with a diagnosis of dementia, irrespective of type, severity, 
age, or living situation. We included observational studies reporting cross-sectional and/or 
longitudinal associations between specific variables and scores on a standardised questionnaires or 
rating scales measuring QoL, life satisfaction or well-being. We excluded studies where fewer than 
75% of participants had dementia, and intervention studies that did not provide baseline data.  
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Procedure  
Figure 1 shows the article selection process. Title, abstract and full text screening were conducted by 
two independent reviewers using a structured proforma, and any disagreements were referred to a 
third individual for resolution. Supplementary Table 1 provides a list of studies excluded at the full 
text screening stage, with reasons. Study quality was assessed by two independent reviewers using a 
checklist adapted from existing measures (DuRant, 1994, Downs and Black, 1998, Zaza et al., 2000, 
Sanderson et al., 2007); see Supplementary Table 2. Scores from the quality assessment of each 
article were summed; articles that scored 19 or lower were judged to be of poor quality, articles that 
scored between 20 and 25 were judged to be of satisfactory quality and articles that scored 26 or 
greater were judged to be of good quality. A structured proforma was used for data extraction.  
 
A description of each outcome measure used in the included studies was taken from either the 
relevant measure development article or, if this was unavailable, from the most comprehensive 
description of the measure provided in an included study. Based on this description, each measure 
was classified as assessing either ‘general QoL’, ‘general HRQoL’, ‘dementia specific QoL/HRQoL’, 
‘life satisfaction’, or ‘subjective well-being’. This process was conducted by three authors working 
independently, with any disagreements being referred to a fourth individual for resolution. 
 
 
Where multiple articles reported data from the same study, details for each factor were taken from the 
article reporting the largest sample size. If an article included data from two sources (e.g. two 
different datasets were analysed separately (e.g. Trigg et al., 2007, Li et al., 2013) or data were 
analysed separately for mild and moderate dementia (e.g. Novelli and Caramelli, 2010)) these were 
classed as separate studies for the purposes of the analysis. We extracted correlational data provided 
in study reports or regression data, standardised betas (Peterson and Brown, 2005), odds ratios, p 
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values, or t or F statistics converted to correlations, adopting a standardised correlation direction to 
facilitate comparison (Borenstein et al., 2009). 
 
(((Figure 1 near here))) 
 
Statistical analysis 
Meta-analysis for each factor was undertaken where comparable data were available from at least 
five studies. All computations were based on Fisher’s z transformations and were conducted using 
Comprehensive Meta-Analysis 2 (Borenstein et al., 2005) software which calculated average z scores 
and p values, weighted effect r values, and 95% confidence intervals. A two-sided 5% significance 
level was applied. Multiple within-study correlations were averaged to correct for violations of 
independence so that all available data could be included in the analysis. Between-study 
heterogeneity for each measure was assessed using the I2 index (Higgins et al., 2003). Estimated 
effect sizes (subsequently ‘effect sizes’) ≤0.09 were considered negligible, 0.10-0.29 small, 0.30-0.49 
moderate and ≥0.50 large (Cohen, 1988). A random-effects model (DerSimonian and Laird, 1986) 
was employed in view of anticipated high heterogeneity across studies. 
 
Where comparisons were described simply as non-significant the correlation was set at zero. Where p 
values were given as a range, the value used to calculate the correlation was set at the upper limit of 
the range (e.g. for p <0.05 the value was set at p = 0.049). 
 
Separate analyses were conducted for each of the rating methods used in cross-sectional studies: self-
rating by the person with dementia, informant rating by a family carer or health care professional 
(reflecting the informant’s appraisal of the person with dementia), proxy rating by a family carer or 
health care professional (reflecting the appraisal that the proxy thinks the person with dementia 
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would make), and differences between parallel self- and informant ratings. Longitudinal studies were 
examined separately to identify baseline predictors at follow-up.  
 
Pre-specified sub-group analyses examined whether associations of relevant factors with living well 
outcomes differed according to type of rating, type of dementia, living situation of the person with 
dementia, relationship with the carer, or type of measure. 
 
Random-effects meta-regression analyses were used to investigate pre-specified moderating effects 
of age and cognitive status, indicated by Mini-Mental State Examination (MMSE) scores (Folstein et 
al., 1975), on moderate associations where ten (Borenstein et al., 2009) or more studies were 
available. 
 
Sensitivity analysis 
To examine whether inserting a correlation of 0 for ‘non-significant’ p values influenced the findings 
we removed these insertions and repeated the meta-analysis. We also investigated the impact of poor-
quality articles on the results. Fourteen articles judged to be of poor quality (seven of which were 
conference abstracts) were removed from the analysis. 
 
Results  
 
We identified 307 articles for inclusion: 282 journal papers, 16 conference abstracts, three Health 
Technology Assessment reports, one book chapter, and five PhD theses (Figure 1). These reported 
findings from 213 individual studies from 36 countries mostly in Europe or North America; 
Supplementary Tables 3-9 provide details and quality ratings. Data on QoL were reported in 205 
studies, well-being in five, and life satisfaction in three.  
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Measures of QoL, well-being and life satisfaction  
 
The studies utilised 45 measures of QoL, seven measures of well-being and four measures of life 
satisfaction (see Supplementary Table 10). The QoL-AD (Logsdon et al., 2000) was the most 
frequently employed measure of QoL in studies where the focus was self-rated or informant-rated 
QoL or the difference between self-rated and informant-rated QoL, including longitudinal studies. 
DEMQOL-Proxy (Smith et al., 2005) was the most frequently employed measure of proxy-rated 
QoL. Distributions of scores on QoL measures are shown in Supplementary Tables 11-12c. Self-
ratings by people with dementia on the QoL-AD and EQ-5D were higher than the corresponding 
informant ratings. For all other measures, insufficient data were available to allow a comparison of 
different rating types. 
 
Studies included in the meta-analysis 
 
In studies of well-being and life satisfaction, there was no overlap in the factors for which 
associations were examined; each study examined associations with a different set of factors, with the 
exception of depression which was included in two separate studies of well-being. Consequently it 
was not possible to conduct meta-analyses of factors associated with well-being and life satisfaction, 
and meta-analyses were conducted only for studies examining QoL. Data from 37,639 people with 
dementia in 198 studies reported in 272 articles were included (seven studies were excluded due to 
lack of any data that met criteria for inclusion in the meta-analysis). These studies examined 
associations of QoL with 159 individual factors relating to the person with dementia and 69 factors 
relating to the carer. Data on 33 factors relating to the person with dementia and 10 factors relating to 
the carer were included in the meta-analysis (Supplementary Tables 13a-17).  
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Self-rated QoL 
 
Self-ratings of QoL by the person with dementia were examined in 130 studies reporting associations 
with 110 factors relating to the person with dementia and 34 factors relating to the carer, of which 28 
and 8 respectively were included in the meta-analysis, based on 129 studies (Figure 2 and 
Supplementary Tables 13a-b). 
 
(((Figure 2 near here))) 
 
Informant-rated QoL 
 
Informant ratings made by the carer were examined in 135 studies reporting associations with 114 
factors relating to the person with dementia and 56 factors relating to the carer, of which 26 and 10 
respectively were included in the meta-analysis, based on 130 studies (Figure 3 and Supplementary 
Tables 14a-b). 
 
(((Figure 3 near here))) 
 
Proxy-rated QoL 
 
Proxy ratings were examined in 27 studies reporting associations of 72 factors relating to the person 
with dementia and 23 factors relating to the carer, of which nine and one respectively were included 
in the meta-analysis, based on 22 studies (Figure 4 and Supplementary Tables 15a-b). 
 
(((Figure 4 near here))) 
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Difference between self- and informant-rated QoL 
 
Scores reflecting differences between self-rated and informant-rated QoL were examined in 23 
studies reporting associations with 30 factors relating to the person with dementia and 13 factors 
relating to the carer, of which 10 and three respectively were included in the meta-analysis, based on 
22 studies (Figure 4 and Supplementary Tables 16a-b). 
 
Comparing self-rated and informant-rated effect sizes 
 
For variables that were assessed in relation to more than one of the different rating methods of self-, 
informant and proxy ratings or discrepancies between self and informant ratings, the direction of 
association was consistent in all cases, although the strength of association varied. Supplementary 
Table 18a-b reports correlations between effect sizes where factors were examined in relation to both 
self-rated and informant-rated QoL. 
 
Factors associated with better QoL 
 
Greater social engagement, better quality of current relationship with the carer, and religious 
beliefs/spirituality were moderately associated with better QoL across rating types. Better functional 
ability, self-rated health and awareness, white ethnicity, having a spouse carer and living in the 
community, and for people in residential settings, being cared for in a specialist dementia unit and 
receiving more person-centred care had small or mainly small associations. Small or negligible 
associations were found for cognitive test scores, self-rated memory functioning and being married. 
The only carer factor with small or moderate associations with better QoL in the person with 
dementia was the carer’s self-rated QoL.  
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Factors associated with poorer QoL 
 
Depression and neuropsychiatric symptoms showed mainly moderate associations with poorer QoL 
across rating types. Greater severity of dementia, anxiety, pain, presence of unmet needs, presence of 
co-morbid conditions, and living alone showed mainly small associations. Use of medication, more 
advanced dementia, and longer duration of stay in residential care showed small or negligible 
associations. Carer burden/stress and distress at symptoms had moderate or small associations with 
poorer QoL, while small associations were found for carer depression, mental health and time spent 
caring.  
 
Factors not significantly associated with QoL 
 
Non-significant or negligible associations with QoL were found across rating types for age, gender or 
educational level of the person with dementia and carer, income of the person with dementia, type of 
dementia, and disease duration. 
 
Factors predicting longitudinal trajectories of QoL 
 
Baseline predictors of QoL outcomes were examined in 20 longitudinal studies reporting associations 
with 25 factors relating to the person with dementia and two factors relating to the carer, of which 
only eight factors pertaining to the person with dementia were included in the meta-analysis, based 
on 19 studies (Figure 4 and Supplementary Table 17). Follow-up ranged from two months to five 
years (mean 18.2 months). Non-significant or negligible associations were found for gender, age and 
more advanced dementia. Depression and neuropsychiatric symptoms in the person with dementia 
had small associations with worse QoL outcomes while better baseline QoL ratings, better functional 
ability and higher scores on cognitive screening tests had small associations with better QoL 
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outcomes. Where comparisons could be made the direction of associations was consistent with that 
found in cross-sectional studies. 
 
Heterogeneity and sub-group analyses 
 
There was a moderate to large degree of between-study heterogeneity for the majority of factors. 
Sub-group analyses investigated the effects of (a) dementia sub-type by separately analysing studies 
that focussed specifically on people diagnosed with Alzheimer’s disease and studies that did not 
focus specifically on people diagnosed with Alzheimer’s disease; (b) living situation of the person 
with dementia (community and residential care settings); (c)  type of carer completing the ratings of 
QoL (family member and health care professionals); and (d) type of QoL measure used (dementia-
specific, health-related, and generic). Distinguishing sub-groups in this way had little impact on 
overall effect sizes or degree of heterogeneity (Supplementary Tables 19a-23j).  
 
Moderator variables 
 
Meta-regressions for moderate effect sizes found no moderation effects of age or MMSE score 
(Supplementary Tables 24a-25d). Sensitivity analyses suggested that inserting 0 for non-significant p 
values and removing articles rated poor in quality had limited impact on the results (Supplementary 
Tables 26a-34).  
 
Discussion  
 
To our knowledge this is the first comprehensive systematic review exploring factors associated with 
QoL, well-being and life satisfaction in people with dementia, and the first meta-analysis of factors 
associated with QoL. We found few studies that have investigated well-being or life satisfaction, 
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possibly because the policy focus on these constructs is relatively recent; therefore, meta-analyses 
could only be conducted for studies assessing QoL. The majority of studies were cross-sectional, 
with considerable between-study heterogeneity. Although most factors examined were significantly 
related to QoL, with the direction of association consistent across rating types, no factors were 
strongly associated, and most associations were small or negligible. Where moderate associations 
were found, confidence intervals were typically wide. Demographic and disease characteristics were 
largely unrelated to QoL, while social, health- and care-related factors were more likely to show 
associations. Factors reflecting relationships, social engagement and functional ability were 
associated with better QoL, along with living in the community and having a spouse carer, or 
receiving specialised and person-centred care in residential settings. Factors indicative of poorer 
physical and mental health, such as co-morbid conditions, pain, depression, anxiety, neuropsychiatric 
symptoms, more advanced dementia and for people in residential settings a longer duration of stay, 
were associated with poorer QoL, as were carer burden and distress. The moderate associations of 
carer burden and distress with informant-rated QoL suggests that subjective burden could be 
contributing to lower scores reported in carer-rated as opposed to self-rated QoL. Due to the small 
number of factors and heterogeneous follow-up periods, longitudinal evidence about predictors of 
QoL was limited, with self-rated QoL at baseline the strongest predictor of later QoL outcomes. 
 
Our observation that demographic factors are largely unrelated to QoL is consistent with a previous 
narrative review of HRQoL (Banerjee et al., 2009). Aside from this, the overall picture is one of a 
large number of factors showing occasionally moderate but mainly small or negligible, though 
statistically significant, associations with QoL. A recent narrative review also reported a complex 
picture of associations across domains (Jing et al., 2016). Thus, QoL appears subject to many 
influences, some interrelated, which may co-vary in differing combinations to influence individual 
ratings.  
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In line with the current meta-analysis, the importance of positive relationships and health for QoL has 
been emphasised in a recent meta-synthesis of qualitative studies (O'Rourke et al., 2015a). However, 
that review also highlighted the domains of agency and place (feeling settled or unsettled), as key 
elements of the experience of people with dementia associated with QoL; these factors have not been 
reflected in quantitative evaluations to date. This serves as a reminder that potential associations 
examined in quantitative studies may not necessarily reflect all those aspects of life that people with 
dementia find most relevant. The finding here of poorer physical and mental health being related to 
QoL is consistent with the emphasis on depression, neuropsychiatric symptoms and functional ability 
in Lawton’s dementia-specific model of QoL (Lawton, 1994), and with evidence from qualitative 
research showing that people with dementia describe mood and functional ability as important for 
QoL (O'Rourke et al., 2015a). However, the relevance of other factors included in Lawton’s model, 
such as cognitive competencies, is less well supported by our findings. Our findings further indicate 
that, beyond the dimensions identified by Lawton, many other factors are associated with QoL, 
though to a lesser degree. 
 
Our review found that numerous measures were employed to assess QoL, although the QoL-AD 
(Logsdon et al., 2000) predominated. Several previous reviews have focused on measurement of QoL 
(Ready and Ott, 2003, Ettema et al., 2005, Bowling et al., 2015, Algar et al., 2016, Missotten et al., 
2016). The absence of a clear shared definition and theoretical model of QoL is reflected in the wide 
variation in focus and content among available measures. Analysis of domains covered in commonly-
used measures of dementia-specific QoL (Missotten et al., 2016), however, indicates that items 
explore some of the same factors for which associations with QoL are typically examined, 
particularly affect, but also social interaction, functional ability, neuropsychiatric symptoms, 
cognition and physical health. This raises concerns about circularity and overlap in measurement. 
Furthermore, it is unclear whether the quantitative assessment of QoL adequately reflects the 
perspective of people with dementia (O'Rourke et al., 2015b). While items in some measures are 
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based on data from qualitative interviews with people with dementia, many measures have been 
developed with little or no direct input from people with dementia (Bowling et al., 2015) and few 
large-scale studies have been conducted that enable people with dementia to say what is important for 
their QoL (Clare et al., 2014a). 
 
Because of the breadth of included studies, we decided to statistically analyse only factors for which 
there was data available from five or more studies. Focusing the review in this way allowed us to 
summarise current understanding and reduce reporting of associations for which there was limited 
evidence. However, this precluded quantitative analyses for life satisfaction and well-being, and 
limited the number of factors in the analysis of longitudinal studies. We necessarily examined factors 
separately, and could not account for likely inter-correlations. A number of studies did not provide 
exact data for non-significant findings, so a potential limitation resulted from inserting zero 
correlations from those studies; however, this had a minimal effect on associations or heterogeneity.  
Most of the studies that did not focus exclusively on those diagnosed with Alzheimer’s disease 
analysed responses from people with different dementia diagnoses as one group, which precluded 
separate analysis for different dementia sub-types. Methodologically, the widespread misuse of the 
term ‘proxy’ when researchers mean ‘informant’ created challenges for comparing findings between 
studies. For example, in DEMQOL-Proxy (Smith et al., 2005), instructions allow informants to make 
either proxy or informant ratings, so ratings from this instrument were difficult to classify correctly.  
Our review highlights the need for application of clear and consistent terminology and the 
standardisation of methods (e.g. standard follow-up periods and sample size calculations), and a 
robust conceptual and methodological framework to guide work in this area. 
 
The findings point to some limitations in how we understand and evaluate living well with dementia. 
Available measures may not capture what is most meaningful to each individual (Bowling et al., 
2015) or indeed everything that is relevant to living well. In this respect, broadening the perspective 
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to include subjective well-being and satisfaction with life may be informative; these constructs have 
rarely been assessed, and as yet evidence is limited (Clare et al., 2014a). The pattern we observed of 
numerous small associations generally supports the idea that QoL is multifaceted, as suggested by 
Lawton’s framework (1994). It might also reflect the operation of individual differences in what is 
deemed most important for QoL, so there may be value in considering more personalised approaches 
to assessment, particularly as no QoL measure includes all of the factors that our review suggests 
may be important to the QoL of people with dementia. However, developing and implementing 
personalised approaches would present significant challenges.  
 
The findings raise questions about the use of QoL as an outcome measure in psychosocial 
intervention trials. First, if QoL is subject to many influences, changes in one area of life may have 
little effect on the overall picture, so it may not be reasonable to expect interventions that are 
effective in improving some primary outcomes to influence scores on QoL measures. Second, as 
noted above, potential circularity in measurement may create a distorted picture. Therefore, the 
relevance of QoL measures for assessing effectiveness of interventions may need re-evaluation. 
 
Conclusion 
 
Our findings suggest that efforts to improve QoL might focus on supporting relationships, social 
engagement and everyday functioning, addressing poor physical and mental health, and ensuring 
high-quality care. However, there is a need for longitudinal evidence that can point to ways of 
maintaining or improving QoL over time and enable identification of people at risk of declining QoL, 
so that preventive interventions can be targeted to this group.  
 
 
  
20 
 
Conflicts of interest: none. 
 
Acknowledgements 
We wish to thank Dr Gill Toms for help with article screening and measure classification, Dr 
Alexandra Hillman, Isobel Evans, and Hannah Scott for help with data quality evaluation, Dr Edward 
Miller, Dr Daniel Murman, and Professor Jean-Luc Novella for providing data for the review, and 
members of the IDEAL project advisory group and ALWAYS involvement group for helpful 
comments on previous drafts. The support of the ESRC and NIHR is gratefully acknowledged. 
 
Author contributions.  
AM: Developing and piloting search strategy; conducting searches; title screening; abstract 
screening; full-text screening; data extraction; assessment of study quality; planning and conducting 
analyses; interpretation of results; drafting review text. 
LC: Developing concept for review; drafting protocol; title screening; abstract screening; full-text 
screening; assessment of study quality; planning analyses; interpretation of results; drafting review 
text.  
RC & RL: Title screening; abstract screening; full-text screening; data extraction; assessment of 
study quality; interpretation of results; commenting on and approving text of review.  
CH, JH, IRJ, RM, SMN, CQ, JR, JT, CRV, YTW: Abstract screening; interpretation of results; 
commenting on and approving text of review 
 21 
 
Figure 2: Forest plot for factors associated with the quality of life self-ratings made by people with dementia  
 
Note: negative scores indicate that factors were related to poorer QoL, and positive scores indicate that factors were related to better QoL 
 
 
Figure 3: Forest plot for factors associated with informant ratings of the quality of life of the person with dementia  
 
Note: negative scores indicate that factors were related to poorer QoL, and positive scores indicate that factors were related to better QoL 
 
 
Figure 4: Forest plots for factors associated with proxy ratings of quality of life, the difference between self- and informant ratings of quality of life, and 
baseline factors associated with longitudinal studies of quality of life 
 
Note: negative scores indicate that factors were related to poorer QoL, and positive scores indicate that factors were related to better QoL. Longitudinal 
studies included both self- and informant ratings of QoL. 
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Figure 1. Flow diagram showing process of study selection 
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Additional records identified through other 
sources 
(n = 28) 
Records after duplicates removed  
(n = 10530) 
Records excluded after title and 
abstract screening  
(n = 10064) 
Full-text articles excluded (n = 159) 
Articles comparing two or more QoL 
measures only (n = 4) 
Intervention study (n = 13) 
Less than 75% participants with 
dementia (n = 54) 
Reviews (n = 15) 
No QoL measure (n = 6) 
No useable data (n = 49) 
Only qualitative data (n = 7) 
No participants with dementia (n = 4) 
Commentaries (n = 4) 
Theoretical articles (n = 3) 
Studies included in quantitative 
synthesis (meta-analysis)  
(n = 199) (reported in 271 
articles) 
Records identified through database 
searching  
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<.0001
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Supplementary Table 1: Articles excluded at the full-text screening stage 
 
Article only investigated comparisons 
between different QoL measures (Number 
of studies=4) 
Crespo et al. (2012); Inouye et al. (2009); Kolanowski et al. 
(2007); Mador et al. (2002) 
Article was an intervention study (Number 
of studies=13) 
Albert (2004); Birks and Cochrane Neurological Network 
(2005); Caramelli et al. (2014); Charras and Gzil (2013); 
Gitlin et al. (2010); Jo and Song (2015); Kwok et al. (2012); 
Larsson et al. (2011); Lee et al. (2008); Meguro et al. (2008); 
Mowrey et al. (2013); te Boekhorst et al. (2013); Yokota et al. 
(2006) 
People with dementia constituted less than 
75% of the sample (Number of studies=54) 
Abrahamson et al. (2012); Abrahamson et al. (2013); Afzal et 
al. (2010); Almomani et al. (2014); Baró et al. (2006); Berwig 
et al. (2009); Bilotta et al. (2012); Bishop et al. (2008); Byrne 
and MacLean (1997); Calero and Navarro (2011); Chaput 
(2000); Charles et al. (2015); Chekani et al. (2016); Comijs et 
al. (2005); Custers et al. (2013); Degenholtz et al. (2008); 
Ding et al. (2009); Fernández-Mayoralas et al. (2015); 
Goodrow et al. (1979); Jetten et al. (2010); Kane et al. (2003); 
Lalic et al. (2016); Lee et al. (2015a); Leroi et al. (2012); Li et 
al. (2013a); Llácer et al. (2002); Lucas-Carrasco and March 
(2010); Luzny and Ivanova (2009); Martín-García et al. 
(2013); Morgan et al. (1987); Moyle et al. (2012); Murphy et 
al. (2009); Müther et al. (2010); Oliva-Moreno et al. (2010); 
Olsson et al. (2013); Oudman and Zwart (2012); Parsaik et al. 
(2012); Patterson et al. (2006); Ready et al. (2002a); Ready et 
al. (2006); Ready and Ott (2007); Richter et al. (2008); Richter 
et al. (2004); Schwartz et al. (2011); Scocco et al. (2006);  
Shippee et al. (2015a); Shippee et al. (2015b); Shippee et al. 
(2016); St. John and Montgomery (2010); Suwalska et al. 
(2002); Terada et al. (2015); Tommis et al. (2007); Waldemar 
et al. (2004a, 2004b)  
Review articles (Number of studies=15) Homma (2003); Kasai and Meguro (2013); Korczyn and 
Davidson (1999); Logsdon et al. (2007); Lund et al. (2005); 
Mills Jr and Glendenning (2014); Russell (1996); Sefton et al. 
(2008); Selai and Trimble (1998); Selai et al. (2001b); Teri 
and Logsdon (1991); Torrington (2006); Whitehouse and 
Rabins (1992); Whitehouse (1999); Whitehouse et al. (2003) 
The article did not include a measure of 
QoL (Number of studies=6) 
Carvalho-Bos et al. (2007); Cicciu et al. (2013); Cipher and 
Clifford (2004); Hickey and Bourgeois (2000); Trudeau et al. 
(2003); Wimo et al. (1990) 
The article did not include any data that 
could be converted to a correlation 
(Number of studies=49) 
Arons et al. (2012); Asakawa et al. (2008); Bureau-Chalot et 
al. (2002); DeJong et al. (1989); Dello Russo et al. (2008); 
Dichter et al. (2015); Elliott et al. (2009); Engel et al. (2006a, 
2006b); Forstmeier et al. (2013); Gómez-Gallego et al. (2014); 
González-Vélez et al. (2015); Gross et al. (2015); Hassani 
Mehraban et al. (2014); Hewitt et al. (2013); Holst and Edberg 
(2011); Hongisto et al. (2015); Hurley et al. (1992); Inouye et 
al. (2010a); Inouye et al. (2010b); Jensen-Dahm et al. (2012); 
Karlawish et al. (2004c); Koopmans et al. (2009); Kuhn et al. 
(2002); Kurz et al. (2003); Lem (2015); Leon et al. (2000); 
Livingston et al. (2006); López-Bastida et al. (2006); Martin-
Cook et al. (2005); Matano (2000); Miller et al. (2010b); 
Missotten et al. (2009); Naglie et al. (2012); Navarro-Gil et al. 
(2014); Neumann et al. (1999); Peitsch et al. (2015); Roberts 
(2007); Sano et al. (1999); Senanarong et al. (2008); Smit et 
al. (2014); University Of Kent Personal Social Services 
Research Unit (2015a, 2015b); Villar et al. (2015); Ward and 
Ashaye (2008); Wettstein et al. (2014); Willemse et al. (2015); 
Yeardley et al. (1995); Zbrozek et al. (2004) 
2 
 
The article included only qualitative 
analyses (Number of studies=7) 
Cahill et al. (2004); du Toit and Surr (2011); Fukushima et al. 
(2005); Innes and Surr (2001); Katsuno (2005); Morioka et al. 
(2005); Steultjens and van’t Leven (2008) 
The sample did not include any participants 
with dementia (Number of studies=4) 
Allerhand et al. (2014); Cuijpers et al. (1999); Hodgson and 
Cutler (1997); Papastavrou et al. (2012) 
The article was a commentary on other 
studies (Number of studies=4) 
Ballard (2009); Banerjee (2007); Forbes (2004); Hess (2009) 
The article was a theoretical paper 
(Number of studies=3) 
Jonker et al. (2004); Lawton (1994); Lawton (1997) 
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Supplementary Table 2: Data quality proforma 
 
The checklist has been designed to act as a traffic light system: 
• If you think that the criteria are met fully this will be graded as green and given a score of 3. 
• If you think that the criteria are partly met or if you can’t tell from the information provided this will be 
graded as amber and given a score of 2. 
• If you think that the criteria are not met this will be graded as red and given a score of 1. 
 
Checklist items: 
 
1) Is there a clear description of the research question? 
 Green: The hypotheses/aim(s) or research question(s) of the study were well described and clear. 
 Amber: The hypotheses/aim(s) or research question(s) of the study were adequately described or 
slightly unclear clear. 
 Red: The hypotheses/aim(s) or research question(s) of the study were poorly described, unclear or non-
existent. 
 
2) Is there a clear description of the inclusion and exclusion criteria? 
 Green: The inclusion/exclusion criteria of the study were well described and clear. 
 Amber: The inclusion/exclusion criteria of the study were adequately described or slightly unclear. 
 Red: The inclusion/exclusion criteria of the study were poorly described, unclear or non-existent. 
 
3) Is there an appropriate description of the sampling method and source of recruitment? 
 Green: The sampling method and source of recruitment of the study were well described and clear (e.g. 
participants were ‘recruited from memory clinics’ or were ‘community-dwelling’). 
 Amber: The sampling method and source of recruitment of the study were adequately described or 
slightly unclear clear. 
 Red: The sampling method and source of recruitment of the study was poorly described, unclear or 
non-existent (i.e. there was no description of how or where participants were recruited). 
 
4a) Was there an appropriate description of the participants’ age and sex? 
 Green: The mean age or age stratification was provided and the number of fe/males was provided. 
 Amber: Either the mean age or age stratification or the number of fe/males was provided. 
 Red: Neither the mean age or age stratification nor the number of fe/males was provided.  
 
4b) Was there an appropriate description of the participants’ diagnoses? 
 Green: The diagnosis was provided for all participants. Analysis included only people diagnosed with 
dementia. 
 Amber: Diagnostic information was provided but analysis included people without dementia, including 
those diagnosed with MCI. 
 Red: There was a vague description of the sample (i.e. "dementia" without specific diagnostic 
categories).  
 
4c) Was there an appropriate description of the participants’ dementia severity and details of the MMSE score or 
equivalent? 
 Green: Both a description of dementia severity (mild, moderate, severe) and MMSE (or equivalent, e.g. 
CDR score or MoCA, 3MS, DRS etc.) was provided. 
 Amber: Either a description of dementia severity (mild, moderate, severe) or MMSE (or equivalent, 
e.g. CDR score or MoCA, 3MS, DRS etc.) was provided. 
 Red: Neither a description of dementia severity (mild, moderate, severe) nor MMSE (or equivalent, e.g. 
CDR score or MoCA, 3MS, DRS etc.) was provided. 
 
5) Is the sample size large enough to test the hypothesis objectively? Was an a priori power calculation reported 
in the paper? 
 Green: There was an a priori power calculation reported irrespective of sample size. 
 Amber: The sample was larger than 30 but there was no a priori power calculation reported. 
 Red: The sample was less than 30 and there was no a priori power calculation reported. 
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6) Did the study use standardised measures (or if new measures were used had they undergone reliability and 
validity testing)? 
 Green: The study used standardised measures (or if new measures were used they had undergone 
reliability and validity testing). 
 Amber: The study used some standardised measures (or if new measures were used they had not 
undergone reliability and validity testing). 
 Red: The study used no standardised measures (or if new measures were used they had not undergone 
reliability and validity testing). 
 
7) Was appropriate statistical testing employed (i.e. suitable covariates used, repeated measures in longitudinal 
studies)? (See Table e1 for appropriate statistical tests) 
 Green: The study used appropriate statistical tests (see extra guidance below for what would be 
considered appropriate statistical tests for cross-sectional and longitudinal studies). 
 Amber: The study used some appropriate statistical tests. 
 Red: The study used inappropriate statistical tests. 
 
Table e1. Appropriate statistical tests for cross-sectional and longitudinal studies 
 
Study questions Statistical analysis 
(1) Cross-sectional study 
(1.1) Compare difference in QoL between 2/3 groups t test 
ANOVA 
Univariable regression 
Multivariable regression 
Non-parametric analysis 
(1.2) Relationship between QoL and other continuous variables Correlation 
Univariable regression 
Multivariable regression 
Non-parametric analysis 
(1.3) QoL (Binary measure) and categorical variables Logistic regression (binary outcome) 
Chi-square test 
Non-parametric analysis 
(2) Longitudinal study  
(2.1) Change in QoL across different groups  ANCOVA 
Univariable regression 
Multivariable regression 
Non-parametric analysis 
(2.2) Adjusting for correlation of repeated measures (QoL)  Multilevel modelling 
Generalised estimating equation 
Time series analysis 
(2.3) Mediator/effect Modifier Structural Equation Modelling (SEM) 
 
8) If multicentre data were used, did the researchers compare the results from multiple sources (e.g. multiple 
centres) before pooling the data for final analysis? 
 Green: The multicentre study had compared the results from different centres and had taken this into 
consideration in the analysis. 
 Amber: The multicentre study had compared the results from different centres but had not taken this 
into consideration in the analysis. 
 Red: The multicentre study did not report a comparison of the results from different centres. 
  
9) Longitudinal studies only: have the characteristics of participants lost to follow-up been described? 
 Green: The characteristics of participants lost to follow-up were well described or there were no 
participants lost to follow-up. 
 Amber: The characteristics of participants lost to follow-up were adequately described or the number 
of participants lost to follow-up was so small that the findings would not have been affected by their 
inclusion. 
 Red: The characteristics of participants lost to follow-up were poorly described or not mentioned at all. 
 
10) Were any conflicts of interest declared that could have biased the findings of the study? 
 Green: Conflicts of interest were declared but could not have biased the findings of the study. 
 Amber: There was no statement concerning conflict(s) of interest in the paper. 
 Red: Conflicts of interest were declared and could have biased the findings of the study (e.g. authors 
receive royalties from measures used is the study). 
Q8 and Q9 were not included in the data quality scoring as these did not apply to the majority of studies.
 5 
 
Supplementary Table 3. Studies utilising self-ratings of quality of life by people with dementia 
 
Study Country of 
study 
n Females Mean age Severity 
 
Dementia type Living situation QoL measure Factors included in the 
meta-analysis 
Quality 
rating 
Allan et al. (2006) UK 198 84 76 (6.2)  CAMCOG 67.8 
(13.76)  
AD 40, PDD 46, DLB 
32, VaD 38, Controls 42 
Not specified SF-36 Co-morbidity Good 
Andersen et al. 
(2004) 
Denmark 211 122 78.1 (5.47) 21.0 (4.75) Mostly AD Mostly community EQ-5D Age, ADL, Gender, 
Diagnosis, Living alone, 
CSM 
Good 
Andrieu et al. 
(2016) 
France 534 331 79.6 (5.9) 19.5 (3.9) AD Community QoL-AD Age, Anxiety, ADL, NPS, 
Depression, Gender, 
Education, Co-morbidity, 
Diet, Relationship, Living 
alone, CSM, Medication, 
Duration, Burden, Age C, 
Gender C 
Good 
Arlt et al. (2008) Germany 100 54 70.49 (8.49) 22.74 (4.37) AD (58%), Mixed and 
MCI (11%), bvFTD 
(9%), VaD (7%), 
Semantic dementia 
(1%) 
Community 98, Nursing 
home 2 
WHO-8 Depression, GDS, CSM Good 
Azcurra (2012) Argentina 44 30 85.3 (5.6) 13.2 (1.2) AD Long-term care 
residents (intervention) 
SRQLS Anxiety, ADL, Depression, 
Education, Religion, Co-
morbidity, Care home stay, 
CSM, Social engagement, 
Medication, Burden 
Good 
44 27 86.4 (4.9) 14.1 (1.4) AD Long-term care 
residents (active control) 
44 29 85.8 (5.1) 14.6 (1.4) AD Long-term care 
residents (passive 
control) 
Bakker et al. 
(2014) 
Netherlands 215 102 61.1 (5.4) Not specified AD 117, bvFTD 27, 
PPA 13, VaD 24, Mixed 
8, Other 16 
Community QoL-AD Age, NPS, Depression, 
Gender, Unmet needs, GDS 
Good 
Beer et al. (2010) Australia 226 not 
specified 
85.3 (7.9) 14 (median) Dementia  Residential care 
facilities 
QoL-AD Age, NPS, Gender, Diet, 
Pain, CSM, Medication, 
Distress 
Satisfactory 
Beerens et al. 
(2014) 
England, 
Estonia, 
Finland, 
France, 
Germany, 
Netherlands, 
Spain, 
Sweden 
791 74% 84.1 (6.4) 11.9 (6.3) Dementia  Long-term care 
residents 
QoL-AD Depression, Pain, Medication Satisfactory  
1123 63% 82.2 (6.6) 14.3 (6.6) Dementia  Home care 
Giebel et al. 
(2015a) 
122 71.30% 83 (6.5) 13.37 (2.27)  AD 44, VaD 39, mixed 
8, FTD 2, DLB 5 
Community 63, Nursing 
home 59 
QoL-AD Age, ADL, NPS, Diagnosis, 
CSM 
Good 
Giebel et al. 
(2015b) 
126 71.30% 82 (6.8) 4.9 (3.1) AD 44, VaD 39, mixed 
8, FTD 2, DLB 5 
Community 214,  
Nursing home 197 
QoL-AD None Good 
Giebel et al. 
(2016b) 
957 596 82.3 (6.5) 14.5 (6.6) AD 514, VaD 153, 
Mixed 53, Other 227 
Community (home care) QoL-AD None Good 
581 423 84.3 (6.1) 12.1 (6.2) AD 248, VaD 127, 
Mixed 35, Other 171 
Nursing home (long 
term care) 
QoL-AD None 
Berwig et al. 
(2011) 
Germany 16 8 78.5 (4.5) 20.3 (2.7) AD Community DEMQOL Depression Good 
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Bhattacharya et 
al. (2010) 
Denmark 321 54.80% 76.2 (7.1) 24.0 (2.6) AD (72.4%), Mixed 
(24.8%) 
Community EQ-5D 
EQ-5D VAS 
QoL-AD 
ADL, NPS, Depression, 
CSM 
Satisfactory 
Black et al. 
(2012) 
US 220 65% 83.6 (5.9) 17.8 (7.6) Dementia  Community QoL-AD Age, ADL, NPS, Depression, 
Gender, Education, Co-
morbidity, Ethnicity, CSM, 
Medication, Distress 
Good 
Black et al. 
(2013) 
254 65% 83.6 (5.9) 17.8 (7.6) 265 AD, 38 MCI Community QoL-AD Unmet needs Good 
Bosboom et al. 
(2012a) 
Australia 226 169 85.9 (7.7) 15.9 (5.9) Dementia  Residential aged care 
facilities 
QoL-AD Medication Satisfactory 
Bosboom et al. 
(2012b) 
Australia 80 67.50% 78.3 (7.9) Not specified AD Community QoL-AD Age, Anxiety, Awareness, 
ADL, NPS, Depression, 
Gender, Education, Living 
alone, Medication, Being 
married, Memory rating, 
Distress, Age C, Gender C 
Good 
Bosboom and 
Almeida (2014) 
47 72.30% 78.7 (8.2) 15.1 (5.6) AD Community QoL-AD CSM Good 
Bosboom et al. 
(2013) 
47 72.30% 78.7 (8.2) 15.1 (5.6) AD Community QoL-AD None  Satisfactory 
Bosboom and 
Almeida (2016) 
80 67.50% 78.3 (7.9) Not specified AD Community QoL-AD None  Good 
Brod et al. (1999) US 95 59% 78.7 (7.43) Mild 45, 
Moderate 50 
Dementia  Community  89, Health 
care facility 6 
DQoL Depression, CSM Good 
Bruvik et al. 
(2012) 
Norway 230 123 78.4 (7.5) 21.3 (3.6) Dementia  Community QoL-AD Age, ADL, NPS, Depression, 
Gender, Education, CSM, 
Duration, Being married 
Good 
Buckley et al. 
(2012) 
US 71 151 85.60 (5.77) 19.78 (7.25) AD 181, remainder not 
specified 
Not specified Single global 
QoL question 
(rated self as 
excellent) 
ADL, NPS, Health, Gender, 
Education, GDS, CSM, 
Duration 
Good 
123 Single global 
QoL question 
(rated self as 
good) 
Buffum et al. 
(2001) 
US 33 1 78.5 (7.2) 14 (9.6; n = 19) Dementia  Nursing home Discomfort 
Scale 
NPS, GDS, Pain, CSM Good 
Burgener et al. 
(2015) 
US 31 26 78.3 (8.3) 20.4 (6.1) Dementia  Community SF-36 Education, CSM, Social 
engagement 
Satisfactory 
Caddell and Clare 
(2012) 
Wales 50 26 77.8 (7.4) 23.7 (2.7) AD 38, VaD 9, Mixed 3 Community QoL-AD Memory rating, Social 
engagement 
Good 
Camic et al. 
(2013) 
England 10 5 75 (6.7) 19 (7.9) AD 6, VaD 2, Mixed 1, 
MCI 1 
Community DEMQOL NPS Satisfactory 
Campbell et al. 
(2008) 
US 149 93 78.7 (8.5) 19.8 (6.2) AD 101, VaD 15, FTD 
1, Mixed 7, Other 22, 
10 Unreported 
Not specified Single question - 
How would you 
rate your general 
health? 
Awareness, Ethnicity Good 
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Castro-Monteiro 
et al. (2016) 
Spain 208 82.67% 85.57 (6.73) 13.24 (8.07) Non-specific dementia 
(49.7%), AD (36.4%), 
VaD (6.5%), Mixed 
(4.4%), Alcohol-related 
dementia (1.1%), DLB 
(1.1%), PDD (.8%) 
14 Residential care 
facilities 
QoL-AD Age, ADL, Depression, 
Gender, Co-morbidity, GDS, 
CSM, Social engagement 
Good 
Chan et al. (2011) Hong Kong 111 80 77.7 (7.4) 15.8 (4.7) AD Community QoL-AD Age, Depression, Gender, 
Education, Co-morbidity, 
Income, Living alone, CSM, 
Being married 
Good 
Chiu et al. (2008) Taiwan 71 61.20% 75.23 (8.03) 17.61 (3.78) AD Not specified DQoL Age, ADL, NPS, Depression, 
Education, CSM, Depression 
C 
Satisfactory 
Cines et al. (2015) US 104 68 77.55 (8.03) 24.19 (2.64) AD Not specified QoL-AD Age, Awareness, Gender, 
Education, Ethnicity 
Good 
Conde-Sala et al. 
(2009) 
Spain 236 157 77.8 (6.9) Mild 76, 
Moderate 154, 
Severe 6 
Dementia  Community  QoL-AD Anxiety, ADL, NPS, 
Education, Living alone, 
CSM, Being married, QoL C, 
Burden 
Good 
Conde-Sala et al. 
(2010) 
251 166 77.4 18.05 Dementia  Community QoL-AD Age, Depression, Gender, 
Relationship, Education C, 
Gender C 
Satisfactory 
Conde-Sala et al. 
(2014b) 
119 76 77.0 (6.7) 18.9 (3.6) Dementia  Community QoL-AD Depression, Awareness Good 
Conde-Sala et al. 
(2013a) 
Spain 164 98 77.6 (7.2) 17.9 (5.8) AD Not specified QoL-AD ADL, CSM Good 
Conde-Sala et al. 
(2014a) 
141 83 77.6 (7.2) 17.6 (5.9) AD Not specified QoL-AD Depression, Burden, Gender 
C 
Good 
Conde-Sala et al. 
(2016) 
221 140 77.8 (0.4) 18.3 (0.3) AD Not specified QoL-AD Awareness, NPS, GDS Good 
Crespo et al. 
(2013) 
Spain 102 79.40% 86.07 (6.46) 13.3 (5.88) Dementia  Nursing home QoL-AD Age, ADL, NPS, Depression, 
Gender, Diet, GDS, CSM, 
Medication, Care home stay 
Good 
Dawson et al. 
(2013) 
US 131 55.70% 77.15 (9.45) 22.48 (5.84) AD 50%, Mixed .8%, 
MCI 5.9%, VaD 5.1%, 
Other 24.6%, other 
memory diagnosis 
13.6% 
Community  QoL-AD Anxiety, ADL, NPS, 
Depression, Gender, 
Education, Ethnicity, 
Relationship, CSM 
Satisfactory 
Dourado et al. 
(2014) 
Brazil 201 130 75.6 (7.3) 20.3 (3.8) AD Not specified QoL-AD Awareness Good 
Dourado et al. 
(2016) 
69 72% 76.8 (7.3) 21.4 (3.5) AD Not specified QoL-AD Age, ADL, NPS, Depression, 
Gender, Education, CSM, 
Duration, Burden, Education 
C, Age C, Gender C 
Good 
Nogueira et al. 
(2015) 
54 18 73.1 (6.3) 20.4 (4.15)  AD Community QoL-AD QoL C Good 
de Sousa et al. 
(2013) 
41 28 77.3 (7.8) 21.0 (3.93) AD Community  QoL-AD None Good 
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de Sousa et al. 
(2015) 
69 72 76.8 (7.3) 21.4 (3.5) AD Not specified QoL-AD None Satisfactory 
Duhig et al. 
(2012) 
France, Italy, 
Spain, UK, 
US 
379 Not 
specified 
Not specified Not specified AD Not specified EQ-5D Age, ADL, NPS, Memory 
rating 
Poor  
Edelman et al. 
(2004a) 
US 36 58.30% 80.5 (5.8) 16.7 (4.5) Dementia  Adult day centres DQoL 
QoL-AD 
None Satisfactory 
Edelman et al. 
(2005) 
27 80.00% 85.3 (5.4) 16.5 (3.5) Dementia  Assisted living facility QoL-AD 
DQoL 
ADL, Depression, Co-
morbidity, CSM 
Satisfactory 
38 85.50% 86.0 (6.8) 15.1 (4.0) Dementia  Special care facilities QoL-AD 
DQoL 
Ettema et al. 
(2007b) 
Netherlands 67 49 84.59 (6.04) GDS 5.28 (.79) Dementia  Nursing home COOP/WONCA ADL, NPS, Depression, Co-
morbidity, Social 
engagement 
Good  
Fleming et al. 
(2016) 
Australia 275 211 84.33 (8.66) GDS2 10, 
GDS3 45, 
GDS4 55, 
GDS5 67, 
GDS6 98 
Controls 51, Dementia 
75, AD 1, DLB 1, FTD 
1, Huntingtons 11, 
Korsakoffs 5, PDD 29, 
VaD 13, Mixed 86, 
unspecified 2 
Nursing home DEMQOL Age, ADL, Gender, Co-
morbidity, Diagnosis, 
Ethnicity, GDS, Care home 
stay, Medication, Being 
married, Memory rating 
Satisfactory 
Fonseca et al. 
(2015) 
Brazil 28 19 77.1 (5.6) 15.8 (3.9) AD Community QoL-AD Age, ADL, NPS, Depression, 
Education, CSM 
Satisfactory 
Fuh and Wang 
(2006) 
Taiwan 81 49 77.2 (6.8) 20.1 (4.5) AD Not specified QoL-AD Age, ADL, NPS, Depression, 
Education, Co-morbidity, 
CSM, Distress 
Satisfactory 
Gallrach (2010) New Zealand 53 22 77.7 CDR.5 19, 
CDR1 25, 
CDR2 8, CDR3 
1 
AD 31, VaD 14, Mixed 
8 
Community  QoL-AD ADL, NPS, Depression, Co-
morbidity, Diagnosis, GDS, 
CSM, QoL C, Burden, 
Distress 
Good  
Gerritsen et al. 
(2005) 
Netherlands 92 79% 79.4 18.4 (6.6) Dementia  Nursing home Single question - 
Overall, how 
would you rate 
the quality of 
your life at the 
moment? 
NPS, CSM Satisfactory 
Gerritsen et al. 
(2007) 
43  78% 80.5 (9.26) 11.8 (9.26) Dementia  Nursing home (low 
cognition group only) 
Single question - 
Overall, how 
would you rate 
the quality of 
your life at the 
moment? 
Depression Satisfactory 
Geschke et al. 
(2013) 
Germany  60 38 78.7 (6.4) 20.2 (6.0) AD 46, VaD 6, 
Unspecified dementia 8 
Community  QoL-AD 
SF-36 
Depression, Co-morbidity, 
CSM 
Poor 
Gitlin et al. 
(2014) 
US 88 46 81.7 (8) 17.7 (4.6) Dementia  Community  QoL-AD NPS, Co-morbidity, Unmet 
needs, Pain, CSM, 
Depression C 
Satisfactory 
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Gómez-Gallego et 
al. (2012a) 
Spain 102 70 78.09 (7.02) Mild 38, 
Moderate 56, 
Severe 8 
AD Community QoL-AD Anxiety, ADL, NPS, 
Depression, CSM, 
Medication, Burden, Distress 
Good 
Gómez-Gallego et 
al. (2012b) 
102 70 78.09 (7.02) 18.51 (5.99) AD Community  QoL-AD Gender, Education, 
Relationship, Being married, 
Gender C 
Good 
Gómez-Gallego et 
al. (2017) 
192 118 75.8 (6.14) 20.41 (3.7) AD Community QoL-AD ADL Good 
Gómez-Gallego et 
al. (2015) 
Spain 81 68.60% 72.09 (6.39) 18.51 (4.29) AD Community  DEMQOL Depression, Co-morbidity, 
Pain, CSM 
Good 
Gräske et al. 
(2012) 
Germany 49 76 79 (9.5) 11.5 (9.6) Dementia (83.7%) Community living in 
shared housing 
QoL-AD Age, ADL, NPS, Gender, 
Care home stay, CSM 
Satisfactory 
Harvey et al. 
(2005) 
US 183 51.90% 78.8 Not specified AD 171, DLB 5, VaD 7 Community  QoL-AD ADL, GDS Good 
Heggie et al. 
(2012) 
Canada 102 75 74.4 (9.5) 3MS 70.6 
(18.7) 
Dementia  Community (rural and 
remote settings) 
QoL-AD Age, ADL, NPS, Depression, 
Education, GDS, CSM, 
Burden 
Good 
Hoe et al. (2005) England 37 58 80.0 (8.8) 7.0 (3.2) AD Nursing home QoL-AD Age, Education Good 
Hoe et al. (2007) 191 160 81 14.7 (8.3) AD Lived alone 51, Lived 
with others 91, Lived in 
care home 82 
QoL-AD Anxiety, ADL, NPS, 
Depression, CSM, 
Medication 
Satisfactory 
Livingston et al. 
(2008) 
195 160 81.1 (7.5) 16.7 (6.9) AD Not specified QoL-AD life as 
whole item 
Health, GDS Good 
Hoe et al. (2006) England, 
Wales 
119 192 86.5 (7.4) 8.7 (7.8) Dementia  Nursing home QoL-AD Anxiety, ADL, NPS, 
Depression, Unmet needs, 
GDS, CSM 
Satisfactory 
Huang et al. 
(2009) 
Taiwan 120 58 78.40 (9.13) 18.64 (6.23) AD Community QoL-AD NPS, Relationship quality, 
Co-morbidity, GDS, CSM, 
QoL C 
Satisfactory 
Huang et al. 
(2015) 
Taiwan 106 64 80.29 (7.86) 15.39 (5.22) Dementia  Community 58, Nursing 
home 48  
QoL-AD Age, Depression, Gender, 
Education, Relationship 
quality, Relationship, GDS, 
CSM, Being married, 
Depression C, Education C, 
Age C, Gender C 
Good 
Hurt et al. (2008) France, 
England, 
Greece 
46  Not 
specified 
78 20.80 (5.4) Dementia  Community QoL-AD Age, Anxiety, NPS, 
Depression, CSM, Duration 
Good 
Hurt et al. (2010) England, 
Finland, 
France, 
Greece, Italy, 
Poland 
174 107 77.2 (6.5) 20.6 (4.9) AD Not specified DEMQOL Age, Awareness, ADL, NPS, 
Depression, Education, CSM, 
Duration, Being married 
Good 
James et al. 
(2005) 
US 181 113 76.7 (8.3) 17.0 (7.1) AD Community  Single question - 
How would you 
rate your overall 
quality of life at 
present? 
Age, Depression, Gender, 
Education, Ethnicity, GDS, 
CSM, Being married 
Satisfactory 
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Karlawish et al. 
(2001a) 
91 Not 
specified 
Not specified Not specified Not specified Community Single question - 
How would you 
rate the overall 
quality of your 
relative’s life at 
present? 
None Satisfactory 
Johnson et al. 
(2014) 
US 104 70.20% 77.8 (9.8) 23.4 (4.24) Dementia or MMSE 
<26 
Not specified QoL-AD CSM Satisfactory 
Jones et al. (2015) England 150 53.80% 79.7 (8.5) 14.6 (6.8) AD Community 86%, 
Residential home 14% 
EQ-5D 
DEMQOL 
BASQID 
ADL, NPS, CSM Good 
Trigg et al. 
(2012a, 2012b) 
166 53.80% 79.7 (8.5) 14.6 (6.8) AD Community 86%, 
Residential home 14% 
BASQID 
EQ-5D 
DEMQOL 
ADL Good 
Trigg et al. (2015) 70 39 78.19 (8.48) 19.40 (4.67) AD Community  EQ-5D 
DEMQOL 
None Good 
Jönsson et al. 
(2006) 
Sweden, 
Denmark, 
Finland, 
Norway 
208 62.30% 75.9 19.2 AD Community  QoL-AD 
EQ-5D VAS 
EQ-5D 
CSM Good 
Kamchatnov et al. 
(2002) 
Russia 56 Not 
specified 
50-59 Mild VaD Not specified SF-36 Anxiety, Depression, CSM Poor 
Karim et al. 
(2008) 
England 36 18 78 Mild 6, 
Moderate 30 
Dementia  Not specified DQoL Health, CSM Satisfactory 
Karlawish et al. 
(2004b) 
US 68 Not 
specified 
Not specified 20.3 (4.5) AD Not specified EQ-5D 
DDI 
HUI2 
SF-12 
Awareness, ADL, 
Depression, CSM 
Poor 
Karlawish et al. 
(2008a) 
93 51 76.8 (2.7) 21.3 (4.3) AD Community  EQ-5D 
HUI2 
Awareness, ADL, 
Depression, Ethnicity, CSM 
Good 
Zbrozek et al. 
(2006) 
110 Not 
specified 
Not specified Not specified AD Community HUI2 ADL, Depression, CSM Satisfactory 
Karttunen et al. 
(2011) 
Finland 228 51.30% 75.1 (6.6) 21.5 (3.4) AD Community QoL-AD 
15D 
Age, ADL, NPS, Gender, 
Education, Income, CSM, 
Medication, Being married, 
Depression C 
Good 
Kasper et al. 
(2009) 
US 146 ≥80% 60% ≥80 75.9% >18 AD Community ADRQL ADL, Co-morbidity, 
Relationship, Living alone, 
CSM, Duration, QoL C, 
Education C, Age C, Gender 
C 
Satisfactory 
Katsuno (2003) Japan 22 18 79.0 (6.2) 20.8 (2.8) AD 18, VaD 3, 
unspecified 1 
Community 20, Assisted 
living 2 
QLI Religion Satisfactory 
Kaufman et al. 
(2007) 
Canada 70 69% 78.43 (8.64) 23.66 (3.86) AD Not specified QoL-AD 
EQ-5D VAS 
Age, Gender, Education, 
Religion, CSM 
Good 
Knorr et al. 
(2007) 
Germany 179 61% 79 Not specified Dementia  Not specified DEMQOL Age, Depression, Duration, 
Memory rating 
Poor 
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Kosteniuk et al. 
(2014) 
Canada 148 99 74.5 (8.8) 3MS 75.2 
(14.7) 
AD 110, Other 55 Community QoL-AD Depression Satisfactory 
Kunz (2010) Germany 335 67.50% 80.2 (6.7) 18.6 (3.8) Dementia  Community  EQ-5D ADL, CSM Satisfactory 
Lacey et al. 
(2015) 
Austria, 
Canada, 
Germany, US 
2204 1188 72.4 (8.94) 21.0 (3.22) AD Community QoL-AD ADL, NPS, CSM Good 
Lai et al. (2015) Hong Kong 125 71 81.34 (7.81) 15.75 (6.62) "Cognitively impaired" 
99 
Nursing home WHOQOL-100 Age, Gender, Diet, Pain, 
Memory rating 
Satisfactory 
Lapid et al. 
(2011) 
US 34 27 94.1 (2.7) 19.1 (4.5) Dementia with stroke 
and Parkinsonism 
Community  LASA Depression, CSM Good 
 41 37 94.2 (2.8) 17.7 (5.7) Dementia  Community  
León-Salas et al. 
(2011a) 
Spain 40 88.10% 83.2 (6.3) 12.0 (4.5) AD 86.8%, Mixed 
13.2% 
Nursing home QoL-AD ADL, NPS, Depression, 
GDS, Care home stay, CSM, 
Duration 
Good 
Li et al. (2013b) China 200 112 77.62 (7.79) Not specified Dementia Community 180, 
Hospital 20 
DQoL  NPS, Co-morbidity, Being 
married 
Satisfactory 
Japan 205 168 85.49 (6.89) Not specified Dementia Nursing home 27, Care 
home 34, Group home 
26, Day service 48, 
Other 70 
NPS, Depression, Education, 
Diet 
Logsdon et al. 
(2000) 
US 77 47% 78.3 (6.1) 17.1 (5.6) AD Community  QoL-AD Depression, Education, 
Depression C 
Satisfactory 
Logsdon et al. 
(2002) 
155 44% 77.2 (6.8) 18.1 (5.9) AD Community  QoL-AD ADL, Depression, CSM, 
Burden, Depression C 
Good 
Logsdon et al. 
(2005) 
95 66% 79.9 (7.7) 14.0 (7.0) AD Community  QoL-AD Age, Anxiety, Gender, 
Duration 
Satisfactory 
Lucas-Carrasco et 
al. (2010) 
Spain 102 67 79.2 (7.0) 19.49 (4.45) MCI 19, AD 47, VaD 
14, Mixed 10, Other 6, 
Unknown 6 
Community  DEMQOL Age, ADL, Depression, 
Health, Gender, Education, 
Diagnosis, CSM, Being 
married 
Good 
Lucas-Carrasco et 
al. (2011a) 
101 68 79.3 (7) 19.5 (4.2) AD 47, VaD 13, Mixed 
10, Unspecified 14,  
Other 17 
Community  DQoL Age, ADL, Depression, 
Gender, Education, CSM, 
Being married 
Good 
Lucas-Carrasco et 
al. (2011b) 
104 62.50% 78.6 (7.2) 18.3 (4.3) AD 47, VaD 13, Mixed 
10, Unspecified 14,  
Other 17 
Community  WHOQOL-
BREF 
Age, ADL, Depression, 
Health, Gender, Education, 
Co-morbidity, CSM, Being 
married 
Good 
Mate et al. (2012) Australia 167 90 83.5 (4.8) CAMCOG-R 
71.1 (10.7) 
Dementia  Community  WHOQOL-
BREF 
Age, ADL, Depression, 
Gender, Diagnosis, CSM, 
Being married 
Good 
Matsui et al. 
(2006) 
Japan 140 84 72.4 (7.3) 20.3 (4.2) AD Community  QoL-AD Age, ADL, NPS, Gender, 
Education, CSM, Memory 
rating 
Good 
Menne et al. 
(2009) 
US 211 51% 76.07 (8.95) 22.01 (4.67) Dementia  Community  QoL-AD Age, Depression, Gender, 
Education, Relationship 
quality, Co-morbidity, 
Diagnosis, Ethnicity, 
Relationship, CSM 
Satisfactory 
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Menne et al. 
(2012) 
210 49.50% 75.8 (9.23) 22 (4.64) Dementia Community QoL-AD ADL, Health, Religion, Diet, 
Income, Duration, Social 
engagement 
Good 
Miranda-Castillo 
et al. (2010a) 
England 152 78 79.2 (6.8) 19.13 (7.2) Dementia  Community  QoL-AD Unmet needs Good 
Miranda-Castillo 
et al. (2010b) 
129 78 79.85 (6.4)  19.1 (7.2) Dementia  Community QoL-AD Living alone Good 
Mo et al. (2004) Canada 319 Not 
specified 
Not specified Not specified Dementia  Not specified HUI3 Diagnosis Poor 
Mulhern et al. 
(2013) 
England 325 220 79.4 (8.5) 18.1 (6.6) AD Community 305, 
Nursing home 50 
DEMQOL-short 
DEMQOL 
EQ-5D 
ADL, NPS, Depression, 
CSM 
Good 
Naglie et al. 
(2006) 
Canada 60 37 78.6 18.9 (4.5) AD Own home 49, Senior’s 
apartment 4, Retirement 
home 6, Nursing home 1 
EQ-5D 
EQ-5D VAS 
QWB 
QoL-AD 
Age, ADL, Depression, 
Health, Co-morbidity, CSM 
Good 
Naglie et al. 
(2011a) 
Canada 369 179 80.7 (7.8) 22.3 (4.3) AD Community  EQ-5D 
EQ-5D VAS 
QWB 
QoL-AD 
Age, ADL, NPS, Depression, 
Gender, Education, Co-
morbidity, CSM, Being 
married 
Good 
Naglie et al. 
(2011c) 
272 50.2% 82.2 20.2 AD Community EQ-5D 
EQ-5D VAS 
QWB 
QoL-AD 
None  Satisfactory 
Nagpal et al. 
(2015) 
US 111 59  76.80 (8.90) 20.7 (3.80) Dementia  Community  QoL-AD Education, Religion, 
Ethnicity, CSM, Being 
married, Burden, Education 
C 
Satisfactory 
Nakanishi et al. 
(2011) 
Japan 116 Not 
specified 
86.2 (6.0) 15.1 (4.2) Dementia  Nursing home QoL-AD Age, Anxiety, ADL, NPS, 
Depression, Gender, Care 
home stay, GDS, CSM 
Satisfactory 
Nikmat et al. 
(2015a) 
Malaysia 219 108 72.61 (4.74)  short MMSE 
5.52 (2.47)  
Cognitive impairment Home care 109, Nursing 
home 110 
WHO-8 Age, ADL, Depression, 
Health, Gender, Education, 
Relationship quality, Co-
morbidity, Ethnicity, Income, 
Living alone, CSM, Being 
married, Social engagement 
Good 
Nikmat et al. 
(2015b) 
49 27 70.11  5.915  Dementia  Nursing home 30, 
Community 19 
WHO-8 
AQoL-8 
Depression Good 
Novella et al. 
(2001a) 
Belgium, 
France, 
Luxembourg, 
Switzerland 
108 120 81.8 (7.0) 12.75 AD 107, VaD 18, 
Alcohol 6, other 17 
Not specified DHP Co-morbidity Satisfactory 
Novella et al. 
(2001b) 
125 76 82.7 13 AD 68.42%, VaD 
16.54%, Mixed 8.27%, 
Metabolic/alcohol 
2.26%, DLB 1.5%, 
Other 3% 
Community 22.5%, 
Hospital 36.8%, 
Institution 40.7% 
SF-36 Co-morbidity Good 
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Ankri et al. 
(2003) 
130 113 82.9 (8.32) 12.8 (5.6) AD (70.4%) Community 22.5%, 
Hospital 36.8%, 
Institution 40.7% 
EQ-5D 
EQ-5D VAS 
Age, ADL, CSM Good 
Novelli and 
Caramelli (2010) 
Brazil 30 73.30% 75.5 (6.7) 20.2 (2.6) AD  Not specified QoL-AD None  Good 
30 66.70% 76.2 (6.2) 14.0 (2.8) AD  Not specified QoL-AD None  
Novelli et al. 
(2010) 
60 42 75.85  17.1  AD  Not specified QoL-AD Age, ADL, NPS, Depression, 
Education, CSM, QoL C, 
Depression C, Age C 
Good 
Oremus et al. 
(2012) 
Canada  216 106 80 Not specified AD Not specified EQ-5D Education C Good 
Orgeta et al. 
(2015a) 
England, 
Wales 
478 238 75.5 (7.3) CDR Mild 
74.6%, CDR 
Moderate 
25.4% 
Dementia  Community  EQ-5D 
EQ-5D VAS 
Anxiety, ADL, Depression, 
Relationship, GDS, Being 
married, Burden 
Satisfactory 
Orgeta et al. 
(2015b) 
463 238 77.6 CDR Mild 
74.6%, CDR 
Moderate 
25.4% 
Dementia  Community  QoL-AD Age, Anxiety, ADL, 
Depression, Health, Gender, 
Education, Living alone, 
GDS, Being married, GHQ, 
Burden, Education C, Age C, 
Gender C 
Good 
Woods et al. 
(2012) 
479 242 77.53 (7.3) CDR Mild 
74.6%, CDR 
Moderate 
25.4% 
AD 106, VaD 23, DLB 
1, Mixed 17, Unknown 
36 
Community  QoL-AD 
EQ-5D 
EQ-5D VAS 
Memory rating Good 
Perales et al. 
(2014) 
England 110 63.60% 86.6 (3.6) 21.3 (4.8) AD 76, VaD 4, Mixed 
25, Other dementia  2, 
AD 2, 1 VaD with 
delirium 1 
House/flat 78, 
Sheltered/warden 18, 
Nursing home 13, 
Hospital 1 
DEMQOL Age, ADL, Health, Gender, 
Education, CSM, Being 
married 
Good 
Rummel (2012) US 27 35 83.89 (6.78) 7.94 (7.49) Dementia  Memory care unit 52%, 
Skilled nursing facility 
35%, Adult day program 
13% 
QoL-AD Anxiety, ADL, NPS, 
Depression, CSM, Burden 
Good 
Sanchez-Arenas 
et al. (2014) 
Mexico 109 70 78.52 (7.09) Not specified 53 AD, 29 VaD, 13 
Mixed, 1 Temporal 
lobe, 1 FTD, 2 Semantic 
Dementia, 1 CBD, 2 
PDD, 4 other 
Not specified EQ-5D 
EQ-5D VAS 
ADL, Co-morbidity, CSM Good 
Schölzel-
Dorenbos et al. 
(2011) 
Netherlands 168 106 78 (6) 22.7 (3.9) AD 105, VaD 15, 
Mixed or other 55 
Community EQ-5D VAS Age, ADL, NPS, Depression, 
Gender, Co-morbidity, GDS, 
CSM, Distress, Depression 
C, Education C, Age C, 
Gender C 
Good 
Schulz et al. 
(2010) 
US 105 63 77.3 (8.2) ≤15 26, 16-23 
37, ≥24 42 
AD Community QoL-AD 
DEMQOL 
SF-12 
None Satisfactory 
Schulz et al. 
(2013) 
79 27 76.0 (8.5) 23.1 (3.6) AD Community SF-12 Age, Gender, Education, 
Ethnicity, Income, CSM, 
Being married, Burden, 
Good 
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Depression C, Education C, 
Age C, Gender C 
Selai et al. 
(2001a) 
England 22 10 65 (8) ≥10 Mostly AD Community  QOLAS Age, ADL, Depression, 
Gender, CSM, Social 
engagement, GHQ 
Satisfactory 
Shata et al. (2015) Egypt 100 56 67.61 (6.41) 11.86 (1.97) Dementia  Community QoL-AD ADL, Depression Good 
Sheehan et al. 
(2012) 
England 48 83 85 CDR 0.5 = 2, 
CDR 1 = 14, 
CDR 2 = 64, 
CDR 3 = 29. 
Dementia  General hospital 
inpatients 
QoL-AD 
EQ-5D 
Age, ADL, Depression, 
Gender, GDS, GHQ 
Satisfactory 
Shin et al. (2005) US 62 36 75.53 (7.87) 19.36 (5.22) AD Community  QoL-AD Anxiety, NPS, Depression Good 
Siedlecki et al. 
(2009) 
France, US 277 56.70% 75.79 (7.82) mMMSE 41.60 
(6.23) 
AD Community AAIQoL Age, ADL, Depression, CSM Good 
Sloane et al. 
(2005) 
US 78 79% 85 Mild 12%, 
Moderate 25%, 
Severe 27%, 
Very severe 
37% 
AD 54%, VaD 4%, 
Mixed 5%, Other 37% 
Nursing home AAIQoL 
DQoL 
QoL-AD 
ADL, NPS, Depression, Pain, 
CSM 
Good 
Smith et al. 
(2005) 
England 69 59 78.65 (8.30) 16.01 (8.53) Dementia  Community DEMQOL 
DQoL 
QoL-AD 
SF-12 
Age, ADL, Depression, 
Gender, CSM 
Good 
Smith et al. 
(2007) 
64 43 78.49 (8.32) 19.93 (4.84) Dementia  Community  DEMQOL 
DQoL 
QoL-AD 
None Satisfactory 
Snow et al. (2005) US 89 0 74.0 (9.37) DRS scores 
<46 9, 47-102 
39, 102-139 45 
 
Dementia  Community  QoL-AD ADL, NPS, Depression, Pain, 
CSM, Depression C 
Satisfactory 
de Sousa and do 
Amaral (2014) 
Portugal 73 42 77.9 (7.7) Not specified AD Not specified QoL-AD Diet Satisfactory 
Spector and Orrell 
(2006) 
England 76 67 85.2 (7.4) 13 (4.8) Dementia  Nursing home QoL-AD None Good 
Spector et al. 
(2016) 
England 50 20 78.40 (6.97) 20.92 (5.20) Dementia  Community QoL-AD Relationship quality Good 
Stewart-Archer 
(2012) 
US 136 98 85 (7.15) 16.87 (4.08) Dementia  Nursing home 89, 
Community 35, 
Supportive housing 12 
QoL-AD Age, Depression, Gender, 
Education, Income, CSM, 
Being married 
Good 
Struttmann et al. 
(1999) 
France 27 26 73.2 (8.0) Not specified Dementia  Neurology hospital ward WHOQOL-100 Age Poor 
Sura et al. (2015) US 112 64 65-79 59, 
≤80 53 
Not specified Dementia  Not specified SF-12 Age, ADL, Health, Gender, 
Education, Ethnicity, 
Income, Medication, Being 
married 
Satisfactory 
Trigg et al. (2007) England 47(sample 
1) 
32 <65 7, 65-74 
24, 75-84 19, 
≤85 10 
18.44 (4.07) AD 49, VaD 8, FTD 3 Living alone 8, Living 
with spouse 45, Living 
with relative/other 5, 
Residential 2 
BASQID Depression Good 
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England 143(sample 
2) 
88 <65 8, 65-74 
29, 75-84 85, 
≤85 28 
18.06 (4.63) AD 123, VaD 19, FTD 
8 
Living alone 25, Living 
with spouse 93, Living 
with relative/other 21, 
Residential 11 
BASQID Age, CSM 
Trigg et al. (2011) England 69 30 <65 3, 65-74 
10, 75-84 49, 
≤85 7 
22.43 (2.44) AD 54, VaD 7, FTD 5, 
DLB 3 
Living alone 14, Living 
with spouse 49, Living 
with relative/other 6 
BASQID Age, Awareness, ADL, 
Gender, CSM 
Good 
Trigg et al. 
(2012c) 
53 30 78.77 (6.53) 21.96 (2.89) AD 45, VaD 9, FTD 3, 
DLB 3 
Living alone 14, Living 
with spouse 49, Living 
with relative/other 6 
BASQID None Good 
Vogel et al. 
(2006) 
Denmark 48 Not 
specified 
77.0 (5.8) 24.9 (2.3) AD Community  QoL-AD 
EQ-5D VAS 
Age, NPS, Depression, 
Gender, CSM 
Good 
Voigt-Radloff et 
al. (2012) 
Germany, 
Netherlands 
285 163 77.3 (7.2) 20.8 (3.5) AD or VaD Community  DQoL ADL, Depression, CSM Good 
Whitlatch et al. 
(2005) 
US 97 60 77 (9) 20.7 (3.8) AD 42%, Non-specific 
dementia 25%, stroke 
11%, Other dementia 
11%, PD 8%, Other 3% 
Community  QoL-AD Social engagement Satisfactory 
Winter et al. 
(2011) 
Russia 98 64 77.5 (8.8) ≤14 83 AD or VaD Not specified EQ-5D VAS 
EQ-5D 
Age, Gender Satisfactory 
Wlodarczyk et al. 
(2004) 
Australia 69 60 71.7 (8.5) 21.09 AD Australian elderly care 
centres 
AQoL ADL, CSM Good 
Wolak et al. 
(2009) 
France, 
Switzerland 
120 77 82.2 (6.0) 20.8 (4.5) AD Living alone 28, Living 
with spouse 70, 
Institution/sheltered 18, 
Other 3 
QoL-AD ADL, NPS, Co-morbidity, 
CSM, Burden, Distress 
Satisfactory 
Wolak et al. 
(2010) 
155 98 81.8 (6.0) 20.8 (4.4) AD 122, Other 33 Living alone 28, Living 
with spouse 70, 
Institution/sheltered 18, 
Other 3 
DQoL Burden Good 
Wolak et al. 
(2011) 
150 98 81.8 (6.0) 20.8 (4.4) AD 122, Other 33 Mix community and 
institution 
DQoL ADL, NPS, Depression, 
GDS, CSM 
Good 
Wolak-Thierry et 
al. (2015) 
123 63.40% 82.0 (6.0) MMSE ranged 
between 11-29 
AD Not specified QoL-AD 
DQoL 
NPS, Depression, GDS Good 
Barbe et al. 
(2017) 
121 78 82.0 (6.2) 20.7 (4.5) AD Community 103 DQoL Age, Anxiety, ADL, 
Education, Diet, Medication 
Good 
Woods et al. 
(2006) 
England 201 158 85.3 (7.0) 14.4 (3.8) Dementia  Residential 172 QoL-AD Anxiety, NPS, Depression, 
GDS, CSM 
Good 
Thorgrimsen et al. 
(2003) 
201 158 85.3 (7.0) 14.4 (3.8) Dementia  Residential 172 QoL-AD None Good 
Selwood et al. 
(2005) 
24 42 81.5 (6.0) 9.8 (7.4) Dementia  Inpatient, Day hospital, 
Nursing home, 
Residential home 
DQOL None Good 
Woods et al. 
(2014) 
Wales 98 54 78.7 (7.7) 24.2 (2.8) AD 51, VaD 30, Mixed 
20 
Community  QoL-AD Age, Anxiety, Awareness, 
ADL, NPS, Depression, 
Education, Relationship 
quality, CSM, GHQ, 
Distress, Age C, Religion*, 
Good 
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Co-morbidity*, Diagnosis*, 
Being married*, Education 
C*, Gender C* 
Nelis et al. (2012) 97 46 77.98 (7.68) 24.43 (2.64) AD 59, VaD 25, Mixed 
13 
Community  QoL-AD Gender Good 
Clare et al. (2013) 95 49 78.56 (7.91) 24.13 (2.87) AD 49, VaD 29, Mixed 
17 
Community  QoL-AD None Good 
Clare et al. 
(2014b) 
51 25 76.75 (7.88) 24.5 (2.80) AD 31, VaD 11, Mixed 
9 
Community  QoL-AD Medication Good 
Yap et al. (2008) Singapore 67 45 78.4 (7.5) 16.1 (5.4) AD 58.6%, mixed 
32.8%, VaD 6.9%, PDD 
1.7% 
Live with spouse 81.7% QoL-AD ADL, Depression, GHQ Satisfactory 
Yeager and Hyer 
(2008) 
US 25 60% 77 Not specified AD or Dementia Community 5 items from 
GDS-15 
NPS Satisfactory 
Yeaman et al. 
(2013) 
US 10 0 82.5 (4.99) 17.8 (6.07) AD Community QoL-AD ADL Satisfactory 
Yu et al. (2013) China 195 48% 73.6 (7.7) MoCA 7.26 
(5.51) 
AD Community QoL-AD Anxiety, ADL, Depression Good 
Zimmerman et al. 
(2005) 
US 71 Not 
specified 
Not specified 7.5 Dementia Residential care or 
Assisted living 
DQoL 
AAIQoL 
QoL-AD 
Medication Good 
Zucchella et al. 
(2015) 
Italy 135 93 78.2 (5.9) 15.3 (7.5) AD Live with carer 56.3% QoL-AD ADL, Depression Satisfactory 
Note: articles were judged to be of poor quality if scored ≤20 or below, satisfactory scored between >20 and <26, good scored ≥26. Shading indicates articles using the same 
study data. “Severity” refers to Mini-Mental State Examination score unless otherwise specified. * indicates data not reported in articles 
 
Quality of life measure abbreviations: 12-Item Short Form Health Survey (SF-12), 15-dimensional (15D), 36-Item Short Form Health Survey (SF-36), Activity and Affect 
Indicators of QOL (AAIQoL), Alzheimer's Disease Related Quality of Life (ADRQL), Assessment of Quality of Life (AQoL), Bath Assessment of Subjective Quality of Life in 
Dementia (BASQID), Dartmouth COOP Functional Health Assessment charts/WONCA (COOP/WONCA), Dementia Quality of Life Questionnaire (DEMQOL), Dementia 
Quality of Life Instrument (DQoL), Disability and Distress Index (DDI), Duke Health Profile (DHP), EuroQol five dimensions questionnaire (EQ-5D), Geriatric Depression 
Scale-15 (GDS-15), Health Utility Index (HUI), Linear Analogue Self Assessment (LASA), Quality of Life Assessment Schedule (QOLAS), Quality of Life Index (QLI), 
Quality of Life in Alzheimer's Disease (QoL-AD), Quality of Well-Being scale (QWB), Self-Reported Quality of Life Scale (SRQLS), Visual Analogue Scale, (VAS), World 
Health Organization (WHO), World Health Organization Quality of Life (WHOQOL) 
 
Severity abbreviations: Cambridge Cognition Examination (CAMCOG), Clinical Dementia Rating (CDR), Dementia Rating Scale (DRS), Global Deterioration Scale (GDS), 
Mini-Mental State Examination (MMSE), Modified Mini-Mental State Examination (3MS), Modified Mini-Mental State Examination (mMMSE), Montreal Cognitive 
Assessment (MoCA) 
 
Dementia type abbreviations: Alzheimer's disease (AD), Behavioural-variant frontotemporal dementia (bvFTD), Corticobasal degeneration (CBD), Dementia with Lewy bodies 
(DLB), Frontotemporal Dementia (FTD), mild cognitive impairment (MCI), Parkinson's Disease Dementia (PDD), Primary Progressive Aphasia (PPA), Vascular dementia 
(VaD) 
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Factors included in the meta-analysis abbreviations: Alzheimer’s (vs. other dementia subtypes) (Diagnosis), Better functional ability (ADL), Better quality of relationship with 
carer (Relationship quality), Better self-rated health (Health), Better self-rated memory functioning (Memory rating), Burden or stress (Burden), Cared for by spouse (vs. other 
carer type) (Relationship), Carer Depression (Depression C), Carer quality of life (self-rated) (QoL C), Distress at NPS symptoms (Distress), Female gender (Gender), Female 
gender carer (Gender C), Greater social engagement (Social engagement), Higher income (Income), Higher level of education (Education), Higher level of carer education 
(Education C), Higher scores on cognitive screening measures (CSM), Longer duration of care home stay (Care home stay), Longer disease duration (Duration), More advanced 
dementia (GDS), More awareness (Awareness), Neuropsychiatric symptoms/BPSD (NPS), Older age (Age), Older age carer (Age C), Poorer mental health (General Health 
Questionnaire (GHQ)) (GHQ), Presence of co-morbid conditions (Co-morbidity), Presence of religious beliefs/spirituality (Religion), Presence of unmet needs (Unmet needs), 
Taking medication (Medication), Underweight (Diet), White ethnicity (Ethnicity) 
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Supplementary Table 4. Studies utilising informant ratings of quality of life in people with dementia 
 
Study Country of 
study 
Relationship 
of informant 
to person 
with 
dementia 
n Females Mean age Severity Dementia type Living situation QoL measure Factors included in 
the meta-analysis 
Quality rating 
Albert et al. (2000) US Mix 145 Not 
specified 
76 (8.7) Not specified AD Mostly community AAIQoL ADL, GDS, CSM Satisfactory 
US Mix 196 Not 
specified 
83.5 (7.5) Not specified AD Mostly community AAIQoL ADL, GDS 
Albert et al. (1996) US Mix 130 60.50% 72.4 (8.1) 37.8 (5.9) AD Mostly community AAIQoL None Satisfactory 
Albert et al. (2001) Mix 150 Not 
specified 
74.18 (8.05) Not specified AD Mostly community AAIQoL  NPS Good 
Andrieu et al. 
(2016) 
France Family 526 331 79.6 (5.9) 19.5 (3.9) AD Community QoL-AD Age, Anxiety, ADL, 
NPS, Depression, 
Gender, Education, 
Co-morbidity, Diet, 
Relationship, Living 
alone, CSM, 
Medication, Duration, 
Burden, Age C, 
Gender C 
Good 
Arismendi 
Arismendi et al. 
(2013) 
Spain Family 58 37 81.2 (6.3) Not specified AD Not specified EQ-5D VAS Age, Gender, Co-
morbidity, 
Relationship, 
Medication, Duration 
Satisfactory 
Arlt et al. (2008) Germany Family 97 54 70.49 (8.49) 22.74 (4.37) AD 58%, Mixed and 
MCI 11%, bvFTD 
9%, VaD 7%, 
Semantic dementia 
1% 
Community 95, 
Nursing home 
WHO-8 
SF-12 
Depression, GDS, 
CSM 
Good 
Arons et al. (2013) Netherlands Family 175 106 78.6 (5.7) Not specified AD 105, VaD 15, 
Mixed 49, Other 6 
Not specified EQ-5D VAS 
EQ-5D 
Age, Gender Good 
Barca et al. (2011) Norway Family 156 103 82.9 (7.7) 11.1 (8.2) AD 107, VaD 18, 
Other 31 
Nursing homes 82,  
Geriatric psychiatry 
departments 74 
QUALID Age, ADL, 
Depression, Gender, 
Co-morbidity, Living 
alone, GDS, CSM, 
Being married 
Satisfactory 
Beer et al. (2010) Australia Health care 
professional 
 
324 Not 
specified 
85.3 (7.9) 14 (median) Dementia  Residential care 
facilities 
QoL-AD 
ADRQL 
Age, NPS, Gender, 
Diet, Pain, CSM, 
Medication, Distress 
Satisfactory 
Family  292 
Beerens et al. 
(2014) 
England, 
Estonia, 
Finland, 
Health care 
professional 
791 74% 84.1 (6.4) 11.9 (6.3) Dementia  Long-term care 
residents 
QoL-AD Depression, Pain, 
Medication 
Good 
Family 1123 63% 82.2 (6.6) 14.3 (6.6) Dementia  Home care 
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Giebel et al. (2014) France, 
Germany, 
Netherlands, 
Spain, 
Sweden 
Mix 263 154 82.6 (5.6) 21.8 (1.4) AD 139, VaD 41, 
Mixed 14, FTD 2, 
DLB 9, Other 58 
Care home or 
community but at 
risk of care home 
within 6 months 
QoL-AD Age, ADL, NPS, 
Diagnosis 
Good 
Mix 521 365 82.7 (6.6) 15 (2.9) AD 282, VaD 81, 
Mixed 35, FTD 2, 
DLB 8, Other 105 
Mix 242 156 81.2 (6.9) 4.8 (3.5) AD 122, VaD 52, 
Mixed 12, DLB 5, 
Other 50 
Giebel et al. 
(2015a) 
Mix 122 71.30% 83 (6.5) 13.37 (2.27)  AD 44, VaD 39, 
Mixed 8, FTD 2, 
DLB 5 
Community 63, Care 
home 59 
QoL-AD Living alone, CSM, 
Age C 
Good 
Giebel et al. 
(2015b) 
Mix 414 71.30% 82 (6.8) 4.9 (3.1) dementia Community 214, 
Care home 197 
QoL-AD None Good 
Giebel et al. 
(2016b) 
Family 957 596 82.3 (6.5) 14.5 (6.6) AD 514, VaD 153, 
Mixed 53, Other 227 
Community (home 
care) 
QoL-AD None Good 
Family 581 423 84.3 (6.1) 12.1 (6.2) AD 248, VaD 127, 
Mixed 35, Other 171 
Nursing home (Long 
term care) 
QoL-AD 
Benhabib et al. 
(2013) 
Canada Health care 
professional 
31 2 85.8 (3.7) 8.7 (6.7) AD Long-term care 
residents 
QUALID Anxiety, NPS, 
Depression, GDS 
Satisfactory 
            
Bhattacharya et al. 
(2010) 
Denmark Family 321 54.80% 76.2 (7.1) 24.0 (2.6) AD 72.4%, Mixed 
24.8% 
Community EQ-5D 
EQ-5D VAS 
QoL-AD 
ADL, NPS, 
Depression, CSM 
Satisfactory 
Vogel et al. (2012) Family 102 76 (7.1) 
Baseline 
76 (7.1) 
Baseline 
22.7 (0.41) 
12 months; 
18.0 (0.75) 
18 months 
AD Community (91% at 
12-month, 86.3% at 
36-month) 
QoL-AD 
EQ-5D VAS 
None Good 
Black et al. (2012) US Family 254 65% 83.6 17.8 Dementia  Community  QoL-AD 
ADRQL 
Age, ADL, NPS, 
Depression, Health, 
Gender, Education, 
Co-morbidity, 
Ethnicity, 
Relationship, CSM 
Medication, QoL C, 
Burden, Distress, 
Depression C, 
Education C, Age C, 
Gender C, Time 
caring (community) 
Good 
Black et al. (2013) Family 254 65% 83.6 (5.9) 17.8 (7.6) 265 AD, 38 MCI Community QoL-AD 
ADRQL 
None Good 
Bosboom et al. 
(2012b) 
Australia Family 80 67.50% 78.3 (7.9) Not specified AD Community  QoL-AD Age, Anxiety, 
Awareness, ADL, 
NPS, Depression, 
Gender, Education, 
Living alone, 
Medication, Being 
Good 
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married, Memory 
rating, Distress, Age 
C, Gender C 
Bosboom and 
Almeida (2014) 
Family 47 72.30% 78.7 (8.2) 15.1 (5.6) AD Community QoL-AD CSM Good 
Bosboom et al. 
(2013) 
Family 47 72.30% 78.7 (8.2) 15.1 (5.6) AD Community QoL-AD None Satisfactory 
Bosboom and 
Almeida (2016) 
Family 80 67.50% 78.3 (7.9) Not specified AD Community QoL-AD None Good 
Boyer et al. (2004) Belgium, 
France, 
Luxembourg, 
Switzerland 
Family  
Health care 
professional 
95 76 81.8 (8.2) 15.7 (4.1) AD 68, VaD 16, 
Mixed 8, Other 8 
Community 20%, 
Hospital 40%, 
Institution 40% 
NHP Age, ADL, Gender, 
Living alone, CSM, 
Duration 
Good 
Bruvik et al. (2012) Norway Family 230 123 78.4 (7.5) 21.3 (3.6) Dementia  Community QoL-AD Age, ADL, NPS, 
Depression, Gender, 
Education, CSM, 
Duration, Being 
married 
Satisfactory 
Bryan et al. (2005) England Family  
Health care 
professional 
64 36 76 (53-91) 18 (5.8) (3-
26) 
AD or VaD Community EQ-5D Anxiety, ADL, NPS, 
Depression 
Good 
Buckley et al. 
(2012) 
US Family 81 151 85.60 (5.77) 19.78 (7.25) AD 181, remainder 
not specified 
Not specified Single global 
QoL question 
(rated self as 
excellent) 
ADL, NPS, Health, 
Gender, Education, 
GDS, CSM, Duration 
Good 
144 Single global 
QoL question 
(rated self as 
good) 
Castro-Monteiro et 
al. (2016) 
Spain Mix 525 434 85.57 (6.73) 13.24 (8.07) Non-specific 
dementia (49.7%), 
AD (36.4%), VaD 
(6.5%), Mixed 
(4.4%), Alcohol-
related dementia 
(1.1%), DLB (1.1%), 
PDD (.8%) 
Residential care 
facilities 
QoL-AD 
QUALID 
Age, ADL, 
Depression, Gender, 
Co-morbidity, GDS, 
CSM 
Satisfactory 
Castro-Monteiro et 
al. (2014) 
Health care 
professional 
274 224 84.70 (6.51) 12.96 (8.51) Dementia  Residential care EQ-5D 
QoL-AD 
None Satisfactory 
Díaz-Redondo et al. 
(2014) 
Mix 525 434 85.57 (6.73) 13.24 (8.07) Mostly AD Nursing home EQ-5D  
EQ-5D VAS 
Age, Depression, 
Gender, Education, 
Co-morbidity, GDS, 
CSM 
Good 
Chan et al. (2011) Hong Kong Family 111 80 77.7 (7.4) 15.8 (4.7) AD Community QoL-AD Age, Depression, 
Gender, Education, 
Co-morbidity, Living 
alone, CSM, Being 
Good 
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married, Time caring 
(community) 
Chiu et al. (2008) Taiwan Family 51 61.20% 75.23 (8.03) 17.61 (3.78) AD Not specified DQoL Age, ADL, NPS, 
Depression, 
Education, CSM, 
Depression C 
Satisfactory 
Clare et al. (2014a) Wales Family  
Health care 
professional 
105 72 81.47 (8.63) FAST 6 25, 
FAST 7 80 
Dementia 40, AD 
26, VaD 19, Mixed 
6, FTD/Picks 3, 
CADASIL 1, Not 
stated 10 
Nursing home QUALID Age, ADL, NPS, 
Gender, Relationship, 
Care home stay, 
Medication, Memory 
rating, PCC 
Good 
Cohen-Mansfield et 
al. (2015) 
US Health care 
professional 
179 72.10% 86.08 (8.62) 8.79 (6.44) Dementia  Nursing home SDS ADL, Pain, CSM, 
Memory rating 
Good 
Conde-Sala et al. 
(2009) 
Spain Family 236 157 77.8 (6.9) Mild 76, 
Moderate 
154, Severe 6 
Dementia  Community QoL-AD Age, Anxiety, NPS, 
Depression, Gender, 
Education, Living 
alone, CSM, Being 
married, QoL C, 
Burden 
Good 
Conde-Sala et al. 
(2010) 
Family 251 166 77.4 18.05  Dementia  Community QoL-AD ADL, Relationship, 
Education C, Gender 
C 
Satisfactory 
Conde-Sala et al. 
(2014b) 
Family 119 76 77.0 (6.7) 18.9 (3.6) Dementia  Community QoL-AD None Good 
Conde-Sala et al. 
(2013b) 
Spain Family 221 140 78.6 (74.4-
82.5) 
19.0 (15.0-
22.5) 
AD Not specified QoL-AD Depression, Gender, 
Education, GDS, 
CSM, Being married, 
QoL C, Burden 
Good 
Conde-Sala et al. 
(2013a) 
Family 164 98 77.6 (7.2) 17.9 (5.8) AD Not specified QoL-AD Awareness, ADL Good 
Conde-Sala et al. 
(2014a) 
Family 141 83 77.6 (7.2) 17.6 (5.9) AD Not specified QoL-AD Gender C Good 
Conde-Sala et al. 
(2016) 
Family 221 140 77.8 (0.4) 18.3 (0.3) AD Not specified QoL-AD Awareness, NPS Good 
Cordner et al. 
(2010) 
US Family  
Health care 
professional 
119 65 81.6 (6.8) SIRS 10.3 
(6.7) 
Dementia  Nursing home Single question 
- How would 
you rate 
[resident’s] 
overall quality 
of life in the 
past two 
weeks? 
ADRQL 
Age, NPS, Gender, 
Education, Co-
morbidity, Ethnicity, 
GDS, Care home 
stay, Duration 
Satisfactory 
Crespo et al. (2013) Spain Family  
Health care 
professional 
197 79.40% 86.07 (6.46) 13.3 (5.88) Dementia  Nursing home QoL-AD Age, ADL, NPS, 
Depression, Gender, 
Diet, GDS, 
Relationship, Care 
home stay, CSM, 
Good 
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Medication, 
Dementia unit, 
Burden, Depression 
C, Age C, Gender C 
Dooley and 
Hinojosa (2004) 
US Family 40 24 77.08 (8.86) Not specified AD Community AAIQoL  Burden Satisfactory 
Dourado et al. 
(2016) 
Brazil Family 69 72% 76.8 (7.3) 21.4 (3.5) AD Not specified QoL-AD Age, Awareness, 
ADL, NPS, 
Depression, Gender, 
Education, CSM, 
Duration, Burden, 
Education C, Age C, 
Gender C 
Good 
de Sousa et al. 
(2013) 
Family 41 28 77.3 (7.8) 21.0 (3.93) AD Community QoL-AD None Good 
de Sousa et al. 
(2015) 
Family 69 72 76.8 (7.3) 21.4 (3.5) AD Not specified QoL-AD None Satisfactory 
Edelman et al. 
(2005) 
US Health care 
professional 
55 80.00% 85.3 (5.4) 11.1 (6.8) Dementia  Assisted living 
facility 
QoL-AD  
ADRQL 
ADL, Depression, 
Co-morbidity, CSM, 
Dementia unit 
Satisfactory 
Health care 
professional 
117 85.50% 86.0 (6.8) 7.9 (6.8) Dementia  Special care facilities QoL-AD  
ADRQL 
ADL, Depression, 
Co-morbidity, CSM 
Satisfactory 
Edelman et al. 
(2004a) 
Health care 
professional 
54 58.30% 80.5 (5.8) 16.7 (4.5) Dementia  Adult day centres QoL-AD  
ADRQL 
None Satisfactory 
Falk et al. (2007) Sweden Health care 
professional 
169 148 86 (6) 10 (7) AD, DLB and VaD 
39, 
Multi-infarct 
dementia, 
Cerebrovascular 
infarcts, 
Postsubarachnoidal 
bleeding 39, Mixed 
8, Non-specified 
dementia 83. 
Dementia special 
care units 
QUALID NPS, Depression, 
CSM, Medication 
Good 
Fuh and Wang 
(2006) 
Taiwan Family 81 49 77.2 (6.8) 20.1 (4.5) AD Not specified QoL-AD Age, ADL, NPS, 
Depression, 
Education, Co-
morbidity, CSM, 
Distress 
Satisfactory 
Gallrach (2010) New Zealand Family 53 22 77.7 CDR.5 19, 
CDR1 25, 
CDR2 8, 
CDR3 1 
AD 31, VaD 14, 
Mixed 8 
Community QoL-AD ADL, NPS, 
Depression, Co-
morbidity, Diagnosis, 
GDS, CSM, QoL C, 
Burden, Distress, 
Time caring 
(community) 
Good 
Garre-Olmo et al. 
(2010) 
Spain Health care 
professional 
160 123 82.6 (11.6) 4.1 (6.3) Dementia  Long-term care QUALID NPS, Pain, CSM Good 
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Garre-Olmo et al. 
(2012) 
Health care 
professional 
160 123 82.6 (11.6) 4.1 (6.3) Dementia  Long-term care QUALID ADL, Pain Good 
Geschke et al. 
(2013) 
Germany Family 60 38 78.7 (6.4) 20.2 (6.0) Dementia  Community QoL-AD 
SF-36 
Depression, Co-
morbidity, CSM 
Good 
Giebel et al. 
(2016a) 
England Family 20 8 77 (8.3) 23.6 (2.26) AD 40%, Not 
specified 60% 
Community QoL-AD ADL, GHQ Good 
Gitlin et al. (2014) US Family 88 46 81.7 (8) 17.7 (4.6) Dementia  Community QoL-AD NPS, Co-morbidity, 
Pain, CSM, 
Depression C 
Satisfactory 
Goldfeld et al. 
(2012) 
US Health care 
professional 
319 86.20% 85.4 Not specified Dementia  Nursing home HUI2 Co-morbidity Satisfactory 
Gómez-Gallego et 
al. (2012a) 
Spain Family 
Health Care 
Professional 
102 70 78.09 (7.02) 38 mild >20, 
56 moderate 
11-20, 8 
severe <11 
AD Community QoL-AD Anxiety, ADL, NPS, 
Depression 
Relationship, CSM, 
Being married, 
Burden, Distress 
Satisfactory 
Gómez-Gallego et 
al. (2012b) 
Family 
Health Care 
Professional 
102 70 78.09 (7.02) 18.51 (5.99) AD Community  QoL-AD Age, Gender, 
Education, 
Medication, Being 
married, Gender C 
Satisfactory 
González-Salvador 
et al. (2000) 
US Health care 
professional 
120 96 81.6 (7.9) 5.8 (6.9) AD 78, VaD 26, 
Other 16 
Long term care ADRQL Age, NPS, 
Depression, GDS, 
Care home stay, 
CSM, Medication, 
Age C, Time caring 
(care home) 
Satisfactory 
Gräske et al. (2012) Germany Health care 
professional 
104 76 79 (9.5) 11.5 (9.6) Dementia (83.7%) Community in shared 
housing 
QoL-AD ADL, NPS, Satisfactory 
Gräske et al. 
(2014b) 
Family 104 73% 79.0 (9.5) GDS  Dementia (83.6%) Not specified ADRQL 
QoL-AD 
QUALIDEM 
Age, Gender, GDS, 
CSM 
Good 
Gräske et al. 
(2014a) 
Germany Health care 
professional 
133 105 85.4 (7.2) GDS4 2, 
GDS5 4, 
GDS6 29, 
GDS7 98 
Dementia  Care home ADRQL 
QUALIDEM 
NPS, Gender, GDS, 
Burden, Time caring 
(care home) 
Good 
Harvey et al. (2005) US Family 183 51.90% 78.8 Not specified AD 171, DLB 5, 
VaD 7 
Community QoL-AD ADL, GDS Good 
Heggie et al. (2012) Canada Family 114 75 74.4 (9.5) 3MS 70.6 
(18.7) 
Dementia  Community (rural 
and remote settings) 
QoL-AD Age, ADL, NPS, 
Depression, 
Education GDS, 
CSM, Burden 
Good 
Hendriks et al. 
(2014) 
Netherlands Health care 
professional 
330 67% 85.2 (7.4) Not specified AD 43%, VaD 24%, 
Mixed 19%, 
DLB/PDD 6%, 
Other 9%  
Nursing home QUALID NPS, Pain Good 
Hoe et al. (2006) England, 
Wales 
Health care 
professional 
224 192 86.5 (7.4) 8.7 (7.8) Dementia  Residential care 
homes 
QoL-AD Anxiety, ADL, NPS, 
Depression, GDS, 
CSM 
Satisfactory 
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Hoe et al. (2007) England Mix 
Family 167 
Health Care 
Professional 
24 
191 160 81 14.7 (8.3) AD Lived alone 51, 
Lived with others 91, 
Lived in care home 
82 
QoL-AD Anxiety, ADL, NPS, 
Depression, CSM, 
Medication, 
Depression C, Time 
caring (care home) 
Satisfactory 
Huang et al. (2009) Taiwan Family 120 58 78.40 (9.13) 18.64 (6.23) AD Community  QoL-AD NPS, GDS, CSM Satisfactory 
Huang et al. (2015) Taiwan Family 106 64 80.29 (7.86) 15.39 (5.22) Dementia  Nursing home 48, 
Community 58 
QoL-AD Age, Depression, 
Gender, Education, 
Co-morbidity, 
Relationship, GDS, 
CSM, Being married, 
Community vs 
residential, QoL C, 
Depression C, 
Education C, Age C, 
Gender C, Time 
caring (care home) 
Good 
Hurt et al. (2008) France, 
England, 
Greece 
Family 116 104 74.80 (8.36) 16.5 (6.79) Dementia  Community QoL-AD Age, Anxiety, NPS, 
Depression, CSM, 
Duration, Distress, 
Time caring 
(community) 
Good 
James et al. (2005) US Family 173 113 76.7 (8.3) 17.0 (7.1) AD Community Single question 
- How would 
you rate the 
overall quality 
of your 
relative’s life at 
present? 
Age, Depression, 
Gender, Education, 
Ethnicity, GDS, 
CSM, Being married 
Satisfactory 
Karlawish et al. 
(2001b) 
Family 40 27 74.9 (8.0) 16.3 (7.8) AD Community Single question 
- How would 
you rate the 
overall quality 
of your 
relative’s life at 
present? 
NPS, Health, Burden, 
Depression C, Age C, 
Gender C 
Satisfactory 
Jönsson et al. 
(2006) 
US Family 208 62.30% 75.9 19.2 AD Community QoL-AD 
EQ-5D VAS 
EQ-5D 
Age, NPS, Gender, 
Education, Living 
alone, CSM, 
Medication, 
Community vs 
residential 
Good 
Bostrom et al. 
(2007) 
Family 34 15 77.4 17.3 DLB Community EQ-5D ADL, Living alone Good 
Karlawish et al. 
(2004a) 
US Family 68 Not 
specified 
Not specified 20.3 (4.5) AD Not specified EQ-5D 
DDI 
HUI2 
SF-12 
ADL, CSM, Burden, 
Depression C 
Poor 
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Karlawish et al. 
(2008b) 
Family 100 Not 
specified 
76.8 (2.7) 20.83 (4.44) AD Community EQ-5D 
HUI2 
ADL, CSM, Burden Good 
Zbrozek et al. 
(2006) 
Family 110 Not 
specified 
Not specified Not specified AD Community HUI2 ADL, CSM, 
Depression C 
Satisfactory 
Karttunen et al. 
(2011) 
Finland Family 240 51.30% 75.1 (6.6) 21.5 (3.4) AD Community 70% 
with spouse, 30% 
alone 
VAS 
QoL-AD 
Age, ADL, GDS, 
Medication, 
Depression C 
Good 
Kavirajan et al. 
(2009) 
US Family 408 224 80 (7) Not specified AD 304, VaD 31, 
Other 63 
Community 387 HUI2 
HUI3 
NPS, Depression, Co-
morbidity, GDS 
Good 
Kazui et al. (2008) Japan Health care 
professional 
91 73.60% 84.1 (6.9) Not specified AD 28, VaD 31, 
Other 2, Unknown 
30 
Care home QLQD Age, Gender, GDS, 
Care home stay 
Poor 
Kerner et al. (1998) US Family 159 35.70% 73.7 (7.1) Not specified AD Community QWB CSM, NPS Satisfactory 
Khoo et al. (2013) Singapore Family 627 459 78 (8) CDR.5 53, 
CDR1 256, 
CDR2 302, 
CDR3 56 
AD 320, AD with 
CVD 241, VaD 84, 
Other 22 
Not specified QoL-AD Anxiety, NPS, 
Depression 
Good 
Kolanowski et al. 
(2009) 
US Researcher 87 77% 85.7 (6.3) 14.2 (4.5) Dementia  Nursing home Activity 
engagement  
CSM Good 
Kolanowski et al. 
(2014) 
Researcher 128 77% 86.11 (6.0) 14.2 (4.5) Dementia  Nursing home Activity 
engagement 
None Satisfactory 
Kolanowski et al. 
(2002) 
US Researcher 1 0 79 4 AD Dementia care unit OERS None Good 
Kunz (2010) Germany Family 351 67.50% 80.2 (6.7) 18.6 (3.8) Dementia  Community EQ-5D ADL, CSM Satisfactory 
Kuo et al. (2010) Taiwan Family 140 69 79.7  Mild 33, 
Mild-
moderate 42, 
Moderate 30, 
Severe 35 
Dementia  Community 89, Care 
home 51 
EQ-5D ADL, CSM, 
Community vs 
residential, Time 
caring (care home) 
Satisfactory 
Lacey et al. (2015) Austria, 
Canada, 
Germany, US 
Family 2204 1188 72.4 (8.94) 21.0 (3.22) AD Community QoL-AD 
HUI3 
ADL, NPS, CSM Good 
McLaughlin et al. 
(2010) 
Family 166 93 75.9 (6.8) 20.3 (4.6) AD Community QoL-AD 
HUI3 
GDS Good 
Lapid et al. (2011) US Family 41 37 94.2 (2.8) 17.7 (5.7) Dementia  Community LASA Depression, CSM Good 
Family 34 27 94.1 (2.7) 19.1 (4.5) Dementia with 
stroke and 
Parkinsonism 
Community 
Lawton et al. 
(1996) 
US Researcher 237 Not 
specified 
87.82 (5.83) Not specified Dementia  Nursing home OERS NPS, Depression, 
CSM 
Satisfactory 
Lee et al. (2015b) US Researcher 171 135 83.64 (6.39) 7.35 (7.20) Dementia  Nursing home 110, 
Assisted living 67 
ODAS Co-morbidity, Pain Satisfactory 
León-Salas et al. 
(2011a) 
Spain Family 101 88.10% 83.2 (6.3) 7.2 (6.1) AD 81.2%, Mixed 
18.8% 
Nursing home QoL-AD ADL, NPS, 
Depression, GDS, 
Care home stay, 
CSM, Duration 
Good 
León-Salas et al. 
(2011b) 
Family 92 54 73.8 (6.7) 14.1 (6.6) AD Community ADRQL Age, ADL, NPS, 
Depression, 
Good 
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Education, Co-
morbidity, GDS, 
Living alone, CSM, 
Medication, Duration, 
Being married, 
Burden, Education C, 
Age C 
León-Salas et al. 
(2013) 
Health care 
professional 
108 87% 83.9 (6.2) 7.0 (6.2) AD Nursing home ADRQL Age, ADL, NPS, 
Depression, 
Education, GDS, 
CSM, Duration, 
Community vs 
residential 
Good 
León-Salas et al. 
(2015) 
Spain Health care 
professional 
475 396 85.8 (6.8) Not specified Dementia  Nursing home EQ-5D Age, ADL, Gender, 
Education, Co-
morbidity, Being 
married, Memory 
rating 
Satisfactory 
Logsdon et al. 
(2000) 
US Family 77 47% 78.3 (6.1) 17.1 (5.6) AD Community QoL-AD Depression, 
Depression C 
Satisfactory 
Logsdon et al. 
(2002) 
Family 155 Not 
specified 
77.2 (6.8) 18.1 (5.9) AD Community QoL-AD ADL, NPS, 
Depression, CSM, 
Memory rating, 
Burden, Depression C 
Good 
Logsdon et al. 
(2005) 
Family 95 66% 79.9 (7.7) 14.0 (7.0) AD Community QoL-AD Age, Anxiety, 
Gender, Education, 
Duration 
Satisfactory 
Logsdon and Teri 
(1997) 
US Family 42 21 74.0 (8.0) 18.4 (6) AD Community PES-AD CSM Good 
Lucas-Carrasco et 
al. (2013) 
Spain Family 100 66 79.18 (7.09) 17.68 (4.19) AD 61, VaD 17, 
Mixed 14, 
Unspecified 8 
Community CBSQLD  Age Good 
Makai et al. (2012) Netherlands Family 
Health Care 
Professional  
96 68.00% 82 (9.1) Not specified dementia Nursing home ICECAP-O 
EQ-5D  
EQ-5D VAS 
Age, ADL, Gender, 
Education C 
Satisfactory 
Makai et al. (2014) Germany Health care 
professional 
95 56.80% 76.7 (8.5) Mild 5.3%, 
Moderate 
34.7%, 
Severe 60% 
AD 60%, Other 40% 
(ICD-10, F01; VaD; 
F02 other specified 
dementias) 
Nursing home ICECAP-O  Age, ADL, Gender, 
Diagnosis, Care home 
stay, CSM, Being 
married, Time caring 
(care home) 
Satisfactory 
Marventano et al. 
(2015) 
Spain Health care 
professional 
429 352 85.8 (6.7) CDR mild 
64, CDR 
moderate 
110, CDR 
severe 255 
Dementia  Nursing home QoL-AD Age, ADL, 
Depression, Gender, 
Education, Care 
home stay, GDS 
Good 
Matsui et al. (2006) Japan Family 140 84 72.4 (7.3) 20.3 (4.2) AD Community QoL-AD Age, ADL, NPS, 
Gender, Education, 
CSM, Memory rating 
Good 
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Miller et al. (2008) US Family 407 55.80% 77.860 
(7.462) 
15.002 
(5.801) 
AD Community HUI3 Age, ADL, NPS, 
Gender, Education, 
Ethnicity, CSM, 
Being married, 
Distress 
Good 
Miller et al. (2009) Family 421 55.80% 77.9 (7.5) 15.00 (5.80) AD Community ADRQL ADL, NPS Good 
Miller et al. (2010a) Family 413 56% 77.9 (7.5) 15.00 (5.80) AD Community and 
Assisted living 
ADRQL 
HUI3 
None Good 
Miller et al. (2012) Family 409 56.00% 77.9 (7.5) 15 (5.8) AD Community HUI3 Burden, Depression C Satisfactory 
Miranda-Castillo et 
al. (2010a) 
England Family 128 78 79.2 (6.8) 19.13 (7.2) Dementia  Community QoL-AD None Good 
Miranda-Castillo et 
al. (2010b) 
Family 119 78 79.85 (6.4)  19.1 (7.2) Dementia  Community QoL-AD Living alone Good 
Missotten et al. 
(2008b) 
Belgium Family 357 303 84.19 (7.14) 8.56 (6.81) Dementia  Long-term care 83% ADRQL Age, ADL, NPS, 
Gender, GDS, CSM, 
Community vs 
residential 
Good 
Missotten et al. 
(2007) 
Family 127 109 82.42 (7.01) 8.46 (7.21) Dementia  Institution 114 ADRQL None  Good 
Missotten et al. 
(2008a) 
Family 42 100 84.57 (6.31) (MMSE 0-3) Dementia  Nursing home or 
Home care 
ADRQL  None Good 
23 47 84.23 (7.18) (MMSE 4-8) 
45 69 84.83 (7.73) (MMSE 9-
13) 
42 59 83.51 (7.19) (MMSE 14-
18) 
18 21 84.76 (6.8) (MMSE 19-
23) 
Mjørud et al. 
(2014b) 
Norway Health care 
professional 
661 472 85.34 (8.63) Not specified AD 353, VaD 26, 
Mixed 12, DLB 22, 
other/unspecified 
221, FTD 27 
Nursing home QUALID Age, ADL, NPS, 
Health, Gender, Care 
home stay, GDS, 
Medication, 
Dementia unit 
Good 
Mjørud et al. 
(2014c) 
Health care 
professional 
198 156 87 (7.7) CDR1 49, 
CDR2 73, 
CDR3 76 
AD 94, Other 104 Nursing home QUALID NPS, Medication Satisfactory 
Mjørud et al. 
(2014a) 
Health care 
professional 
661 472 85.34 (8.63) CDR1 149, 
CDR2 222, 
CDR3 290 
AD 353, VaD 26, 
mixed 12, DLB 22, 
FTD 27, unspecified 
221 
Nursing home QUALID None Good 
Mougias et al. 
(2011) 
Greece Family 161 109 76.87 (7.03) 11.5 (7.08) AD 101, VaD 32, 
DLB 13, FTD 13, 
PDD 2 
Community ADRQL Age, ADL, NPS, 
Depression, Gender, 
Education, Co-
morbidity, Diagnosis, 
GDS, Relationship, 
Living alone, CSM, 
Medication, Being 
married, Burden, 
Depression C, 
Good 
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Education C, Age C, 
Gender C, Time 
caring (community) 
Mulhern et al. 
(2013) 
England Family 325 220 79.4 (8.5) 18.1 (6.6) AD Community 275, 
Nursing home 50 
EQ-5D ADL, NPS, 
Depression, CSM 
Good 
Murman et al. 
(2002), Murman et 
al. (2009) 
US Family 149 54% 76.75 (8.62) 14.94 (8.35) AD 89.26%, DLB 
10.74% 
Not specified QWB 
EQ-5D 
HUI2 
Age*, ADL*, NPS*, 
Education*, Co-
morbidity*, GDS*, 
CSM*, Burden*, 
Distress*, Age C* 
Satisfactory 
Naglie et al. (2006) US Family 60 37 78.6 18.9 (4.5) AD Own home 49, 
Senior’s apartment 4, 
Retirement home 6, 
Nursing home 1 
QWB 
HUI3 
EQ-5D  
EQ-5D VAS 
QoL-AD 
SF-36 
ADL, Depression, 
Health, Co-morbidity, 
CSM 
Good 
Naglie et al. 
(2011b) 
US Family 410 208 80.7 (7.9) 20.8 (6.2) AD Community QWB 
HUI3 
EQ-5D  
EQ-5D VAS 
QoL-AD 
SF-36 
Age, ADL, NPS, 
Depression, Gender, 
Co-morbidity, CSM, 
Being married, 
Burden, Depression C 
Good 
Naglie et al. 
(2011c) 
Family 272 50.2% 82.2 20.2 AD Community EQ-5D 
EQ-5D VAS 
QWB 
QoL-AD 
HUI3 
SF-36 
None Satisfactory 
Nagpal et al. (2015) US Family 111 59  76.80 (8.90) 20.7 (3.80) Dementia  Community QoL-AD Education, Ethnicity, 
CSM, Being married, 
Burden, Education C 
Satisfactory 
Nakanishi et al. 
(2011) 
Japan Health care 
professional 
116 Not 
specified 
86.2 (6.0) 15.1 (4.2) Dementia  Nursing home QoL-AD Age, Anxiety, ADL, 
NPS, Depression, 
Gender, Care home 
stay, GDS, CSM 
Satisfactory 
Nakanishi et al. 
(2012) 
Japan Health care 
professional 
1366 83.20% 85.56 (7.43) 4.15 (.87) out 
of 6, higher is 
worse 
Dementia  Nursing home ADRQL ADL Satisfactory 
Neumann et al. 
(2000) 
US Family 679 67% 81 (9) CDR.5 7%, 
CDR1 29%, 
CDR2 34%, 
CDR3 21%, 
CDR4 7%, 
CDR5 2% 
AD Community 52%, 
assisted living 24%, 
Nursing home 24% 
HUI2 
HUI3 
GDS Poor 
Novelli et al. (2010) Brazil Family 60 42 75.85  17.1  AD Not specified QoL-AD ADL, NPS, 
Depression, CSM, 
QoL C, Depression 
Good 
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C, Education C, 
Gender C 
Novelli and 
Caramelli (2010) 
Family 30 73.30% 75.5 (6.7) 20.2 (2.6) AD  Not specified QoL-AD None Good 
Family 30 66.70% 76.2 (6.2) 14.0 (2.8) AD  Not specified QoL-AD None 
Orgeta et al. 
(2015a) 
England, 
Wales 
Family 488 238 75.5 (7.3) CDR mild 
74.6%, CDR 
moderate 
25.4% 
Dementia  Community EQ-5D 
EQ-5D VAS 
Age, Anxiety, 
Depression, 
Relationship, GDS, 
GHQ, Burden, Age C 
Satisfactory 
Orgeta et al. 
(2015b) 
Family 488 238 77.6 CDR mild 
74.6%, CDR 
moderate 
25.4% 
Dementia  Community QoL-AD Age, Anxiety, 
Depression, Health, 
Gender, Education, 
Relationship, Living 
alone, GDS, Being 
married, GHQ, 
Burden, Education C, 
Age C, Gender C 
Good 
Woods et al. (2012) Family 488 242 77.53 (7.3) CDR mild 
74.6%, CDR 
moderate 
25.4% 
AD 106, VaD 23, 
DLB 1, Mixed 17, 
Unknown 36 
Community QoL-AD 
EQ-5D 
EQ-5D VAS 
ADL, QoL C, 
Depression C 
Good 
Pelletier and 
Landreville (2007) 
Canada Health care 
professional 
49 89.80% 82.7 (7.8) FAST 3 
4.1%, FAST 
4 2%, FAST 
5 16.3%, 
FAST 6 
53.1%, FAST 
7 24.5% 
AD Not specified Discomfort 
Scale 
NPS Good 
Porzsolt et al. 
(2004) 
Austria Health care 
professional 
217 173 84 (61-105) GDS 5.7 
(1.1) 
AD 34.5%, VaD 
61.5%, other 4% 
Nursing home The Vienna 
List  
ADL, GDS Satisfactory 
Rabins (2000) US Family 61 Not 
specified 
Not specified Not specified Dementia  Not specified ADRQL Depression, GDS, 
CSM 
Poor 
Røen et al. (2015) Norway Mix 169 117 84.9 (6.7) 14.0 (6.0) Dementia  Nursing home QUALID Age, ADL, NPS, 
Depression, Gender, 
GDS 
Satisfactory 
Rummel (2012) US Family  
Health care 
professional 
48 35 83.89 (6.78) 7.94 (7.49) Dementia  Memory care unit 
52%, Skilled nursing 
facility 35%, Adult 
day program 13% 
QoL-AD Anxiety, ADL, NPS, 
Depression, CSM, 
PCC, Burden 
Good 
Salek et al. (1996), 
Salek et al. (1999) 
Wales Family 70 34 75.3 (52-90) Not specified AD 45, Mixed 25 Community CDQLP  CSM Satisfactory 
Samus et al. (2005) US Health care 
professional 
134 108 86.1 (6.7) 14.64 (7.67) AD 78, VaD 17, 
DLB 1, Mixed/Not 
specified 38 
Nursing home ADRQL Age, Anxiety, NPS, 
Depression, Health, 
Gender, Education, 
Co-morbidity, 
Ethnicity, Care home 
stay, CSM, Being 
married 
Satisfactory 
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Samus et al. (2006) Health care 
professional 
198 156 86.1 (6.7) 13.6 (3.1) AD 78, VaD 17, 
DLB 1, Mixed/Not 
specified 38, no 
dementia 64 
Nursing home ADRQL None Good 
Bicket et al. (2010) Health care 
professional 
194 77.80% 85.4 (8.8) Not specified Dementia  Assisted living ADRQL None Satisfactory 
Schulz et al. (2010) US Family 105 63 77.3 (8.2) ≤15 26, 16-
23 37, ≥24 42 
AD Community QoL-AD None Satisfactory 
Family 121 Not 
specified 
Not specified ≤15 82, 16-
23 25, ≥24 10 
AD Community QoL-AD None 
Selai et al. (2001a) England Family 22 10 65 (8) ≥10 Mostly AD Community QOLAS ADL, NPS, Gender Satisfactory 
Shata et al. (2015) Egypt Family 100 56 67.61 (6.41) 11.86 (1.97) Dementia  Community QoL-AD ADL, Depression Good 
Sheehan et al. 
(2012) 
England Family 109 83 85 CDR.5 2, 
CDR1 14, 
CDR2 64, 
CDR3 29 
Dementia  General hospital 
inpatients 
QoL-AD 
EQ-5D 
Age, ADL, 
Depression, Gender, 
GDS, GHQ 
Good 
Shin et al. (2005) US Family 62 36 75.53 (7.87) 19.36 (5.22) AD Community QoL-AD Anxiety, NPS, 
Depression 
Good 
Siedlecki et al. 
(2009) 
France, US Family 277 56.70% 75.79 (7.82) mMMSE 
41.60 (6.23) 
AD Community AAIQoL Age, ADL, NPS, 
Depression, CSM 
Good 
Sixsmith et al. 
(2008) 
Estonia, 
Finland, 
Germany, 
Sweden, UK 
Health care 
professional 
394 292 83.86 (8.37) 5.4 Dementia  Residential care 320, 
Community 74 
QUALID ADL, Gender, Co-
morbidity, Diet, Pain, 
Medication 
Poor 
Sjögren et al. 
(2013) 
Sweden Health care 
professional 
1245 870 85.0 (7.5) Not specified, 
but mostly 
severe 
Dementia  Nursing home QUALID PCC Satisfactory 
Edvardsson et al. 
(2014) 
Health care 
professional 
1257 872 86 (7.5) GRS 11.30  Dementia  Nursing home QUALID None Satisfactory 
Sloane et al. (2005) US Health care 
professional 
246 79% 85 Mild 12%,  
Moderate 
25%, Severe 
27%, Very 
severe 37% 
Dementia  Nursing home AAIQoL 
ADRQL 
QoL-AD 
ADL, NPS, 
Depression, Pain, 
CSM 
Good 
Dobbs et al. (2005) Health care 
professional 
329 Not 
specified 
84.7 Not specified Dementia  Residential care or 
Assisted living 
AAIQoL ADL, NPS, 
Depression, Diet, 
Pain, CSM 
Satisfactory 
Winzelberg et al. 
(2005) 
Health care 
professional 
335 268 85.25 7.5 Dementia  Residential care or 
Assisted living 
QoL-AD Age, ADL, NPS, 
Depression, Gender, 
Ethnicity, Pain, CSM, 
PCC 
Satisfactory 
Zimmerman et al. 
(2005) 
Health care 
professional 
241 333 203 under 
85, 206 85 
and over 
7.5 Dementia  Residential care or 
Assisted living 
ADRQL Medication, PCC Good 
Smith et al. (2005) England Family 48 59 78.65 (8.30) 16.01 (8.53) Dementia  Not specified QoL-AD 
SF-12 
Age, ADL, 
Depression, Gender, 
CSM, GHQ, Age C, 
Gender C 
Good 
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Smith et al. (2007) Family 77 43 78.49 (8.32) 19.93 (4.84) Dementia  Community QoL-AD GHQ Satisfactory 
Family 21 16 79.23 (8.42) 2.9 (3.6) Dementia  Community QoL-AD None 
Snow et al. (2005) US Family 89 0 74.0 (9.37) DRS scores 
<46 9, 47-
102 39, 102-
139 45 
 
Dementia  Community QoL-AD ADL, NPS, 
Depression, Pain, 
CSM, Depression C 
Satisfactory 
Snow et al. (2009) Family 171 52 75.81 (6.19) Not specified Dementia  Community PES-AD  Pain Good 
Ball et al. (2010) Family 171 3% 76 (6.04) Not specified Dementia  Community PES-AD None Satisfactory 
Spector et al. 
(2016) 
England Family 50 20 78.40 (6.97) 20.92 (5.20) Dementia  Community QoL-AD None Good 
Telenius et al. 
(2013) 
Norway Health care 
professional 
166 125 86.9 (7.36) 15.6 (4.9) Dementia  Nursing home QUALID Age, ADL, Gender, 
Co-morbidity, Care 
home stay, CSM, 
Medication 
Good 
Terada et al. (2002) Japan Mix 
(Health care 
professional 
90%) 
264 180 81.5 (7.9) Moderate to 
Severe 
dementia 
AD 119, VaD 79, 
Mixed 37, Other 27 
Geriatric health 
services 112, 
Hospital 104, 
Nursing home 11%, 
home 7%, Group 
home 1% 
QLQD  ADL, CSM Good 
Terada et al. (2013) Health care 
professional 
112 80 80.9 Not specified AD 70, VaD 35, 
Other 7 
Geriatric health 
services facilities 
QLQD  PCC Satisfactory 
Health care 
professional 
104 59 80.9 Not specified AD 56, VaD 29, 
Other 19 
Hospital None 
Thomas et al. 
(2006) 
France Health care 
professional 
100 64 80.2 (6.8) 12.8 (5.8) AD 84, Mixed 9, 
DLB 7 
Community ADRQL Age, ADL, NPS, 
Depression, 
Diagnosis, CSM, 
Duration, QoL C, 
Age C 
Satisfactory 
Trigg et al. (2011) England Family 68 30 <65 3, 65-74 
10, 75-84 49, 
≤85 7 
22.43 (2.44) AD 54, VaD 7, FTD 
5, DLB 3 
Living alone 14, 
Living with spouse 
49, Living with 
relative/other 6 
ADRQL Awareness, ADL, 
CSM 
Good 
Trigg et al. (2015) England Family 145 88 77.78 (9.24) 12.64 (8.57) AD Community EQ-5D 
DEMQOL 
ADL, NPS, CSM Good 
Vogel et al. (2006) Denmark Family 48 Not 
specified 
77.0 (5.8) 24.9 (2.3) AD Community QoL-AD 
EQ-5D VAS 
Age, NPS, 
Depression, Gender, 
CSM 
Good 
Volicer et al. (1999) US Researcher 57 77.20% 82.7 (7.5) 5.2 (4.8) AD Nursing home OERS  NPS, Depression Satisfactory 
Warden et al. 
(2003) 
US Health care 
professional 
19 Not 
specified 
78.1 (5) 2.8 (4.5) Dementia  Nursing home Discomfort 
Scale 
Pain Satisfactory 
Weiner et al. (2000) US Health care 
professional 
41 28 80.6 11.53 (6.23) AD Nursing home QUALID Anxiety, ADL, NPS, 
Depression, CSM 
Satisfactory 
Weyerer et al. 
(2010) 
Germany Health care 
professional 
725 600 83.15 dementia 
score 9.9 (1 
no 
Dementia  Nursing home AAIQoL Dementia unit Satisfactory 
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impairment - 
16 severe) 
Whitlatch et al. 
(2005) 
US Family 111 60 77 (9) 20.7 (3.8) AD 42%, non-
specific dementia 
25%, stroke 11%, 
Other dementia 11%, 
PD 8%, Other 3% 
Community QoL-AD None Satisfactory 
Wlodarczyk et al. 
(2004) 
Australia Family 78 60 71.7 (8.5) 20.2 (5.6) AD Australian elderly 
care centres 
AQoL ADL, CSM Good 
Wolak et al. (2009) France, 
Switzerland 
Family 120 77 82.2 (6.0) 20.8 (4.5) AD Living alone 28, 
Living with spouse 
70, 
Institution/sheltered 
18, other 3 
QoL-AD ADL, NPS, Co-
morbidity, Burden, 
Distress 
Satisfactory 
Wolak-Thierry et 
al. (2015) 
Family 123 63.40% 82.0 (6.0) MMSE 
between 11-
29 
AD Not specified QoL-AD Depression, GDS, 
CSM 
Good 
Wolfs et al. (2007) Netherlands Family 196 150 77.8 (6.7) 20.21 (5.78) AD 97, VaD 26, 
Mixed 21, Other 20 
Community EQ-5D 
EQ-5D VAS 
CSM Satisfactory 
Yamamoto-Mitani 
et al. (2004) 
Japan Health care 
professional 
623 477 81.7 (7.9) Early 92, 
Moderate 
209, Severe 
186, Very 
severe 136 
AD 184, VaD 281, 
Mixed 43, Other 115 
Nursing home 185, 
Hospital 81, Geriatric 
health services 
facilities 114, Day 
care 243 
ADRQL Age, ADL, Gender, 
Diagnosis, GDS, 
Dementia unit, 
Education C, Gender 
C 
Satisfactory 
Yap et al. (2008) Singapore Family 67 45 78.4 (7.5) 16.1 (5.4) AD 58.6%, Mixed 
32.8%, VaD 6.9%, 
PDD 1.7% 
Live with spouse 
81.7% 
QoL-AD ADL, NPS, 
Depression, Memory 
rating, GHQ, Burden 
Satisfactory 
Young (2001) US Health care 
professional 
104 82 86.3 8.55 (7.78) Dementia  Nursing home Discomfort 
Scale 
ADL, NPS, 
Depression, Pain, 
CSM 
Good 
Yu et al. (2013) China Family 87 48% 73.6 (7.7) MoCA 7.26 
(5.51) 
AD Community QoL-AD Anxiety, ADL, 
Depression, Burden 
Good 
Zucchella et al. 
(2015) 
Italy Family 135 93 78.2 (5.9) 15.3 (7.5) AD Live with carer 
56.3% 
QoL-AD NPS, Depression Satisfactory 
Note: articles were judged to be of poor quality if scored ≤20 or below, satisfactory scored between >20 and <26, good scored ≥26. Shading indicates articles using the same 
study data. “Severity” refers to Mini-Mental State Examination score unless otherwise specified. * indicates data not reported in articles 
 
Quality of life measure abbreviations: 12-Item Short Form Health Survey (SF-12), 36-Item Short Form Health Survey (SF-36), Activity and Affect Indicators of QOL (AAIQoL), 
Alzheimer's Disease Related Quality of Life (ADRQL), Assessment of Quality of Life (AQoL), Community Dementia Quality of Life Profile (CDQLP), Cornell-Brown Scale for 
Quality of Life in Dementia (CBSQLD), Dementia Quality of Life Questionnaire (DEMQOL), Dementia Quality of Life Instrument (DQoL), Disability and Distress Index 
(DDI), EuroQol five dimensions questionnaire (EQ-5D), Health Utility Index (HUI), Investigating Choice Experiments for the Preferences of Older People CAPability for Older 
people (ICECAP-O), Linear Analogue Self Assessment (LASA), Nottingham Health Profile (NHP), Observable Displays of Affect Scale (ODAS), Observed Emotion Rating 
Scale (OERS), Pleasant Events Schedule-Alzheimer's disease (PES-AD), Quality of Life Assessment Schedule (QOLAS), Quality of Life in Alzheimer's Disease (QoL-AD), 
QUAlity of LIfe in DEMentia (QUALIDEM), Quality of Life in Late Stage Dementia Scale (QUALID), Quality of Life Questionnaire for Dementia (QLQD), Quality of Well-
Being scale (QWB), Source of Discomfort Scale (SDS), Visual Analogue Scale, (VAS), World Health Organization (WHO) 
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Severity abbreviations: Clinical Dementia Rating (CDR), Dementia Rating Scale (DRS), Functional Assessment Staging Test (FAST), Geriatric Rating Scale (GRS), Global 
Deterioration Scale (GDS), Mini-Mental State Examination (MMSE), Modified Mini-Mental State Examination (3MS), Modified Mini-Mental State Examination (mMMSE), 
Montreal Cognitive Assessment (MoCA), Severe Impairment Rating Scale (SIRS) 
 
Dementia type abbreviations: Alzheimer's disease (AD), Behavioural-variant frontotemporal dementia (bvFTD), Cerebral Autosomal-Dominant Arteriopathy with Subcortical 
Infarcts and Leukoencephalopathy (CADASIL), Cerebrovascular disease (CVD), Dementia with Lewy bodies (DLB), Frontotemporal Dementia (FTD), mild cognitive 
impairment (MCI), Parkinson's Disease Dementia (PDD), Vascular dementia (VaD) 
 
Factors included in the meta-analysis abbreviations: Alzheimer’s (vs. other dementia subtypes) (Diagnosis), Better functional ability (ADL), Better self-rated health (Health), 
Better self-rated memory functioning (Memory rating), Burden or stress (Burden), Cared for by spouse (vs. other carer type) (Relationship), Carer Depression (Depression C), 
Carer quality of life (self-rated) (QoL C), Community vs residential (Community dwelling (vs. residential care)), Degree to which residential care is person-centred (PCC), 
Dementia unit (Special dementia unit (vs. other residential facility)), Distress at NPS symptoms (Distress), Higher level of education (Education), Higher level of carer education 
(Education C), Higher scores on cognitive screening measures (CSM), Female gender (Gender), Female gender carer (Gender C), Longer duration of care home stay (Care home 
stay), Longer disease duration (Duration), More awareness (Awareness), More advanced dementia (GDS), More time spent caring (community only) (Time caring (community)), 
More time spent caring (residential care only) (Time caring (care home)), Neuropsychiatric symptoms/BPSD (NPS), Older age (Age), Older age carer (Age C), Poorer mental 
health (General Health Questionnaire (GHQ)) (GHQ), Presence of co-morbid conditions (Co-morbidity), Taking medication (Medication), Underweight (Diet), White ethnicity 
(Ethnicity) 
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Supplementary Table 5. Studies utilising proxy ratings of quality of life in people with dementia 
 
Study Country of 
study 
Relationship of 
informant to 
person with 
dementia 
n Females Mean age Severity Dementia type Living situation QoL 
measure 
Factors included in the 
meta-analysis 
Quality 
rating 
Ballard et al. (2001) England Health care 
professional 
112 79.50% 85.5 (6.8) 8.4 (7.2) Dementia Residential/ 
Nursing home 
DCM NPS, Medication Satisfactory 
Bosboom et al. 
(2012b) 
Australia Family 80 67.50% 78.3 (7.9) Not specified AD Community  QoL-AD  Age, ADL, NPS, 
Depression, Medication, 
Gender, Age C 
Good 
Chung (2004) Hong Kong Researcher 43 29 81.2 (7.01) CDR1 6, CDR2 
15 CDR3 22 
AD 28, VaD 10, 
Mixed 5 
Nursing home DCM GDS Good 
de Rooij et al. 
(2012) 
Netherlands 
 
Health care 
professional 
102 75 84.25 (5.49)  6.29 (5.93)  Dementia  Dutch traditional 
sized Nursing 
home 51, Dutch 
small scale 
Nursing home 51 
QUALIDEM  None Good 
Belgium Health care 
professional 
77 67 86.81 (6.36)  7.09 (6.82)  Dementia  Belgian traditional 
sized Nursing 
home 30, Belgium 
small scale 
Nursing home 47 
QUALIDEM  Depression 
Edelman et al. 
(2004b) 
US Researcher 166 75% 83.5 (6.1) 10.6 (7.1) Dementia  Special care 
facilities 62, 
Assisted living 
facilities 49, Adult 
day centres 55 
DCM  Age, ADL, Depression, 
Co-morbidity, CSM, 
Gender 
Satisfactory 
Edelman et al. 
(2007) 
Health care 
professional 
30 77% 85.0 (7.8) 80% MMSE of 
0 
Dementia  Nursing home OQOLDA Age, ADL, Depression, 
CSM 
Satisfactory 
Edelman et al. 
(2004a) 
Researcher 54 61.80% 80.8 (6.5) 12.5 (7.3) Dementia Nursing home DCM None Satisfactory 
Edelman et al. 
(2005) 
Researcher 117 85.50% 86.0 (6.8) 7.9 (6.8) Dementia  special care 
facilities 
DCM None Satisfactory 
Researcher 55 80.00% 85.3 (5.4) 11.1 (6.8) Dementia  assisted living 
facility 
DCM None 
Kuhn et al. (2005) Researcher 111 75% 83.5 10.6 Dementia  Special care 
facilities 62, 
Assisted living 
facilities 49, Adult 
day centres 55 
DCM None Satisfactory 
Ettema et al. 
(2007a) 
Netherlands Health care 
professional 
202 182 84.69 (6.85) GDS2 2, GDS3 
5, GDS4 21, 
GDS5 64, 
GDS6 110, 
GDS7 36 
AD 117, VaD 29, 
Mixed 22, other 
21, unknown 49 
Nursing home QUALIDEM  ADL, NPS, Depression, 
GDS 
Satisfactory 
 35 
 
Fleming et al. 
(2016) 
Australia Health care 
professional 
275 211 84.33 (8.66) GDS2 = 10, 
GDS3 = 45, 
GDS4 = 55, 
GDS5 = 67, 
GDS6 = 98 
Controls 51, 
Dementia 75, AD 
1, DLB 1, FTD 1, 
Huntingtons 11, 
Korsakoffs 5, 
PDD 29, VaD 13, 
Mixed 86, 
unspecified 2 
Nursing home DEMQOL Age, ADL, GDS, Co-
morbidity, Medication, 
Gender 
Satisfactory 
Funaki et al. (2005) Japan Researcher 25 18 81.2 (6.38) HDS-R 10.6 
(5.9) 
AD 14, VaD 2, 
other 9 
Group home QLQD ADL, NPS, Satisfactory 
Gómez-Gallego et 
al. (2015) 
Spain Family 81 68.60% 72.09 (6.39) 18.51 (4.29) AD Community  DEMQOL NPS, Depression, Co-
morbidity, CSM 
Good 
Gräske et al. (2015) Germany Health care 
professional 
396 275 78.4 (11.1) GDS0-5 63, 
GDS6 167, 
GDS7 152 
Dementia  Nursing home QUALIDEM Age, NPS, GDS, Gender Satisfactory 
Hodgson et al. 
(2014) 
US Family 88 46 81.67 (8.02) 17.7 (4.57) Dementia  Community  DEMQOL Age, Co-morbidity, 
CSM 
Good 
Hurt et al. (2010) England, 
Finland, 
France, 
Greece, Italy, 
Poland 
Family 155 107 77.2 (6.5) 20.6 (4.9) AD Not specified DEMQOL Age, ADL, NPS, Good 
Jones et al. (2015) England Family 221 53.80% 79.7 (8.5) 14.6 (6.8) AD Community 86%, 
Residential home 
14% 
EQ-5D 
DEMQOL 
ADL, NPS, CSM Good 
Trigg et al. (2012a, 
2012b) 
Family 249 53.80% 79.7 (8.5) 14.6 (6.8) AD Community 86%, 
Residential home 
14% 
EQ-5D 
DEMQOL 
ADL Satisfactory 
Karlawish et al. 
(2001b) 
US Family 40 27 74.9 (8.0) 16.3 (7.8) AD Community  Single 
question - 
How would 
your relative 
rate his or her 
overall 
quality of 
your 
relative’s life 
at present? 
Age, NPS, GDS, CSM, 
Gender, Age C 
Satisfactory 
Lucas-Carrasco et 
al. (2010) 
Spain Family 95 67 79.2 (7.0) 19.49 (4.45) MCI 19, AD 47, 
VaD 14, Mixed 
10, Other 6, 
unknown 6 
Community  DEMQOL Age, ADL, Depression, 
CSM, Gender 
Good 
Mulhern et al. 
(2013) 
England Family 317 220 79.4 (8.5) 18.1 (6.6)  AD Community 267, 
Nursing home 50 
DEMQOL ADL, NPS, Depression, 
CSM 
Good 
Ní Mhaoláin et al. 
(2012) 
Ireland Family 115 71 74.13 (9.14) 20.5 (6.5) AD Community  DEMQOL Age, ADL, NPS, GDS, 
CSM, Gender 
Good 
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Schiffczyk et al. 
(2011) 
Germany Family 194 57 73.0 (7.1) 17.3 (6.8) AD or Mixed Community  QoL-AD Age, ADL, NPS, 
Depression, Medication, 
CSM, Age C 
Satisfactory 
Schiffczyk et al. 
(2010) 
Family 137 30.70% 73.0 (6.7) 16.9 (6.4) AD or Mixed Community  EQ-5D None Good 
Schulz et al. (2010) US Family 105 63 77.3 (8.2) 26=0-16, 
37=16-23, 
42=24+ 
AD Community  DEMQOL None Satisfactory 
Sloane et al. (2005) US Researcher 222 79% 85 (65-101) Mild 12%, 
Moderate 25%, 
Severe 27%, 
Very severe 
37% 
AD 54%, VaD 
4%, Mixed 5%, 
Other 37% 
Nursing home DCM 
RSOC-QOL, 
OERS 
Age, ADL, NPS, 
Depression, Co-
morbidity, Gender 
Good 
Zimmerman et al. 
(2005) 
Health care 
professional 
211 333 <85 203, ≥85 
206 
7.5 Dementia  Residential care or 
Assisted living 
OERS 
DCM 
Medication Good 
Sloane et al. (2007) UK Researcher 133 Not 
specified 
Not specified Not specified Dementia  Nursing home 
(UK descriptive 
studies) 
DCM  GDS, CSM Poor 
Smit et al. (2016) Netherlands Health care 
professional 
1144 75.20% 84.22 (7.57) CPS 3.99 (1.50) Dementia  Nursing home QUALIDEM  None Good 
Smith et al. (2005) England Family 99 59 78.65 (8.30) 16.01 (8.53) Dementia  Community 79%, 
21% Residential, 
Nursing, Sheltered 
or Dual registered 
DEMQOL ADL, Depression, 
Gender, Age C 
Good 
Banerjee et al. 
(2006) 
Family 99 59 78.7 (8.3) 16.0 (8.5) Dementia Community 79%, 
21% Residential, 
Nursing, Sheltered 
or Dual registered 
DEMQOL Age, NPS, Depression, 
CSM 
Satisfactory 
Smith et al. (2007) Family 77 43 78.49 (8.32) 19.93 (4.84)  Dementia  Community  DEMQOL None Satisfactory 
Family 21 16 79.23 (8.42) 2.9 (3.6) Dementia  Community  DEMQOL None 
Thornton et al. 
(2004) 
UK Researcher 64 27 74.46 (9.58) CAPE -CAS 10 
(7.92) 
Dementia  Hospital ward 22, 
Day hospital 42 
DCM None Satisfactory 
Wetzels et al. 
(2010) 
Netherlands Health care 
professional 
207 72.50% 83.4 (6.8) 9.5 (6.0) (GDS 
4-6) 
AD 36.2%, VaD 
11.6%, Mixed 
7.2%, Other 
44.9% 
Nursing home QUALIDEM Age, ADL, NPS, 
Depression, GDS, 
Medication, Gender 
Good 
Health care 
professional 
81 86.40% 84.6 (8.0) 0.7 (1.6) (GDS 
7) 
AD 45.7%, VaD 
7.4%, Mixed 
3.7%, Other 
43.2% 
Nursing home QUALIDEM Age, ADL, NPS, 
Depression, Medication, 
Gender 
Ven-Vakhteeva et 
al. (2013) 
Health care 
professional 
207 150 83.7  9.4 (6.1) Dementia  Nursing home QUALIDEM None Good 
Wolf-Ostermann et 
al. (2012) 
Germany Health care 
professional 
56 43 82.3 (9.25)  GDS4 6, GDS5 
5, GDS6 38, 
GDS7 7 
Dementia  Shared-housing 
34, Special care 
units 22 
QUALIDEM  Gender Good 
Note: articles were judged to be of poor quality if scored ≤20 or below, satisfactory scored between >20 and <26, good scored ≥26. Shading indicates articles using the same 
study data. “Severity” refers to Mini-Mental State Examination score unless otherwise specified.  
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Quality of life measure abbreviations: Dementia Care Mapping (DCM), Dementia Quality of Life Questionnaire (DEMQOL), EuroQol five dimensions questionnaire (EQ-5D), 
Health Utility Index (HUI), Observed Emotion Rating Scale (OERS), Observing QOL for Dementia Advanced (OQOLDA), Resident and Staff Observation Checklist-Quality of 
Life Measure (RSOC-QOL), Quality of Life in Alzheimer's Disease (QoL-AD), QUAlity of LIfe in DEMentia (QUALIDEM), Quality of Life Questionnaire for Dementia 
(QLQD) 
 
Severity abbreviations: Clifton Assessment Procedure for the Elderly-Cognitive Assessment Scale (CAPE-CAS), Clinical Dementia Rating (CDR), Cognitive Performance Scale 
(CPS), Global Deterioration Scale (GDS), Hasegawa Dementia Scale-Revised (HDS-R), Mini-Mental State Examination (MMSE) 
 
Dementia type abbreviations: Alzheimer's disease (AD), Dementia with Lewy bodies (DLB), Frontotemporal Dementia (FTD), mild cognitive impairment (MCI), Parkinson's 
Disease Dementia (PDD), Vascular dementia (VaD) 
 
Factors included in the meta-analysis abbreviations: Better functional ability (ADL), Female gender (Gender), Higher scores on cognitive screening measures (CSM), More 
advanced dementia (GDS), Neuropsychiatric symptoms/BPSD (NPS), Older age (Age), Older age carer (Age C), Presence of co-morbid conditions (Co-morbidity), Taking 
medication (Medication) 
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Supplementary Table 6. Studies utilising difference scores for ratings of quality of life in people with dementia 
 
Study Country of 
study 
Difference n Females Mean age Severity Dementia type Living situation QoL measure Factors included in the 
meta-analysis 
Quality 
rating 
Andrieu et al. 
(2016) 
France Self vs. Family 501 331 79.6 (5.9) 19.5 (3.9) AD Community QoL-AD Age, ADL, NPS, CSM, 
Gender, Age C, Living alone, 
Education, Burden, Gender C 
Good 
Buckley et al. 
(2012) 
US Self vs. Family 144 151 85.60 (5.77) 19.78 
(7.25) 
Dementia  Not specified Single global 
QoL question 
NPS, Co-morbidity, CSM, 
Gender, Education 
Good 
Conde-Sala et al. 
(2014b) 
Spain Self vs. Family 119 76 77.0 (6.7) 18.9 (3.6) Dementia  Community QoL-AD ADL, NPS, Burden Good 
Conde-Sala et al. 
(2014a) 
Spain Self vs. Family 141 83 77.6 (7.2) 17.6 (5.9) AD Not specified QoL-AD ADL, NPS, CSM, Burden, 
Gender C 
Good 
Conde-Sala et al. 
(2016) 
Self vs. Family 221 140 77.8 (0.4) 18.3 (0.3) AD Not specified QoL-AD None Good 
Devine et al. (2014) England Self vs. Health 
care professional 
proxy 
565 430 86.2 (7.4) 19.0 (6.5) Dementia  Nursing home EQ-5D Age, Depression, CSM, 
Gender 
Good 
Edelman et al. 
(2005) 
US Self vs. Health 
care professional 
65 81.5 85.6 (5.8) 15.6 (3.8) Dementia  Nursing home QoL-AD CSM Satisfactory 
Fuh and Wang 
(2006) 
Taiwan Self vs. Family 81 49 77.2 (6.8) 20.1 (4.5) AD Not specified QoL-AD Age, ADL, NPS, CSM, 
Education 
Satisfactory 
Gómez-Gallego et 
al. (2015) 
Spain Self vs. Family 
proxy 
81 68.60% 72.09 (6.39) 18.51 
(4.29) 
AD Community DEMQOL NPS, Depression, Co-
morbidity, CSM, Burden 
Good 
Huang et al. (2009) Taiwan Self vs. Family 120 58 78.40 (9.13) 18.64 
(6.23) 
AD Community QoL-AD Age, NPS, Co-morbidity, 
CSM, Gender, Age C, Being 
married, Education, Gender 
C 
Satisfactory 
Kunz (2010) Germany Self vs. Family 319 67.50% 80.2 (6.7) 18.6 (3.8) Dementia  Community EQ-5D Age, ADL, CSM, Gender, 
Age C, Living alone, Burden, 
Gender C 
Satisfactory 
Novella et al. 
(2001c) 
Belgium, 
France, 
Luxembourg, 
Switzerland 
Self vs. Family 
Self vs. Health 
care professional 
66 63 82 (7.9) 15.6 (3.95) AD Community 26.3%, 
Hospital 46.1%, 
Institution 27.6% 
DHP Age, ADL, Gender, Living 
alone 
Good 
Novella et al. (2006) Self vs. Family 
Self vs. Health 
care professional 
63 54 82 (7.9) 15.7 (4.2) AD Community 26.3%, 
Hospital 46.1%, 
Institution 27.6% 
SF-36 Age, ADL, Gender Good 
Novelli and 
Caramelli (2010) 
Brazil Self vs. Family 30 73.30% 75.5 (6.7) 20.2 (2.6)  AD Not specified QoL-AD ADL, NPS, Depression, 
CSM 
Good 
Self vs. Family 30 66.70% 76.2 (6.2) 14.0 (2.8) AD Not specified QoL-AD 
Rummel (2012) US Self vs. Family 
Self vs. Health 
care professional 
Family vs. Health 
care professional 
26 35 83.89 (6.78) 7.94 (7.49) Dementia  Memory care unit 
52%, Skilled nursing 
facility 35%, Adult 
day program 13% 
QoL-AD ADL, NPS, Depression, 
CSM 
Good 
Sands et al. (2004) US Self vs. Family 91 63.00% 78.7 (7.6) 19.7 (4.5) AD, DLB, FTD, 
PDD, VaD 
Community DQoL Age, ADL, Depression, 
CSM, Gender, Age C, Being 
Satisfactory 
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married, Living alone, 
Burden, Gender C 
Schiffczyk et al. 
(2010) 
Germany Self vs. Family 137 30.70% 73.0 (6.7) 16.9 (6.4) AD or Mixed Community EQ-5D CSM Good 
Schulz et al. (2013) US Self vs. Family 79 27 76.0 (8.5) 23.1 (3.6) AD Community QoL-AD 
DEMQOL 
Age, CSM, Gender, Age C, 
Being married, Education, 
Burden, Gender C 
Good 
Spector and Orrell 
(2006) 
England Self vs. Health 
care professional 
76 67 85.2 (7.4) 13 (4.8) Dementia  Nursing home QoL-AD Age, CSM Good 
Tay et al. (2014) Singapore Self vs. Family 165 91 76.8 (6.9) 18.4 (4.2) Dementia  Community QoL-AD Age, ADL, NPS, Depression, 
CSM, Gender, Age C, Being 
married, Living alone, 
Education, Burden, Gender C 
Good 
Vogel et al. (2006) Denmark Self vs. Family 17 Not 
specified 
77.0 (5.8) 24.9 (2.3) AD Community QoL-AD 
EQ-5D  
EQ-5D VAS 
None Good 
Zbrozek et al. 
(2006) 
US Self vs. Family 110 Not 
specified 
Not specified Not 
specified 
AD Community HUI2 ADL, Depression, CSM, Satisfactory 
Zhao et al. (2012) France, 
Switzerland 
Self vs. Family 122 78 82 (6) 21 (5) AD Community or 
Institutional  
QoL-AD Age, ADL, NPS, Depression, 
Co-morbidity, CSM, Gender, 
Age C, Being married, 
Living alone, Education, 
Burden, Gender C 
Good 
Zucchella et al. 
(2015) 
Italy Self vs. Family 135 93 78.2 (5.9) 15.3 (7.5) AD Live with carer 56.3% QoL-AD ADL, NPS, Depression, 
CSM, Living alone, Burden 
Satisfactory 
Note: articles were judged to be of poor quality if scored ≤20 or below, satisfactory scored between >20 and <26, good scored ≥26. Shading indicates articles using the same 
study data. “Severity” refers to Mini-Mental State Examination score unless otherwise specified. 
 
Quality of life measure abbreviations: 36-Item Short Form Health Survey (SF-36), Dementia Quality of Life Questionnaire (DEMQOL), Dementia Quality of Life Instrument 
(DQoL), Duke Health Profile (DHP), EuroQol five dimensions questionnaire (EQ-5D), Health Utility Index (HUI), Quality of Life in Alzheimer's Disease (QoL-AD), Visual 
Analogue Scale, (VAS) 
 
Dementia type abbreviations: Alzheimer's disease (AD), Dementia with Lewy bodies (DLB), Frontotemporal Dementia (FTD), Parkinson's Disease Dementia (PDD), Vascular 
dementia (VaD) 
 
Factors included in the meta-analysis abbreviations: Better functional ability (ADL), Burden or stress (Burden), Higher level of education (Education), Higher scores on 
cognitive screening measures (CSM), Female gender (Gender), Female gender carer (Gender C), Neuropsychiatric symptoms/BPSD (NPS), Older age (Age), Older age carer 
(Age C), Presence of co-morbid conditions (Co-morbidity) 
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Supplementary Table 7. Longitudinal studies of quality of life in people with dementia 
 
Study Country of 
study 
Time 
period 
n Females Mean age Severity Dementia type Living situation QoL measure Factors included in the 
meta-analysis 
Quality 
rating 
Albert et al. (2001) US 24 months 
median 
122 Not 
specified 
74.175 (8.05) Not specified AD Mostly 
community 
AAIQoL  CSM Good 
Beerens et al. 
(2015) 
England, 
Estonia, 
Finland, 
France, 
Germany, 
Netherlands, 
Spain, Sweden 
3 months 343 256 84.3 (6.0) 14.1 (5.2) Dementia  Not specified QoL-AD Baseline QoL Satisfactory 
Castro-Monteiro et 
al. (2014) 
Spain 20 months 274 224 84.70 (6.51) 12.96 (8.51) Dementia  Residential care EQ-5D 
QoL-AD 
Baseline QoL Satisfactory 
Clare et al. (2014b) Wales 20 months 51 25 76.75 (7.88) 24.5 (2.80) AD 31, VaD 11, 
Mixed 9 
Community QoL-AD  Age*, Depression, 
Baseline QoL, ADL*, 
NPS*, CSM*, Gender*, 
Baseline QoL* 
Good 
Funaki et al. (2005) Japan 3 months 25 18 81.2 (6.38) HDS-R 10.6 
(5.9) 
AD 14, VaD 2, 
Other 9  
Group home QLQD Baseline QoL, Satisfactory 
Heggie et al. (2012) Canada 12 months 32 15 72.5 (9.4) 3MS 75.8 (18.7) Dementia  Community (rural 
and remote 
settings) 
QoL-AD  Depression, Baseline QoL Good 
Hoe et al. (2009) England, Wales 5 months 182 152 85.8 (7.6) 7.4 (8.0) Dementia  Nursing home QoL-AD  Age, ADL, NPS, 
Depression, CSM, Gender, 
GDS, Baseline QoL 
Good 
Livingston et al. 
(2008) 
England 18 months 122 Not 
specified 
80.4 (7.3) 16.7 (6.9) AD Not specified QoL-AD life as 
whole item  
Age, ADL, NPS, GDS, 
CSM, Baseline QoL 
Good 
Lyketsos et al. 
(2003) 
US 24 months 47 45 80.4 (7.3) 8.4 (7.2) Dementia  Long term care ADRQL  Age, NPS, Depression, 
CSM, Gender, Baseline 
QoL 
Good 
Mjørud et al. 
(2014c) 
Norway 10 months 143 116 87.2 7.9) CDR1 23, 
CDR2 57, 
CDR3 63 
AD 94, Other 104 Nursing home QUALID  Baseline QoL Satisfactory 
Nakanishi et al. 
(2016) 
Japan 35.9 (5.4) 
months 
32 27 84.3 (5.5) 15.9 (3.7) Dementia  Nursing home QoL-AD  Age, ADL, NPS, CSM, 
Gender, GDS, Baseline 
QoL 
Poor 
Sheehan et al. 
(2013) 
England 6 months 66 51 86.0 (76.5) CDR1 4, CDR2 
31, CDR3 31. 
Dementia General hospital 
inpatients 
QoL-AD  Age, Gender, GDS, 
Baseline QoL 
Good 
12 months 59 37 86.5 (6.2) CDR1 4, CDR2 
24, CDR3 31 
Dementia  General hospital 
inpatients 
QoL-AD  Age, Baseline QoL 
de Sousa et al. 
(2015) 
Brazil 12 months 55 72 76.8 (7.3) 21.4 (3.5) AD Not specified QoL-AD  None Satisfactory 
Sura et al. (2015) US 60 months 112 64 65-79 59; ≥80 
53 
Not specified Dementia  Not specified SF-12 Baseline QoL Satisfactory 
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Tatsumi et al. 
(2009) 
Japan 24 months 96 62.50% 71.8 (8.0) 17.86 (3.3) AD Community QoL-AD  Age, ADL, NPS, CSM Good 
Trigg et al. (2015) England 18 months 69 39 78.19 (8.48) 19.40 (4.67) AD Community EQ-5D  
DEMQOL 
Baseline QoL Good 
Uhlmann et al. 
(1987) 
US 12 months 115 64.90% 73.8 16.1 (10.0) AD 75.7% Lived at home 
74%,  Lived with 
adult children 
13%,  Long term 
care 13% 
Single global 
HRQoL rating 
CSM Satisfactory 
Vogel et al. (2012) Denmark 12 months 102 Not 
specified 
76 (7.1) 
Baseline 
22.7 AD Community 91% QoL-AD 
EQ-5D VAS 
Baseline QoL Good 
36 months 102 Not 
specified 
76 (7.1) 
Baseline 
18.0 AD Community 
86.3% 
QoL-AD 
EQ-5D VAS 
Baseline QoL 
Wolf-Ostermann et 
al. (2012) 
Germany 12 months 56 43 82.3 (9.25)  GDS4 6, GDS5 
5, GDS6 38, 
GDS7 7 
Dementia  Shared-housing 
34, Special care 
units 22 
QUALIDEM  Gender Good 
Woods et al. (2006) England 2 months 201 158 85.3 (7.0) 14.4 (3.8) Dementia  Mostly residential 
172 
QoL-AD  NPS, Depression, CSM, 
Gender, GDS, Baseline 
QoL 
Good 
Note: articles were judged to be of poor quality if scored ≤20 or below, satisfactory scored between >20 and <26, good scored ≥26. Shading indicates articles using the same 
study data. “Severity” refers to Mini-Mental State Examination score unless otherwise specified. * indicates data not reported in articles 
 
Quality of life measure abbreviations: 12-Item Short Form Health Survey (SF-12), Activity and Affect Indicators of QOL (AAIQoL), Alzheimer's Disease Related Quality of 
Life (ADRQL), Dementia Quality of Life Questionnaire (DEMQOL), EuroQol five dimensions questionnaire (EQ-5D), Quality of Life in Alzheimer's Disease (QoL-AD), 
Quality of Life in Late Stage Dementia Scale (QUALID), Quality of Life Questionnaire for Dementia (QLQD), Visual Analogue Scale, (VAS) 
 
Severity abbreviations: Clinical Dementia Rating (CDR), Hasegawa Dementia Scale-Revised (HDS-R), Modified Mini-Mental State Examination (3MS) 
 
Dementia type abbreviations: Alzheimer's disease (AD), Vascular dementia (VaD) 
 
Factors included in the meta-analysis abbreviations: Better functional ability (ADL), Female gender (Gender), Higher scores on cognitive screening measures (CSM), More 
advanced dementia (GDS), Neuropsychiatric symptoms/BPSD (NPS), Older age (Age), Quality of life rating at baseline (Baseline QoL) 
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Supplementary Table 8. Studies assessing well-being in people with dementia 
 
Study Country of 
study 
n Females Mean age Severity 
 
Dementia type Living situation Well-being measure Rating type Data 
quality 
Burgener and 
Dickerson-Putman 
(1999) 
US 84 51 76.5 20.5 AD or VaD Not specified PWB-CIP Informant 
Longitudinal 
Satisfactory 
Burgener and 
Twigg (2002) 
US 70 55 77.3 21.52 (4.7) Dementia Community PWB-CIP Informant 
Longitudinal 
Good 
Burgener et al. 
(2005) 
US 96 55 77.3 (7.8) 21.52 (4.7) AD, VaD, 
Mixed, DLB 
Assisted living 12, 
Community 84 
PWB-CIP Informant Satisfactory 
Gerritsen et al. 
(2007) 
Netherlands 34 78% 80.5 (9.26) 5-13  Dementia  Nursing home Positive Affect Scales 
Negative Affect Scales 
Self  Satisfactory 
Gilbart and Hirdes 
(2000) 
Canada 385  75.6 (15.6) CPS 3.2 (2.2) Dementia  Nursing home SHARP  
MIDAS 
Mood state 
Informant Poor 
Muurinen et al. 
(2015) 
Finland 237
9 
78% 85 Mild 11%, 
Moderate 53% 
Severe 36%  
Dementia  Nursing home Psychological wellbeing was 
assessed by 6 questions 
Self Satisfactory 
Note: articles were judged to be of poor quality if scored ≤20 or below, satisfactory scored between >20 and <26, good scored ≥26. Shading indicates articles using the same 
study data. “Severity” refers to Mini-Mental State Examination score unless otherwise specified. 
 
Quality of life measure abbreviations: Measure of Intensity and Duration of Affective States (MIDAS), Psychological Well-being in Cognitively Impaired Persons (PWB-CIP), 
Short Happiness and Affect Research Protocol (SHARP) 
 
Severity abbreviations: Cognitive Performance Scale (CPS) 
 
Dementia type abbreviations: Alzheimer's disease (AD), Dementia with Lewy bodies (DLB), Vascular dementia (VaD) 
 
Supplementary Table 9. Studies assessing life satisfaction in people with dementia 
 
Study Country of 
study 
n Females Mean age Severity 
 
Dementia type Living situation Well-being measure Rating type Data 
quality 
Eshkoor et al. 
(2014) 
Malaysia 1210 770 Not specified Not specified Dementia  Not specified Single question - Are you satisfied 
with your current life? 
Self  Poor 
Makai et al. (2012) Netherlands 96 68.00% 82 (9.1) Not specified Dementia  Nursing home Cantril’s ladder 
Overall life satisfaction 
Informant  Satisfactory 
Zank and Leipold 
(2001) 
Germany 63 76% 79.2 (8.6) 17.7 (4.3) Dementia  Community Life Satisfaction Questionnaire Self  Satisfactory 
Note: articles were judged to be of poor quality if scored ≤20 or below, satisfactory scored between >20 and <26, good scored ≥26. Shading indicates articles using the same 
study data. “Severity” refers to Mini-Mental State Examination score unless otherwise specified.  
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Supplementary Table 10: Measures of quality of life used in the included studies, with frequency of use 
overall and by type of rating  
 
QoL measure Number of studies 
 Total  Self-
ratings 
Informant 
ratings 
Proxy 
ratings  
Difference 
scores 
Longitudinal 
measurement 
Dementia specific QoL/HRQoL measures  
Activity and Affect Indicators of QoL (Albert et al., 1996) 8 3 7   1 
Pleasant Events Schedule-AD (Logsdon and Teri, 1997, Teri and 
Logsdon, 1991) 
2  2    
Observed Emotion Rating Scale (Lawton et al., 1996) 4  3 1   
Activity Engagement (Nolan et al., 1995) 1  1    
Alzheimer's Disease Related Quality of Life (ADRQL) (Rabins et al., 
1999) 
13 1 18   1 
Bath Assessment of Subjective Quality of Life in Dementia (BASQID) 
(Trigg et al., 2007) 
3 4     
Community Dementia Quality of Life Profile (Salek et al., 1996, Salek et 
al., 1999) 
1  1    
Cornell-Brown Scale for Quality of Life in Dementia (Ready et al., 
2002b) 
1  1    
Dementia Care Mapping (Kitwood and Bredin, 1992) 7   6   
Dementia Quality of Life Questionnaire (DEMQOL) (Smith et al., 2005) 16 11 1 10 2 1 
Discomfort Scale-Dementia Alzheimer Type (Hurley et al., 1992) 4 1 3    
Dementia Quality of Life instrument (Brod et al., 1999) 14 13 1  1  
Observable Displays of Affect Scale (Vogelpohl and Beck, 1997) 1  1    
Observing QOL for Dementia Advanced (Edelman et al., 2007) 1   1   
Quality of Life in Alzheimer’s Disease (Logsdon et al., 2000) 82 73 60 2 15 12 
Quality of Life in Late Stage Dementia Scale (QUALID) (Weiner et al., 
2000) 
12  11   1 
QUALIDEM (Ettema et al., 2007a) 9  4 8   
Quality of Life Questionnaire for Dementia (Terada et al., 2002) 4  2 1  1 
Resident and Staff Observation Checklist-Quality of Life Measure 
(Sloane et al., 1991) 
1   1   
Self-Reported Quality of Life Scale (Kane et al., 2003) 3 3     
Source of Discomfort Scale (Cohen-Mansfield et al., 2015) 1  1    
The Vienna List (Porzsolt et al., 2004) 1  1    
Generic QoL measures 
5 items from Geriatric Depression Scale-15 (Sheikh and Yesavage, 1986) 1 1     
COOP/WONCA (Nelson et al., 1987) 1 1     
Investigating Choice Experiments for the Preferences of Older People 
CAPability measure-Older people (Grewal et al., 2006) 
2  2    
Linear Analogue Self Assessment (Grunberg et al., 1996) 2 2 2    
Quality of Life Assessment Schedule (Selai et al., 2001a) 1 1 1    
Quality of Life Index (Ferrans and Powers, 1985) 1 1     
Single item global QoL question (Buckley et al., 2012, Campbell et al., 
2008, Cordner et al., 2010, Gerritsen et al., 2005, James et al., 2005) 
5 4 5 1 1  
World Health Organization-8 (Power, 2003) 2 2 1    
World Health Organization Quality of Life-100 (Power et al., 1999) 2 2     
World Health Organization Quality of Life-BREF (World Health 
Organization, 1996) 
2 2     
Generic HRQoL or health status measures 
15-dimensional (15D) (Sintonen, 1995) 1 1     
Assessment of Quality of Life (Hawthorne et al., 1999) 2 2 1    
Disability and Distress Index (Rosser and Kind, 1978) 1 1 1    
Duke Health Profile (Parkerson et al., 1990) 1 1   1  
EQ-5D (The EuroQol Group, 1990) 25 16 19 2 4 2 
EQ-5D VAS (The EuroQol Group, 1990) 14 11 11  1 1 
Health Utility Index II (Torrance et al., 1996) 5 1 5  1  
Health Utility Index III (Furlong et al., 1998) 7 1 7    
Nottingham Health Profile (Hunt et al., 1981) 1  1    
Quality of Well-being scale (Kaplan et al., 1976) 4 2 4    
Single item global HRQoL question (Uhlmann et al., 1987) 1 1    1 
12-Item Short Form Health Survey (SF-12) (Ware et al., 1995) 4 4 3   1 
36-Item Short Form Health Survey (SF-36) (Ware et al., 1993) 7 5 3  1  
Note: the Activity and Affect Indicators of QoL was split into two sections, in the analysis the first (Activity) 
was combined with Pleasant Events Schedule-AD and the second (Affect)) was combined with Observed 
Emotion Rating Scale in the analysis. Health Utility Index II and Health Utility Index II, and SF-12 and SF-36 
were combined in the analysis.
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Supplementary Table 11: Mean scores for self-ratings of quality of life 
 
QoL measure Range of 
possible scores 
Number of 
studies 
Mean Range of means reported 
in the studies  
Range of scores reported in 
the studies 
Direction of scoring 
Dementia Quality of Life Questionnaire (DEMQOL) 28-112 7 87.5 81.2-91.2 33–112 Higher is better 
Dementia Quality of Life Instrument-Aesthetics 1-5 6 3.3 2.81-3.7 1-5 Higher is better 
Dementia Quality of Life Instrument-Feelings of Belonging 1-5 6 3.6 3.3-3.9 1-5 Higher is better 
Dementia Quality of Life Instrument-Negative Affect 1-5 8 2.4 1.9-3.8 1-5 Lower is better 
Dementia Quality of Life Instrument-Positive Affect 1-5 6 3.5 3.2-3.6 1.5-5 Higher is better 
Dementia Quality of Life Instrument-Self-Esteem 1-5 6 3.3 3.2-3.5 1.5-5 Higher is better 
EQ-5D -.59-1 9 0.7 .4-.9 -.1-1 Higher is better 
EQ-5D Visual Analogue Scale 0-100 4 67.9 34.0-79.1 20-100 Higher is better 
Quality of Life in Alzheimer's Disease 13-56 85 35.2 26.7-42.8 2-52a Higher is better 
Quality of Life in Alzheimer's Disease (different scoring) 1-4 6 2.9  2.51-3.1 1.3–4.0 Higher is better 
a One paper provided data for all participants even where the QoL-AD was only partially completed; hence the lowest score reported (2) is below the minimum score for the 
full scale (13).  
 
 
Supplementary Table 12a: Mean scores for informant ratings of quality of life made by family carers 
 
QoL measure Range of 
possible scores 
Number of 
studies 
Mean Range of means reported 
in the studies  
Range of scores reported in 
the studies 
Direction of score 
Alzheimer's Disease Related Quality of Life 0-100 11 71.3 55.5-83.1 18-100 Higher is better 
EQ-5D -.59-1 13 .6 .2-.8 -.4-1 Higher is better 
EQ-5D Visual Analogue Scale 0-100 8 61.1 48.6-.70.8 10-100 Higher is better 
Health Utility Index 2 -.03-1 5 .61 .5-.7 .2-.1 Higher is better 
Health Utility Index 3 -.36-1 8 .27 .2-.5 -.3-1 Higher is better 
Quality of Life in Alzheimer's Disease 13-56 57 30.7 24.5-38.0 13-52 Higher is better 
 
 
Supplementary Table 12b: Mean scores for informant ratings of quality of life made by health care professionals  
 
QoL measure Range of 
possible scores 
Number of 
studies 
Mean Range of means reported 
in the studies  
Range of scores reported in 
the studies 
Direction of score 
Alzheimer's Disease Related Quality of Life 0-100 8 70.4 59.2-79.9 15-100 Higher is better 
Quality of Life in Alzheimer's Disease 13-56 12 31.2 27.0-37.7 Ranges not provided Higher is better 
Quality of Life in Late Stage Dementia Scale 11-55 14 22.4 18.1-28.8 11-45 Lower is better 
 
 
Supplementary Table 12c: Mean scores for informant ratings of quality of life made by mixed groups of informants including family carers and health care 
professionals 
 
QoL measure Range of 
possible scores 
Number of 
studies 
Mean Range of means reported 
in the studies  
Range of scores reported in 
the studies 
Direction of score 
Quality of Life in Alzheimer's Disease 13-56 5 31.1 27.26-36.6 Ranges not provided Higher is better 
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Supplementary Table 13a: Factors associated with self-ratings of quality of life by people living with dementia – factors pertaining to the person with dementia 
factors 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 58 8485 -.019 -.042-.004 .1135 63.302 .264 9.956 
Female gender 47 7030 .005 -.019-.030 .6607 47.700 .403 3.565 
White ethnicity 12 1885 .157 .092-.221 <.0001 22.143 .023 50.323 
Higher income 7 1008 .156 -.024-.326 .0890 48.791 <.001 87.703 
Higher level of education 44 5874 .053 .019-.086 .0021 33.140 .019 33.140 
Underweight 8 1587 -.014 -.102-.074 .7531 19.581 .007 64.250 
Alzheimer’s (vs. other dementia subtypes) 9 1552 .136 -.042-.305 .1333 96.171 <.001 91.681 
Longer disease duration 12 1918 -.012 -.066-.041 .6566 13.908 .238 20.910 
More advanced dementia 24 3548 -.096 -.146--.045 .0002 48.410 .001 52.489 
Global Deterioration Scale 6 886 -.103 -.177--.029 .0067 5.897 .316 15.207 
Clinical Dementia Rating 15 2184 -.087 -.161--.012 .0232 40.148 <.001 65.129 
Higher scores on cognitive screening measures 93 13504 .086 .057-.115 <.0001 218.065 <.001 57.811 
Mini-Mental State Examination 84 12046 .081 .050-.112 <.0001 199.242 <.001 58.342 
Alzheimer's Disease Assessment Scale-Cognitive Subscale 5 3095 .066 .030-.100 .0003 3.239 .519 0 
Taking medication 19 4606 -.120 -.168--.071 <.0001 37.773 .004 52.347 
Acetylcholinesterase inhibitors 7 1141 -.111 -.178--.043 .0014 7.058 .316 14.990 
Polypharmacy  8 1718 -.106 -.163--.049 .0003 9.441 .223 25.854 
Psychotropic drugs 9 2518 -.120 -.203--.034 .0061 21.104 .007 62.093 
Longer duration of care home stay 8 714 -.096 -.169--.021 .0117 5.874 .555 0 
Better functional ability 79 13216 .173 .139-.206 <.0001 262.432 <.001 70.278 
Alzheimer's Disease Co-operative Study-Activities of Daily 
Living Inventory 
5 981 .085 -.069-.235 .2773 22.156 <.001 81.946 
Disability Assessment for Dementia  5 3122 .073 -.007-.153 .0751 11.492 .022 65.192 
Basic activities of daily living 50 8558 .217 .172-.261 <.0001 179.342 <.001 72.678 
Barthel Index 17 2414 .200 .097-.299 .0001 98.376 <.001 83.736 
Katz Index of Independence in Activities of Daily Living  11 1338 .219 .122-.312 <.0001 25.762 .004 61.183 
Physical Self-Maintenance Scale  6 703 .216 .132-.297 <.0001 6.403 .269 21.917 
Basic activities of daily living measures excluding Barthel 
Index, Katz Index of Independence in Activities of Daily Living 
& Physical Self-Maintenance Scale 
18 4352 .189 .130-.246 <.0001 41.009 .001 58.545 
Instrumental activities of daily living 25 3330 .148 .087-.208 <.0001 65.771 <.001 63.510 
Functional Activities Questionnaire 5 398 .176 .077-.271 .0005 2.319 .678 0 
Lawton’s Instrumental Activities of Daily Living 13 1660 .115 .059-.170 <.0001 14.161 .291 15.259 
Instrumental activities of daily living measures excluding 
Lawton’s Instrumental Activities of Daily Living & Functional 
Activities Questionnaire 
8 1372 .208 .059-.349 .0066 50.192 <.001 86.054 
Presence of unmet needs 5 838 -.204 -.305--.100 .0002 9.273 .055 56.866 
More awareness 10 1285 .145 .090-.198 <.0001 7.769 .558 0 
Better self-rated memory functioning 9 1699 .027 -.021-.075 .2681 6.595 .581 0 
Depression 80 11435 -.315 -.353--.276 <.0001 363.600 <.001 78.273 
Cornell Scale for Depression in Dementia 27 5537 -.245 -.300--.189 <.0001 102.956 <.001 74.746 
Geriatric Depression Scale (all versions) 28 2828 -.436 -.521--.342 <.0001 212.993 <.001 87.324 
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Geriatric Depression Scale-15 16 1646 -.490 -.604--.357 <.0001 155.722 <.001 90.367 
Geriatric Depression Scale-30 11 1079 -.320 -.397--.240 <.0001 15.873 .103 36.999 
Neuropsychiatric Inventory-Depression 12 1855 -.262 -.363--.154 <.0001 55.863 <.001 80.309 
Depression measures excluding Geriatric Depression Scale, 
Cornell Scale for Depression in Dementia & Neuropsychiatric 
Inventory-Depression 
28 2802 -.332 -.401--.259 <.0001 109.001 <.001 75.229 
Anxiety 21 3012 -.237 -.317--.154 <.0001 98.595 <.001 79.715 
Neuropsychiatric Inventory-Anxiety 9 1503 -.054 -.105--.003 .0382 7.068 .529 0 
Rating of Anxiety in Dementia 6 925 -.328 -.462--.180 <.0001 21.077 .001 76.278 
Anxiety measures excluding Rating of Anxiety in Dementia & 
Neuropsychiatric Inventory-Anxiety 
8 872 -.351 -.482--.204 <.0001 35.812 <.001 80.453 
Neuropsychiatric symptoms/BPSD 56 9629 -.110 -.134--.086 <.0001 64.570 .177 14.821 
Neuropsychiatric Inventory 41 8061 -.108 -.135--.080 <.0001 50.662 .120 21.045 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory 
17 1654 -.127 -.175--.078 <.0001 13.292 .651 0 
Pain 10 2720 -.157 -.236--.077 .0001 24.305 .004 62.971 
Better self-rated health 11 1702 .269 .167-.366 <.0001 44.359 <.001 77.457 
Presence of co-morbid conditions 31 4188 -.213 -.268--.157 <.0001 94.600 <.001 68.288 
Better quality of relationship with carer 6 802 .384 .148-.579 .0019 62.659 <.001 92.020 
Cared for by spouse (vs. other carer type) 8 1775 .124 .060-.186 .0001 11.873 .105 41.044 
Being married 22 2847 .078 .046-.110 <.0001 18.132 .641 0 
Living alone 9 2129 -.124 . -.240--004 .0436 58.329 <.001 86.285 
Greater social engagement 11 1035 .314 .121-.483 .0017 94.157 <.001 89.379 
Presence of religious beliefs/spirituality 8 641 .352 .120-.547 .0035 60.621 <.001 88.453 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 13b: Factors associated with self-ratings of quality of life by people living with dementia – factors pertaining to the carer 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 10 1808 -.061 -.121--.001 .0453 12.653 .179 28.870 
Female gender 12 2242 .017 -.036-.070 .5221 15.644 .155 29.684 
Higher level of education 11 1767 .088 .030-.144 .0028 13.597 .192 26.456 
Depression  9 1008 -.120 -.199--.040 .0034 12.445 .132 35.715 
Center for Epidemiologic Studies Depression Scale 5 564 -.118 -.244-.011 .0738 9.181 .057 56.432 
Distress at NPS symptoms 9 1089 -.140 -.202--.078 .0001 8.536 .383 6.284 
Burden or stress  20 2840 -.146 -.202--.089 <.0001 38.857 .005 51.103 
Zarit Burden Interview 15 1808 -.140 -.217--.061 .0006 33.997 .002 58.820 
Burden or stress measures excluding Zarit Burden Interview 5 1032 -.166 -.225--.105 <.0001 3.010 .556 0 
Poorer mental health (GHQ) 5 702 -.156 -.275--.034 .0126 6.753 .150 40.767 
Carer quality of life (self-rated) 6 667 .253 .081-.411 .0043 23.736 <.001 78.935 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 14a: Factors associated with informant ratings of the quality of life of the person with dementia – factors pertaining to the person with 
dementia  
 
Factor   Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 59 12017 -.027 -.055-.001 .0581 121.613 <.001 52.308 
Female gender 49 10315 -.003 -.034-.028 .8527 108.209 <.001 55.642 
White ethnicity 7 1486 .101 .042-.159 .0008 7.612 .268 21.180 
Higher level of education 32 6092 .037 .012-.063 .0038 29.143 .562 0 
Underweight 5 1755 -.065 -.129--.002 .0447 7.119 .130 43.809 
Alzheimer’s (vs. other dementia subtypes) 9 2719 .050 -.027-.126 .2054 27.443 .001 70.849 
Longer disease duration 12 1731 -.066 -.113--.019 .0064 8.143 .700 0 
More advanced dementia 40 8094 -.296 -.371--.216 <.0001 549.596 <.001 92.904 
Clinical Dementia Rating 25 5868 -.266 -.367--.160 <.0001 417.838 <.001 94.256 
Global Deterioration Scale 6 910 -.262 -.383--.132 <.0001 20.558 .001 75.678 
Advanced dementia measures excluding Clinical Dementia Rating 
& Global Deterioration Scale 
9 1327 -.388 -.535--.216 <.0001 86.493 <.001 90.751 
Higher scores on cognitive screening measures 87 14672 .183 .147-.218 <.0001 377.741 <.001 77.233 
Dementia Rating Scale 6 602 .266 .091-.425 .0032 22.092 .001 77.367 
Mini-Mental State Examination  77 12947 .172 .135-.210 <.0001 321.090 <.001 76.331 
Cognitive screening measures excluding Dementia Rating Scale & 
Mini-Mental State Examination 
15 4719 183 .095-.269 .0001 95.064 <.001 85.273 
Taking medication 21 6003 -.054 -.081--.027 .0001 20.911 .402 4.354 
Acetylcholinesterase inhibitors 10 1892 -.082 -.147--.015 .0156 17.145 .046 47.508 
Polypharmacy 9 1834 -.060 -.105--.014 .0112 6.754 .563 0 
Psychotropic drugs 12 4043 -.066 -.112--.018 .0064 19.261 .057 42.889 
Antipsychotic 5 1244 -.171 -.290--.047 .0069 15.322 .004 73.893 
Antidepressants 6 1221 -.098 -.195--.000 .0492 11.134 .049 55.092 
Anxiolytics  7 1617 -.056 -.149-.038 .2459 17.494 .008 65.702 
Longer duration of care home stay 12 2312 -.105 -.162--.047 .0004 18.574 .069 40.778 
Degree to which residential care is person-centred 6 1814 .155 .049-.257 .0042 13.729 .017 63.581 
Community dwelling (vs. residential care) 5 1011 .123 .062-.184 .0001 3.398 .494 0 
Special dementia unit (vs. other residential facility) 5 2366 .114 .069-.158 <.0001 4.753 .314 15.838 
Better functional ability 87 18707 .337 .292-.380 <.0001 893.737 <.001 90.377 
Alzheimer's Disease Co-operative Study-Activities of Daily 
Living Inventory 
6 1264 .346 .223-.458 <.0001 25.967 <.001 80.745 
Bristol Activities of Daily Living Scale 5 859 .450 .393-.504 <.0001 4.094 .393 2.296 
Disability Assessment for Dementia  6 3206 .249 .110-.378 .0005 45.745 <.001 89.070 
Basic activities of daily living 61 13149 .371 .317-.423 <.0001 695.854 <.001 91.378 
Barthel Index  19 3429 .484 .372-.583 <.0001 268.501 <.001 93.296 
Dependence Scale  7 3523 .328 .154-.483 .0003 123.388 <.001 95.137 
Katz Index of Independence in Activities of Daily Living  16 2991 .300 .247-.354 <.0001 31.816 .007 52.854 
Physical Self-Maintenance Scale  9 1494 .333 .265-.398 <.0001 13.285 .102 39.780 
Basic activities of daily living measures excluding Barthel 
Index, Dependence Scale, Katz Index of Independence in 
Activities of Daily Living & Physical Self-Maintenance Scale 
11 1859 .300 .208-.386 <.0001 40.364 <.001 75.225 
Instrumental activities of daily living 24 3234 .351 .270-.428 <.0001 134.793 <.001 82.937 
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Lawton’s Instrumental Activities of Daily Living 15 2306 .303 .210-.390 <.0001 72.120 <.001 80.588 
Instrumental activities of daily living measures excluding 
Lawton’s Instrumental Activities of Daily Living 
10 1039 .458 .382-.528 <.0001 16.148 .064 44.267 
More awareness 5 557 .275 .037-.484 .0241 31.084 <.001 87.132 
Better self-rated memory functioning 8 1185 .213 .054-.363 .0092 47.334 <.001 85.211 
Depression  68 12320 -.304 -.349--.259 <.0001 459.021 <.001 85.404 
Cornell Scale for Depression in Dementia 28 6671 -.339 -.396--.280 <.0001 171.626 <.001 84.268 
Geriatric Depression Scale (all versions) 19 1953 -.259 -.342--.172 <.0001 64.056 <.001 71.899 
Geriatric Depression Scale-30 10 1082 -.289 -.414--.154 <.0001 40.764 <.001 77.922 
Geriatric Depression Scale-15 8 837 -.211 -.324--.092 .0006 19.448 .007 64.006 
Neuropsychiatric Inventory-Depression 12 2223 -.263 -.396--.118 .0004 117.702 <.001 90.654 
Other depression measures excluding Geriatric Depression Scale, 
Cornell Scale for Depression in Dementia & Neuropsychiatric 
Inventory-Depression 
19 2503 -.309 -.392--.221 <.0001 93.689 <.001 80.787 
Anxiety 18 3143 -.148 -.189--.107 <.0001 20.328 .258 16.371 
Neuropsychiatric Inventory-Anxiety 12 2128 -.151 -.209--.092 <.0001 16.069 .139 31.545 
Anxiety measures excluding Neuropsychiatric Inventory-Anxiety 7 1201 -.163 -.235--.089 <.0001 8.765 .187 31.546 
Neuropsychiatric symptoms/BPSD  76 15358 -.329 -.372--.285 <.0001 630.810 <.001 88.111 
Cohen-Mansfield Agitation Inventory 9 1332 -.150 -.213--.085 <.0001 10.839 .211 26.191 
Neuropsychiatric Inventory 51 11213 -.338 -.392--.282 <.0001 487.984 <.001 89.754 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
23 3685 -.353 -.417--.286 <.0001 107.094 <.001 79.457 
Pain 13 4048 -.203 -.307--.095 .0003 124.860 <.001 90.389 
Better self-rated health 8 1826 .198 .131-.263 <.0001 12.123 .097 42.260 
Presence of co-morbid conditions 27 5349 -.090 -.126--.055 <.0001 39.872 .040 34.792 
Cared for by spouse (vs. other carer type) 10 2139 .117 .053-.180 .0004 17.386 .043 48.234 
Being married 18 3713 .100 .056-.143 <.0001 28.012 .045 39.311 
Living alone 13 2396 -.137 -.193--.081 <.0001 20.782 .054 42.258 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 14b: Factors associated with informant ratings of the quality of life of the person with dementia – factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 15 2500 -.037 -.020-.094 .2006 24.345 .042 42.494 
Female gender 15 3089 .046 -.005-.096 .0766 23.249 .056 39.782 
Higher level of education 12 2313 .084 .035-.132 .0007 13.597 .256 19.098 
More time spent caring (residential care only) 6 772 -.159 -.253--.061 .0016 9.538 .089 47.578 
More time spent caring (community only) 5 681 -.137 -.267--.002 .0462 11.630 .020 65.606 
Depression  14 2694 -.255 -.338--.169 <.0001 64.440 <.001 79.826 
Center for Epidemiologic Studies Depression Scale 6 905 -.299 -.458--.122 .0012 32.272 <.001 84.507 
Geriatric Depression Scale (all versions) 5 591 -.362 -.496--.211 <.0001 14.617 .006 72.634 
Depression measures excluding Geriatric Depression Scale & 
Center for Epidemiologic Studies Depression Scale 
6 1449 -.202 -.313--.085 .0008 22.218 <.001 77.496 
Burden or stress  25 4460 -.324 -.398--.247 <.0001 180.102 <.001 86.674 
Zarit Burden Interview 18 3284 -.345 -.435--.248 <.0001 148.814 <.001 88.576 
Burden or stress measures excluding Zarit Burden Interview 8 1247 -.276 -.391--.152 <.0001 32.129 <.001 78.213 
Distress at NPS symptoms 10 1665 -.320 -.379--.258 <.0001 15.219 .085 40.863 
Poorer mental health (GHQ) 6 715 -.242 -.311--.170 <.0001 3.990 .551 0 
Carer quality of life (self-rated) 8 1509 .314 .212-.410 <.0001 28.246 <.001 75.218 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 15a: Factors associated with proxy ratings of the quality of life of the person with dementia – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 15 2283 -.015 -.113-.083 .7650 71.987 <.001 80.552 
Female gender 12 2023 -.003 -.049-.043 .8911 6.387 .846 0 
More advanced dementia 8 1421 -.302 -.413--.183 <.0001 35.674 <.001 80.378 
Higher scores on cognitive screening measures 16 1978 .104 .018-.189 .0185 50.789 <.001 70.466 
Mini-Mental State Examination 13 1557 .062 -.032-.154 .1965 35.941 <.001 66.612 
Taking medication 7 1160 -.099 -.170--.026 .0076 8.884 .180 32.465 
Better functional ability  15 2301 .149 .062-.233 .0008 56.388 <.001 75.172 
Basic activities of daily living 12 1875 .141 .050-.230 .0025 38.616 <.001 71.514 
Basic activities of daily living measures excluding Barthel 
Index & Katz Index of Independence in Activities of Daily 
Living 
8 1249 .166 .058-.270 .0027 22.654 .002 69.100 
Depression 13 1651 -.317 -.409--.219 <.0001 47.495 <.001 74.734 
Cornell Scale for Depression in Dementia 5 811 -.200 -.361--.027 .0235 19.089 .001 79.046 
Geriatric Depression Scale 5 466 -.446 -.608--.248 <.0001 20.722 <.001 80.697 
Neuropsychiatric symptoms/BPSD  17 2559 -.316 -.373--.257 <.0001 37.956 .002 57.845 
Neuropsychiatric Inventory 12 1645 -.315 -.387--.238 <.0001 28.633 .003 61.582 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory 
6 1120 -.315 -.396--.228 <.0001 10.134 .072 50.659 
Presence of co-morbid conditions 6 873 -.121 -.186--.054 .0004 3.383 .641 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 15b: Factors associated with proxy ratings of the quality of life of the person with dementia – factors pertaining to the carer 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 5 412 -.017 -.160-.126 .8173 7.963 .093 49.768 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 16a: Factors associated with the difference between self- and informant-rated quality of life for the person with dementia – factors pertaining 
to the person with dementia 
 
Factor   Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 12 2249 -.042 -.083--.000 .0497 2.254 .997 0 
Female gender 11 2237 .007 -.052-.066 .8093 16.622 .083 39.840 
Higher level of education 7 1212 .027 -.056-.110 .5198 10.832 .094 44.606 
Higher scores on cognitive screening measures 23 3203 .128 .079-.175 <.0001 35.229 .037 37.552 
Mini-Mental State Examination 21 2974 .126 .074-.177 <.0001 33.508 .030 40.312 
Better functional ability  17 2080 .221 .147-.292 <.0001 40.001 .001 60.011 
Basic activities of daily living 8 1207 .204 .115-.291 <.0001 12.960 .073 45.988 
Instrumental activities of daily living 7 1019 .099 .037-.160 .0018 1.227 .976 0 
Lawton’s Instrumental Activities of Daily Living 7 1019 .099 .037-.160 .0018 1.227 .976 0 
Depression 11 1354 -.277 -.397--.148 <.0001 46.807 <.001 78.635 
Geriatric Depression Scale (all versions) 9 1067 -.337 -.486--.168 .0002 47.848 <.001 83.281 
Neuropsychiatric symptoms/BPSD  14 1700 -.224 -.289--.157 <.0001 22.251 .052 41.576 
Neuropsychiatric Inventory 13 1580 -.218 -.287--.147 <.0001 21.047 .050 42.984 
Presence of co-morbid conditions 5 467 -.131 -.311-.058 .1739 15.201 .004 73.686 
Being married 6 668 .075 -.002-.151 .0559 2.727 .742 0 
Living alone 7 1402 -.061 -.113--.008 .0234 5.335 .502 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 16b: Factors associated with the difference between self- and informant-rated quality of life of the person with dementia – factors pertaining 
to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 7 1397 -.038 -.090-.015 .1629 3.621 .728 0 
Female gender 8 1538 .034 -.036-.104 .3398 11.970 .102 41.519 
Burden or stress  11 1753 -.242 -.317--.163 <.0001 25.123 .005 60.196 
Zarit Burden Interview 10 1434 -.259 -.341--.174 <.0001 21.812 .009 58.738 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 17: Baseline factors associated with longitudinal quality of life ratings for the person with dementia – factors pertaining to the person with 
dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 7 544 -.079 -.166-.009 .0771 2.901 .821 0 
Female gender 7 583 -.105 -.226-.020 .0984 11.330 .079 47.045 
More advanced dementia 6 561 -.062 -.147-.024 .1600 .879 .972 0 
Clinical Dementia Rating 5 439 -.078 -.175-.021 .1227 .459 .977 0 
Higher scores on cognitive screening measures 9 885 .160 .051-.265 .0041 19.115 .014 58.149 
Mini-Mental State Examination 9 885 .160 .053-.265 .0037 18.862 .016 57.587 
Better functional ability  5 371 .115 .012-.216 .0287 2.867 .580 0 
Depression 5 447 -.144 -.255--.029 .0144 5.052 .282 20.826 
Neuropsychiatric symptoms/BPSD  7 619 -.120 -.199--.041 .0031 4.361 .628 0 
Quality of life rating at baseline 15 1782 .280 .140-.408 .0001 117.942 <.001 88.130 
Quality of Life-Alzheimer’s Disease rating at baseline 10 1352 .233 .022-.425 .0309 125.859 <.001 92.849 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 18a: Correspondence between factor effect sizes for self-rated and informant-rated 
quality of life – factors pertaining to the person with dementia  
 
Factor Z p 
Neuropsychiatric symptoms/BPSD -17.7886 <.0001 
Better functional ability -15.4824 <.0001 
More advanced dementia -10.2832 <.0001 
Higher scores on cognitive screening measures -8.2902 <.0001 
Better self-rated memory functioning -4.9962 <.0001 
More awareness -2.6795 .0074 
Pain -1.9170 .0552 
Longer disease duration -1.6304 .1030 
Being married -.8898 .3736 
Older age -.5644 .5725 
Living alone -.4438 .6572 
Longer duration of care home stay -.2120 .8321 
Cared for by spouse (vs. other carer type) .2211 .8251 
Female gender .5959 .5512 
Higher level of education .8765 .3807 
Depression .9367 .3489 
Underweight 1.4736 .1406 
White ethnicity 1.6405 .1009 
Better self-rated health 2.2281 .0259 
Alzheimer’s (vs. other dementia subtypes) 2.7264 .0064 
Taking medication 3.3954 .0007 
Anxiety 3.6258 .0003 
Presence of co-morbid conditions 6.1080 <.0001 
Note: Negative Z score indicates that the informant rating effect size was higher than self-rating effect size, and 
vice versa. 
 
 
Supplementary Table 18b: Correspondence between factor effect sizes for self-rated and informant-rated 
quality of life – factors pertaining to the carer  
 
Factor Z p 
Burden or stress -7.8716 <.0001 
Distress at NPS symptoms -4.8879 <.0001 
Depression -3.7917 .0002 
Poorer mental health (GHQ) -1.6830 .0924 
Carer quality of life (self-rated) -1.4246 .1543 
Female gender -1.0457 .2957 
Higher level of education .1275 .8986 
Older age .7787 .4361 
Note: Negative Z score indicates that the informant rating effect size was higher than self-rating effect size, and 
vice versa. 
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Supplementary Table 19a: Factors associated with self-ratings of quality of life by the person with dementia using the Quality of Life-Alzheimer’s Disease (QoL-
AD) – factors pertaining to the person with dementia  
 
Factor Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 35 5041 -.014 -.048-.020 .4198 45.690 .087 25.586 
Female gender 30 4655 -.004 -.033-.025 .7806 25.252 .665 0 
White ethnicity 5 777 .194 .104-.281 <.0001 6.490 .165 38.365 
Higher level of education 28 4145 .081 .040-.121 .0001 41.002 .041 34.150 
Underweight 5 1145 -.043 -.115-.029 .2407 5.363 .252 25.412 
Longer disease duration 7 1225 -.017 -.103-.069 .6956 10.641 .100 43.616 
More advanced dementia 18 2848 -.100 -.158--.042 .0008 38.149 .002 55.437 
Global Deterioration Scale 5 853 -.085 -.152--.018 .0135 1.561 .816 0 
Clinical Dementia Rating 10 1517 -.108 -.213--.001 .0474 35.067 <.001 74.335 
Higher scores on cognitive screening measures 52 8809 .064 .033-.095 .0001 83.982 .002 39.272 
Mini-Mental State Examination 47 8123 .062 .026-.097 .0006 90.333 <.001 49.077 
Taking medication 12 3740 -.100 -.155--.045 .0004 23.845 .013 53.869 
Acetylcholinesterase inhibitors 6 1029 -.116 -.196--.035 .0051 6.909 .228 27.627 
Polypharmacy 5 1096 -.118 -.211--.022 .0159 8.386 .078 52.304 
Psychotropics 5 2267 -.066 -.149-.018 .1254 9.793 .044 59.153 
Better functional ability 48 8741 .142 .106-.177 <.0001 106.485 <.001 55.862 
Basic activities of daily living 27 5159 .160 .109-.210 <.0001 58.406 <.001 55.484 
Physical Self-Maintenance Scale 5 612 .215 .113-.312 <.0001 6.338 .175 36.884 
Katz Index of Independence in Activities of Daily Living  8 1030 .176 .075-.273 .0007 12.844 .076 45.500 
Barthel Index 10 990 .112 -.009-.230 .0689 29.253 .001 69.234 
Instrumental activities of daily living 17 2165 .124 .067-.181 <.0001 25.144 .067 36.366 
Functional Activities Questionnaire 5 398 .176 .077-.271 .0005 2.319 .678 0 
Lawton’s Instrumental Activities of Daily Living 10 1421 .114 .037-.190 .0038 15.646 .075 42.476 
Presence of unmet needs* 5 838 -.204 -.305--.100 .0002 9.273 .055 56.866 
More awareness 6 823 .134 .066-.201 .0001 4.525 .477 0 
Better self-rated memory functioning 5 737 .068 -.005-.140 .06763 3.274 .513 0 
Depression 50 8539 -.287 -.331--.241 <.0001 218.287 <.001 77.552 
Geriatric Depression Scale (all versions) 12 1380 -.386 -.492--.268 <.0001 57.174 <.001 80.760 
Geriatric Depression Scale-30 7 902 -.271 -.357--.181 <.0001 9.701 .138 38.152 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
17 1911 -.301 -.387--.210 <.0001 68.920 <.001 76.785 
Neuropsychiatric Inventory-Depression 9 1426 -.263 -.389--.126 .0002 47.431 <.001 83.133 
Cornell Scale for Depression in Dementia 22 5013 -.271 -.333--.206 <.0001 101.847 <.001 79.381 
Anxiety 16 2695 -.190 -.271--.106 <.0001 65.530 <.001 77.110 
Anxiety measures excluding Neuropsychiatric Inventory-Anxiety 7 816 -.299 -.417--.170 <.0001 20.940 .002 71.347 
Neuropsychiatric Inventory-Anxiety 8 1384 -.048 -.101-.005 .0754 6.501 .483 0 
Neuropsychiatric symptoms/BPSD 40 7540 -.106 -.128--.083 <.0001 38.582 .489 0 
Neuropsychiatric Inventory 31 6603 -.112 -.142--.082 <.0001 35.850 .213 16.317 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory 
11 1023 -.103 -.164--.041 .0012 2.913 .983 0 
Pain 6 2495 -.113 -.187--.038 .0032 11.852 .037 57.812 
Presence of co-morbid conditions 15 2321 -.175 -.253--.095 <.0001 46.292 <.001 69.757 
Better quality of relationship with carer 5 583 .311 .114-.485 .0024 23.547 <.001 83.013 
Cared for by spouse (vs. other carer type) 6 1199 .159 .103-.215 <.0001 4.169 .525 0 
Being married 11 1991 .087 .042-.132 .0002 10.351 .410 3.388 
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Living alone 6 1553 -.072 -.127--.016 .0113 5.762 .330 13.222 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 19b: Factors associated with self-ratings of quality of life by the person with dementia using the Quality of Life-Alzheimer’s Disease (QoL-
AD) – factors pertaining to the carer 
 
Factor Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 7 1410 -.058 -.103-.012 .0137 7.859 .447 0 
Female gender 9 1844 .067 .016-.117 .0104 9.082 .335 11.916 
Higher level of education 7 1154 .112 .023-.198 .0135 11.511 .074 47.874 
Depression 6 687 -.140 -.299-.025 .0963 22.061 .001 77.336 
Distress at NPS symptoms 8 918 -.164 -.227--.099 <.0001 5.209 .635 0 
Burden or stress 16 2581 -.127 -.183--.071 <.0001 27.663 .024 45.776 
Burden or stress measures excluding Zarit Burden Interview 5 1022 -.191 -.250--.131 <.0001 2.177 .703 0 
Zarit Burden Interview 11 1559 -.090 -.164--.016 .0172 18.530 .047 46.034 
Carer quality of life (self-rated) 5 521 .297 .087-.481 .0060 21.397 <.001 81.305 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 19c: Factors associated with self-ratings of quality of life made by the person with dementia using the Dementia Quality of Life Questionnaire 
(DEMQOL)  
 
Factor Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 913 -.063 -.164-.039 .2234 11.361 .045 55.991 
Higher scores on cognitive screening measures 8 919 .019 -.046-.085 .5600 4.244 .751 0 
Mini-Mental State Examination 7 747 .008 -.065-.080 .8358 3.710 .716 0 
Better functional ability  6 863 .093 -.060-.242 .2341 24.110 <.001 79.262 
Basic activities of daily living 5 715 .114 -.065-.285 .2117 21.256 <.001 81.181 
Depression  8 804 -.417 -.566--.243 <.0001 47.237 <.001 85.181 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 19d: Factors associated with self-ratings of quality of life made by the person with dementia quality of life using the EQ-5D  
 
Factor Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 1234 -.083 -.224-.061 .2587 28.510 <.001 82.462 
Higher scores on cognitive screening measures 12 2463 .043 -.011-.096 .1229 18.879 .063 41.733 
Mini-Mental State Examination 11 2095 .047 -.015-.109 .1338 19.118 .039 47.694 
Better functional ability  13 2858 .194 .067-.314 .0028 135.774 <.001 91.162 
Basic activities of daily living 8 1474 .331 .190-.458 <.0001 54.577 <.001 87.174 
Depression  7 1581 -.225 -.316--.131 <.0001 18.998 .004 68.418 
Geriatric Depression Scale (all versions) 5 667 -.264 -.352--.171 <.0001 5.251 .263 23.823 
Neuropsychiatric symptoms/BPSD 5 1511 -.107 -.159--.055 .0001 4.327 .363 7.568 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 19e: Factors associated with self-ratings of quality of life made by the person with dementia using the EQ-5D Visual Analogue Scale  
 
Factor Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 879 -.082 -.222-.061 .2600 28.479 <.001 82.443 
Female gender 5 749 .010 -.062-.083 .7781 2.773 .597 0 
Higher scores on cognitive screening measures 8 1342 .040 -.022-.101 .2031 8.411 .298 16.778 
Mini-Mental State Examination 7 980 .012 -.051-.076 .6990 5.285 .508 0 
Better functional ability  6 1498 .100 -.032-.229 .1356 29.328 <.001 82.952 
Depression  6 1379 -.273 -.375--.164 <.0001 19.010 .002 73.698 
Geriatric Depression Scale (all versions) 5 730 -.334 -.443--.216 <.0001 9.401 .052 57.450 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 19f: Factors associated with self-ratings of quality of life made by the person with dementia using the Dementia Quality of Life instrument  
 
Factor Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Higher scores on cognitive screening measures 10 821 .116 .005-.225 .0408 19.534 .021 53.927 
Mini-Mental State Examination 10 879 .111 -.001-.220 .0518 20.508 .015 56.115 
Better functional ability  9 1070 .134 .044-.222 .0037 14.919 .061 46.379 
Basic activities of daily living 8 766 .168 .077-.257 .0003 10.021 .187 30.143 
Depression  10 898 -.196 -.287--.102 .0001 16.782 .052 46.370 
Cornell Scale for Depression in Dementia 6 486 -.119 -.208--.029 .0095 2.694 .747 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 19g: Factors associated with self-ratings of quality of life made by the person with dementia using the 12-Item Short Form Health Survey 
(SF-12) and 36-Item Short Form Health Survey (SF-36)  
 
Factor Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Higher scores on cognitive screening measures 6 344 .102 -.174-.362 .4715 31.812 <.001 84.282 
Mini-Mental State Examination 5 276 .108 -.234-.426 .5409 31.763 <.001 87.407 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 19h: Factors associated with self-ratings of quality of life by the person with dementia using dementia-specific quality of life measures – 
factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 45 6547 -.020 -.044-.005 .1148 35.842 .801 0 
Female gender 34 5198 -.000 -.028-.028 .9913 33.321 .452 .963 
White ethnicity 6 1052 .168 .083-.251 .0001 9.681 .085 48.351 
Higher level of education 37 5075 .063 .024-.101 .0017 61.494 .005 41.458 
Underweight 7 1462 .000 -.094-.095 .9919 17.601 .007 65.912 
Alzheimer’s (vs. other dementia subtypes) 6 855 .066 -.065-.195 .3222 16.836 .005 70.302 
Longer disease duration 10 1724 -.009 -.055-.073 .7841 13.850 .128 35.019 
More advanced dementia* 19 2904 -.116 -.173--.057 .0001 41.359 .001 56.478 
Global Deterioration Scale* 6 886 -.103 -.177--.029 .0067 5.897 .316 15.207 
Clinical Dementia Rating 10 1540 -.121 -.223--.016 .0236 34.106 <.001 73.612 
Higher scores on cognitive screening measures 71 10869 .077 .049-.106 <.0001 126.989 <.001 44.877 
Mini-Mental State Examination 64 9792 .077 .043-.110 <.0001 141.095 <.001 55.349 
Alzheimer’s Disease Assessment Scale-Cognitive Subscale 5 3095 .068 .033-.103 .0002 3.369 .498 0 
Taking medication 17 4266 -.122 -.174--.068 <.0001 36.857 <.001 56.589 
Acetylcholinesterase inhibitors 6 1029 -.116 -.196--.035 .0051 6.909 .228 27.627 
Polypharmacy 8 1705 -.108 -.166--.049 .0003 9.725 .205 28.021 
Psychotropics* 9 2518 -.120 -.203--.034 .0061 21.104 .007 62.093 
Longer duration of care home stay* 8 714 -.096 -.169--.021 .0117 5.874 .555 0 
Better quality of relationship with carer* 5 583 .311 .114-.485 .0024 23.547 <.001 83.013 
Better functional ability 63 10913 .161 .128-.194 <.0001 159.449 <.001 61.116 
Alzheimer's Disease Co-operative Study-Activities of Daily 
Living Inventory 
5 981 .087 -.064-.234 .2584 21.346 <.001 81.261 
Disability Assessment for Dementia 5 3123 .089 .014-.162 .0198 9.834 .043 59.324 
Basic activities of daily living 39 6821 .193 .149-.237 <.0001 99.324 <.001 61.741 
Physical Self-Maintenance Scale 5 612 .215 .113-.312 <.0001 6.338 .175 36.884 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
13 3562 .202 .128-.274 <.0001 33.612 .001 64.299 
Katz Index of Independence in Activities of Daily Living 8 1030 .182 .083-.277 .0004 12.474 .086 43.882 
Barthel Index 14 1894 .122 .036-.206 .0057 41.627 <.001 68.770 
Instrumental activities of daily living 18 2476 .119 .065-.172 <.0001 26.861 .060 36.711 
Functional Activities Questionnaire 5 398 .176 .077-.271 .0005 2.318 .678 0 
Lawton’s Instrumental Activities of Daily Living 10 1447 .124 .050-.196 .0010 14.611 .102 38.404 
Presence of unmet needs* 5 838 -.204 -.305--.100 .0002 9.273 .055 56.866 
More awareness 8 1064 .153 .093-.212 <.0001 6.798 .450 0 
Better self-rated memory functioning 7 1191 .039 -.018-.096 .1820 5.203 .518 0 
Depression  66 10226 -.302 -.341--.261 <.0001 278.686 <.001 76.676 
Geriatric Depression Scale (all versions) 17 1692 -.424 -.510--.329 <.0001 71.101 <.001 77.497 
Geriatric Depression Scale-15 8 651 -.506 -.630--.358 <.0001 35.667 <.001 80.374 
Geriatric Depression Scale-30 8 938 -.319 -.417--.214 <.0001 15.531 <.001 54.929 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
23 2515 -.320 -.391--.244 <.0001 84.279 <.001 73.896 
Neuropsychiatric Inventory-Depression 11 1788 -.274 -.379--.162 <.0001 54.205 <.001 81.551 
Cornell Scale for Depression in Dementia 25 5421 -.253 -.310--.194 <.0001 104.748 <.001 77.088 
Anxiety 20 2946 -.212 -.286--.136 <.0001 76.236 <.001 75.077 
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Rating of Anxiety in Dementia 6 915 -.330 -.461--.184 <.0001 20.357 .001 75.439 
Anxiety measures excluding Rating of Anxiety in Dementia & 
Neuropsychiatric Inventory-Anxiety 
7 816 -.299 -.417--.170 <.0001 20940 .002 71.347 
Neuropsychiatric Inventory-Anxiety 9 1503 -.054 -.105--.003 .0382 7.068 .529 0 
Neuropsychiatric symptoms/BPSD 48 8660 -.117 -.143--.091 <.0001 58.786 .116 20.049 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory 
13 1127 -.113 -.171--.054 .0002 8.956 .707 0 
Neuropsychiatric Inventory 37 7621 -.119 -.149--.089 <.0001 50.020 .060 28.028 
Pain 9 2595 -.134 -.210--.056 .0008 18.287 .019 56.253 
Better self-rated health 6 1115 .269 .101-.422 .0020 36.456 <.001 86.285 
Presence of co-morbid conditions 23 3155 -.216 -.283--.147 <.0001 75.635 <.001 70.913 
Cared for by spouse (vs. other carer type) 7 1345 .144 .083-.204 <.0001 7.461 .280 19.578 
Being married 16 2848 .085 .048-.122 <.0001 12.931 .608 0 
Living alone 7 1699 -.064 -.114--.014 .0125 6.380 .382 5.958 
Presence of religious beliefs/spirituality 7 619 .349 .102-.556 .0064 58.178 <.001 89.687 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 19i: Factors associated with self-ratings of quality of life made by the person with dementia using dementia-specific quality of life measures – 
factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 8 1556 -.051 -.024-.125 .1845 12.269 .092 42.944 
Female gender 10 1990 .054 .009-.098 .0176 8.303 .504 0 
Higher level of education 8 1300 .096 .017-.174 .0178 12.475 .086 43.886 
Depression 7 758 -.178 -.323--.025 .0229 25.505 <.001 76.476 
Distress at NPS symptoms* 8 918 -.164 -.227--.099 <.0001 5.209 .635 0 
Burden or stress 19 2751 -.154 -.213--.093 <.0001 40.152 .002 55.171 
Burden/stress measures excluding Zarit Burden Interview 5 1022 -.191 -.250--.131 <.0001 2.177 .703 0 
Zarit Burden Interview 14 1729 -.143 -.225--.059 .0009 33.991 .001 61.755 
Carer quality of life (self-rated)* 6 667 .253 .081-.411 .0043 23.736 <.001 78.935 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 19j: Factors associated with self-ratings of quality of life made by the person with dementia using health related quality of life measures 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 13 2005 -.032 -.117-.053 .4620 38.657 <.001 68.957 
Female gender 11 1504 .010 -.041-.061 .6939 7.602 .668 0 
Higher level of education 6 885 .030 -.036-.097 .3715 4.383 .496 0 
Higher scores on cognitive screening measures 22 3316 .043 -.016-.101 .1503 52.682 <.001 60.138 
Mini-Mental State Examination 21 2957 .043 -.021-.105 .1864 52.908 <.001 62.199 
Better functional ability 18 3469 .140 .051-.227 .0021 111.365 <.001 84.735 
Basic activities of daily living 10 1633 .257 .147-.361 <.0001 44.408 <.001 79.733 
Instrumental activities of daily living 7 884 .143 -.010-.290 .0667 27.452 <.001 78.143 
Depression 12 1924 -.277 -.354--.196 <.0001 31.847 .001 65.460 
Geriatric Depression Scale (all versions) 8 882 -.324 -.416--.225 <.0001 14.021 .051 50.074 
Geriatric Depression Scale-30 5 575 -.236 -.312--.156 <.0001 2.630 .622 0 
Neuropsychiatric symptoms/BPSD 8 1954 -.082 -.127--.036 .0005 7.352 .393 4.788 
Neuropsychiatric Inventory 6 1529 -.062 -.112--.012 .0150 3.754 .585 0 
Presence of co-morbid conditions 6 1009 -.166 -.265--.064 .0015 12.257 .031 59.208 
Being married 5 1259 .059 .004-.114 .0364 3.749 .441 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 19k: Factors associated with self-ratings of quality of life made by the person with dementia using generic quality of life measures 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 7 1033 -.026 -.087-.036 .4107 4.238 .645 0 
Higher scores on cognitive screening measures 9 1116 .173 .027-.311 .0201 39.800 <.001 79.900 
Mini-Mental State Examination 6 361 .161 .006-.308 .0421 9.776 .082 48.857 
Better functional ability 7 968 .218 .018-.401 .0333 50.832 <.001 88.196 
Basic activities of daily living 5 472 .301 .154-.435 .0001 9.221 .056 56.621 
Depression 10 1091 -.409 -.544--.253 <.0001 60.277 <.001 85.069 
Geriatric Depression Scale (all versions) 8 1087 -.475 -.665--.227 .0004 138.284 <.001 94.938 
Geriatric Depression Scale-15 6 665 -.508 -.710--.231 .0007 80.499 <.001 93.789 
Presence of co-morbid conditions 5 819 -.156 -.305-.000 .0507 17.053 .002 76.544 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 19l: Factors associated with self-ratings of quality of life made by the people with dementia diagnosed with Alzheimer’s disease – factors 
pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 22 3277 .006 -.028-.041 .7153 19.720 .539 0 
Female gender 16 2281 .003 -.039-.044 .8932 12.019 .678 0 
Higher level of education 23 2825 .027 -.011-.064 .1616 10.054 .986 0 
Longer disease duration 5 1018 -.030 -.134-.075 .5743 8.912 .063 55.115 
Higher scores on cognitive screening measures 37 6846 .114 .073-.155 <.0001 76.809 <.001 53.130 
Mini-Mental State Examination 33 5956 .107 .058-.155 <.0001 81.391 <.001 60.684 
Taking medication 9 1386 -.167 -.247--.084 <.0001 15.618 .048 48.778 
Psychotropics 6 433 -.206 -.312--.094 .0004 6.723 .242 25.633 
Better functional ability 33 6763 .165 .121-.209 <.0001 81.629 <.001 60.798 
Basic activities of daily living 20 5051 .190 .145-.234 <.0001 33.568 .021 43.399 
Physical Self-Maintenance Scale 5 636 .248 .173-.320 <.0001 1.067 .899 0 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
9 3328 .198 .119-.274 <.0001 21.083 .007 62.055 
Instrumental activities of daily living 11 1383 .098 .045-.151 .0003 4.619 .915 0 
Lawton’s Instrumental Activities of Daily Living 8 1184 .093 .036-.150 .0015 3.270 .859 0 
More awareness 6 850 .149 .082-.214 .0002 3.309 .652 0 
Depression 31 3841 -.350 -.410--.288 <.0001 123.201 <.001 75.650 
Geriatric Depression Scale (all versions) 14 1658 -.398 -.496--.291 <.0001 73.145 <.001 82.227 
Geriatric Depression Scale-15 7 665 -.482 -.646--.275 <.0001 54.511 <.001 88.993 
Geriatric Depression Scale-30 6 889 -.285 -.367--.198 <.0001 7.967 .158 37.243 
Neuropsychiatric Inventory-Depression 5 1051 -.351 -.529--.144 .0012 43.027 <.001 90.704 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
11 1116 -.325 -.413--.231 <.0001 23.635 .009 57.690 
Cornell Scale for Depression in Dementia 7 871 -.316 -.445--.174 <.0001 28.599 <.001 79.020 
Anxiety 11 1510 -.164 -.265--.059 .0023 35.155 <.001 71.554 
Neuropsychiatric Inventory-Anxiety 5 1008 -.026 -.088-.036 .4102 3.012 .556 0 
Neuropsychiatric symptoms/BPSD 23 5718 -.096 -.130--.062 <.0001 28.140 .171 21.820 
Neuropsychiatric Inventory 19 5101 -.092 -.132--.053 <.0001 25.724 .106 30.026 
Presence of co-morbid conditions 12 1632 -.152 -.229--.074 .0002 21.616 .028 49.112 
Being married 8 1334 .059 .005-.113 .0331 3.159 .870 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 19m: Factors associated with self-ratings of quality of life made by the people with dementia diagnosed with Alzheimer’s disease – factors 
pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 968 -.053 -.169-.065 .3810 12.295 .031 59.335 
Female gender 7 1151 .039 -.019-.097 .1857 3.733 .713 0 
Depression 5 554 -.160 -.290--.023 .0220 9.247 .055 56.741 
Burden or stress 11 1559 -.109 -.171--.047 .0007 13.870 .179 27.902 
Zarit Burden Interview 9 1209 -.075 -.133--.016 .0127 8.305 .404 3.674 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 19n: Factors associated with self-ratings of quality of life by people with dementia, excluding studies that focused specifically on people 
diagnosed with Alzheimer’s disease – factors pertaining to the person with dementia 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 36 5205 -.043 -.077--.009 .0124 49.150 .057 28.789 
Female gender 31 4749 .007 -.025-.039 .6684 35.667 .219 15.888 
White ethnicity 8 1428 .146 .070-.220 .0002 14.655 .041 52.234 
Higher level of education 20 3034 .072 .013-.131 .0161 46.331 <.001 58.991 
Underweight 5 863 .003 -.131-.125 .9587 14.084 .007 71.600 
Alzheimer’s (vs. other dementia subtypes) 8 1233 .058 -.035-.150 .2250 17.733 .013 60.525 
Longer disease duration 7 900 .033 -.034-.098 .3348 2.872 .825 0 
More advanced dementia 19 2731 -.095 -.156--.034 .0024 42.107 .001 57.252 
Global Deterioration Scale 5 665 -.106 -.204--.006 .0377 5.700 .223 29.828 
Clinical Dementia Rating 12 1783 -.088 -.175-.001 .0516 34.818 <.001 68.407 
Higher scores on cognitive screening measures 56 6657 .066 .025-.107 .0017 139.605 <.001 60.603 
Mini-Mental State Examination 51 6090 .054 .015-.092 .0059 99.527 <.001 49.762 
Taking medication 10 3220 -.086 -.140--.031 .0022 16.385 .059 45.072 
Polypharmacy 5 972 -.149 -.210--.087 <.0001 .982 .913 0 
Longer duration of care home stay 5 582 -.062 -.144-.020 .1380 .614 .961 0 
Better functional ability 46 6454 .174 .124-.223 <.0001 170.431 <.001 73.596 
Basic activities of daily living 29 3452 .202 .130-.271 <.0001 118.961 <.001 76.463 
Katz Index of Independence in Activities of Daily Living 7 536 .296 .161-.420 <.0001 13.647 .034 56.034 
Barthel Index 15 2263 .197 .079-.309 .0012 105.346 <.001 86.710 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
9 1024 .180 .083-.274 .0003 18.425 .018 56.580 
Instrumental activities of daily living 14 1948 .188 .089-.283 .0002 57.590 <.001 77.427 
Instrumental activities of daily living measures excluding IADL & 
FAQ 
8 1372 .208 .059-.349 .0066 50.192 <.001 86.054 
Lawton’s Instrumental Activities of Daily Living 5 477 .178 .024-.324 .0241 9.822 .044 59.274 
Presence of unmet needs* 5 838 -.204 -.305--.100 .0002 9.273 .055 56.866 
Better self-rated memory functioning 5 1100 .036 -.037-.109 .3328 5.335 .255 25.022 
Depression 49 7594 -.293 -.342--.242 <.0001 233.321 <.001 79.428 
Geriatric Depression Scale (all versions) 14 1170 -.468 -.588--.327 <.0001 94.727 <.001 86.276 
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Geriatric Depression Scale-15 9 980 -.496 -.640--.318 <.0001 84.433 <.001 90.525 
Geriatric Depression Scale-30 5 190 -.407 -.531--.266 <.0001 4.295 .368 6.863 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
17 1686 -.324 -.423--.218 <.0001 83.732 <.001 80.891 
Cornell Scale for Depression in Dementia 20 4666 -.220 -.276--.162 <.0001 61.713 <.001 69.212 
Neuropsychiatric Inventory-Depression 7 804 -.203 -.305--.097 .0002 12.299 .056 51.215 
Anxiety 10 1502 -.256 -.368--.137 <.0001 44.750 <.001 79.888 
Neuropsychiatric symptoms/BPSD 33 3911 -.126 -.158--.093 <.0001 33.928 .375 5.683 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory 
13 1037 -.123 -.183--.061 .0001 11.947 .450 0 
Neuropsychiatric Inventory 22 2960 -.127 -.164--.089 <.0001 22.137 .392 5.135 
Pain 8 2639 -.158 -.242--.071 .0004 22.538 .002 68.942 
Better self-rated health 9 1447 .231 .123-.333 <.0001 31.509 <.001 74.610 
Presence of co-morbid conditions 19 2557 -.210 -.270--.148 <.0001 43.338 .001 58.466 
Better quality of relationship with carer 5 682 .453 .235-.627 .0001 39.223 <.001 89.802 
Cared for by spouse (vs. other carer type) 5 1129 .178 .052-.298 .0056 17.025 .002 76.506 
Being married 14 2514 .090 .048-.0131 <.0001 14.215 .359 8.545 
Living alone 5 1258 -.200 -.371--.015 .0339 42.488 <.001 90.585 
Greater social engagement* 8 903 .345 .102-.549 .0061 92.625 <.001 92.443 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 19o: Factors associated with self-ratings of quality of life by people with dementia, excluding studies that focused specifically on people 
diagnosed with Alzheimer’s disease – factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Female gender 5 1091 .085 .004-.166 .0394 6.555 .161 38.982 
Higher level of education 7 1257 .110 .029-.190 .0077 10.968 .089 45.295 
Distress at NPS symptoms 5 711 -.150 -.248--.049 .0036 6.313 .177 36.636 
Burden or stress 9 1281 -.144 -.215--.071 .0001 11.674 .166 31.472 
Zarit Burden Interview 6 599 -.151 -.271--.027 .0175 10.098 .072 50.487 
Poorer mental health (GHQ)* 5 702 -.156 -.275--.034 .0126 6.753 .150 40.767 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 19p: Factors associated with self-ratings of quality of life by people with dementia living in the community – factors pertaining to the person 
with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 29 4624 -.023 -.058-.012 .1969 36.584 .128 23.464 
Female gender 27 4437 .004 -.028.037 .7994 29.075 .308 10.576 
White ethnicity 7 1026 .237 .177-.294 <.0001 3.186 .785 0 
Higher level of education 24 3945 .062 .025-.099 .0010 28.830 .186 20.221 
Alzheimer’s (vs. other dementia subtypes) 5 625 .137 .029-.241 .0130 6.938 .139 42.345 
Longer disease duration 6 1185 .015 -.078-.107 .7575 10.245 .069 51.196 
More advanced dementia 8 1481 -.144 -.248--.036 .0089 28.005 <.001 75.005 
Clinical Dementia Rating 5 983 -.183 -.348--.006 .0425 26.814 <.001 85.083 
Higher scores on cognitive screening measures 48 8542 .067 .040-.094 <.0001 59.157 .002 20.550 
Mini-Mental State Examination 41 7476 .063 .029-.096 .0003 62.786 .012 36.292 
Taking medication 8 2664 -.083 -.139--.025 .0047 11.573 .116 39.512 
Polypharmacy  5 1288 -.104 -.181--.026 .0087 7.178 .127 44.273 
Better functional ability 38 8470 .182 .131-.232 <.0001 174.584 <.001 78.807 
Basic activities of daily living 20 5126 .236 .161-.309 <.0001 104.875 <.001 81.883 
Katz Index of Independence in Activities of Daily Living 5 833 .293 .100-.465 .0034 20.200 <.001 80.198 
Barthel Index 7 1055 .243 .064-.407 .0083 47.165 <.001 87.279 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
6 2903 .198 .091-.301 .0003 18.004 .003 72.228 
Instrumental activities of daily living 16 2657 .176 .094-.256 <.0001 61.289 <.001 75.526 
Instrumental ADL measures excluding IADL & FAQ 7 1260 .232 .066-.386 .0065 48.642 <.001 87.662 
Lawton’s Instrumental Activities of Daily Living 6 1168 .132 .034-.228 .0088 11.810 .037 57.661 
Better self-rated memory functioning 5 741 .050 -.026-.126 .1990 4.126 .389 3.062 
Depression 40 6743 -.315 -.369--.260 <.0001 201.589 <.001 80.654 
Geriatric Depression Scale (all versions) 17 1761 -.393 -.481--.298 <.0001 72.052 <.001 77.794 
Geriatric Depression Scale-15 9 780 -.474 -.590--.340 <.0001 36.822 <.001 78.274 
Geriatric Depression Scale-30 8 981 -.275 -.341--.206 <.0001 8.135 .321 13.955 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
15 1724 -.357 -.447--.259 <.0001 62.906 <.001 77.745 
Neuropsychiatric Inventory-Depression 6 1092 -.289 -.463--.093 .0043 44.993 <.001 88.887 
Cornell Scale for Depression in Dementia 8 2840 -.213 -.288--.136 <.0001 25.401 .001 72.442 
Anxiety 11 2051 -.196 -.289--.099 .0001 43.156 <.001 76.828 
Anxiety measures excluding Rating of Anxiety in Dementia & 
Neuropsychiatric Inventory-Anxiety 
5 598 -.360 -.464--.247 <.0001 9.065 .060 55.873 
Neuropsychiatric Inventory-Anxiety 6 1077 -.057 -.131-.017 .1302 6.268 .281 20.233 
Neuropsychiatric symptoms/BPSD 29 6006 -.110 -.138--.081 <.0001 29.851 .370 6.199 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory 
8 539 -.130 -.214--.045 .0029 4.586 .710 0 
Neuropsychiatric Inventory 22 5513 -.111 -.144--.077 <.0001 25.108 .243 16.362 
Pain 5 1481 -.138 -.247--.026 .0157 6.944 .139 42.400 
Presence of co-morbid conditions 14 2196 -.217 -.301--.131 <.0001 48.928 <.001 73.430 
Cared for by spouse (vs. other carer type) 6 1523 .149 .056-.239 .0018 15.511 .008 67.764 
Being married 14 2567 .079 .039-.118 .0001 13.225 .431 1.698 
Living alone 6 1553 -.072 -.127--.016 .0113 5.762 .330 13.222 
Greater social engagement 5 409 .287 .070-.478 .0102 15.481 .004 74.161 
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Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 19q: Factors associated with self-ratings of quality of life by people with dementia living in the community – factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 7 1496 -.057 -.132-.018 .1368 10.398 .109 42.297 
Female gender 9 1849 .051 .005-.097 .0296 6.975 .539 0 
Higher level of education 7 1242 .076 -.001-.153 .0523 9.789 .134 38.704 
Depression 6 771 -.106 -.178--.033 .0045 5.182 .394 3.508 
Distress at NPS symptoms 6 667 -.175 -.265--.082 .0002 6.637 .249 24.660 
Burden or stress 13 2358 -.137 -.192--.080 <.0001 20.709 .055 42.056 
Zarit Burden Interview 8 1326 -.113 -.199--.026 .0108 15.403 .031 54.555 
Burden/stress measures excluding Zarit Burden Interview 5 1032 -.166 -.225--.105 <.0001 3.010 .556 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 19r: Factors associated with self-ratings of quality of life by people with dementia living in residential care – factors pertaining to the person 
with dementia  
  
Factor  Number of 
studies 
Number of 
participants 
Number of 
participants 
95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 1052 -.008 -.068-.053 .8060 2.385 .794 0 
Female gender 6 1052 .015 -.070-.100 .7245 9.295 .098 46.209 
More advanced dementia 7 893 -.052 -.159-.055 .3412 13.555 .035 55.735 
Higher scores on cognitive screening measures 14 1197 .102 -.015-.216 .0873 46.304 <.001 71.925 
Mini-Mental State Examination 14 1197 .115 -.011-.238 .0739 54.900 <.001 76.321 
Taking medication 9 1746 -.154 -.238--.069 .0004 18.922 .015 57.721 
Psychotropics 5 994 -.231 -.408--.036 .0207 15.908 .003 74.855 
Longer duration of care home stay 7 665 -.069 -.146-.008 .0783 .793 .992 0 
Better functional ability 13 1211 .206 .096-.312 .0003 40.820 <.001 70.603 
Basic activities of daily living 13 1211 .207 .097-.313 .0003 40.974 <.001 70.713 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
5 301 .178 .064-.287 .0024 3.007 .557 0 
Barthel Index 6 860 .120 -.069-.300 .2126 35.449 <.001 85.895 
Depression 14 1756 -.244 -.336--.147 <.0001 40.746 <.001 68.095 
Cornell Scale for Depression in Dementia 9 1470 -.201 -.320-.074 .0020 32.210 <.001 75.163 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
6 330 -.325 -.439--.200 <.0001 7.146 .210 30.031 
Anxiety 5 367 -.225 -.430-.001 .0511 17.665 .001 77.356 
Neuropsychiatric symptoms/BPSD 9 873 -.086 -.154--.018 .0135 8.212 .413 2.583 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory 
6 464 -.097 -.209-.017 .0937 7.187 .207 30.434 
Presence of co-morbid conditions 8 747 -.177 -.247--.106 <.0001 5.159 .641 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 20a: Factors associated with informant ratings of quality of life for the person with dementia made by family carers only – factors pertaining 
to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 41 7101 -.033 -.066-.001 .0544 72.245 .001 44.633 
Female gender 36 6465 -.020 -.060-.020 .3197 80.622 <.001 56.588 
Higher level of education 28 4841 .047 .019-.075 .0012 19.449 .853 0 
Longer disease duration 10 1504 -.071 -.122--.020 .0061 7.556 .579 0 
More advanced dementia 20 3696 -.296 -.431--.148 .0001 413.353 <.001 95.403 
Global Deterioration Scale 5 767 -.288 -.388--.181 <.0001 9.593 .048 58.301 
Clinical Dementia Rating 16 2933 -.252 -.408--.081 .0042 325.168 <.001 95.387 
Higher scores on cognitive screening measures 64 11057 .155 .115-.195 <.0001 247.699 <.001 74.566 
Mini-Mental State Examination 56 9836 .148 .104-.191 <.0001 223.071 <.001 75.344 
Cognitive screening measures excluding Dementia Rating Scale & 
Mini-Mental State Examination 
16 4304 .174 .086-.259 .0001 81.672 <.001 81.634 
Taking medication 14 3586 -.060 -.092--.027 .0004 11.910 .535 0 
Acetylcholinesterase inhibitors 7 1317 -.055 -.122-.013 .1131 8.134 .228 26.235 
Polypharmacy 8 1652 -.064 -.115--.013 .0140 7.536 .375 7.116 
Psychotropics 6 1731 -.093 -.163--.022 .0100 6.640 .249 24.696 
Better functional ability 60 11082 .328 .275-.378 <.0001 476.001 <.001 87.605 
Bristol Activities of Daily Living Scale 5 859 .443 .387-.496 <.0001 2.642 .619 0 
Alzheimer's Disease Co-operative Study-Activities of Daily Living 
Inventory 
5 1172 .341 .199-.468 <.0001 25.946 <.001 84.583 
Disability Assessment for Dementia* 5 3172 .231 .085-.367 .0021 42.953 <.001 90.687 
Basic activities of daily living 35 6833 .369 .295-.438 <.0001 334.697 <.001 89.842 
Barthel Index 10 1021 .522 .377-.642 <.0001 63.199 <.001 85.759 
Dependence scale 5 3182 .342 .112-.537 .0041 117.287 <.001 96.850 
Physical Self-Maintenance Scale 6 622 .310 .214-.401 <.0001 8.025 .155 37.696 
Katz Index of Independence in Activities of Daily Living 9 1581 .298 .212-.380 <.0001 23.071 .003 65.324 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
6 611 .271 .157-.378 <.0001 9.812 .081 49.044 
Instrumental activities of daily living 24 3234 .350 .269-.426 <.0001 134.795 <.001 82.937 
Lawton’s Instrumental Activities of Daily Living* 15 2306 .303 .210-.390 <.0001 72.120 <.001 80.588 
Instrumental activities of daily living measures excluding Lawton’s 
Instrumental Activities of Daily Living 
10 1039 .453 .373-.526 <.0001 17.506 .041 48.590 
Better self-rated memory functioning 6 515 .177 -.000-.343 .0503 19.765 .001 74.703 
Depression 49 8469 -.301 -.352--.248 <.0001 292.145 <.001 83.570 
Cornell Scale for Depression in Dementia 16 3601 -.364 -.435--.289 <.0001 79.254 <.001 81.074 
Geriatric Depression Scale (all versions) 18 1919 -.253 -.338--.164 <.0001 62.570 <.001 72.830 
Geriatric Depression Scale-30 10 1082 -.294 -.419--.158 <.0001 41.161 <.001 78.135 
Geriatric Depression Scale-15 8 837 -.200 -.308--.087 .0006 17.439 .015 59.861 
Neuropsychiatric Inventory-Depression 8 1877 -.291 -.462--.098 .0036 115.445 <.001 93.937 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
15 1612 -.287 -.350--.221 <.0001 29.273 .010 52.174 
Anxiety 13 2675 -.148 -.194--.102 <.0001 15.224 .229 21.178 
Neuropsychiatric Inventory-Anxiety 8 1877 -.168 -.232--.101 <.0001 12.173 .095 42.495 
Neuropsychiatric symptoms/BPSD 53 10716 -.354 -.406--.301 <.0001 448.528 <.001 88.407 
Neuropsychiatric Inventory 39 8635 -.363 -.425--.296 <.0001 396.376 <.001 90.413 
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Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory 
15 2209 -.364 -.430--.294 <.0001 43.166 <.001 67.567 
Better self-rated health 6 1031 .232 .140-.320 <.0001 9.258 .099 45.992 
Presence of co-morbid conditions 17 2873 -.107 -.154--.061 <.0001 22.593 .125 29.182 
Cared for by spouse (vs. other carer type)* 10 2139 .117 .053-.180 .0004 17.386 .043 48.234 
Being married 14 2998 .117 .073-.161 <.0001 17.980 .158 27.699 
Living alone 12 2271 -.120 -.176--.063 <.0001 18.067 .080 39.114 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 20b: Factors associated with informant ratings of quality of life for the person with dementia made by family carers only – factors pertaining 
to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 12 2158 -.059 -.111--.006 .0303 14.758 .194 25.464 
Female gender 14 2466 .040 -.014-.093 .1498 20.256 .089 35.821 
Higher level of education 11 1676 .077 .018-.134 .0102 13.080 .219 23.550 
More time spent caring (community only)* 5 681 -.137 -.267--.002 .0462 11.630 .020 65.606 
Depression* 14 2694 -.255 -.338--.169 <.0001 64.440 <.001 79.826 
Center for Epidemiologic Studies Depression Scale* 6 905 -.299 -.458--.122 .0012 32.272 <.001 84.507 
Geriatric Depression Scale* 5 591 -.362 -.496--.211 <.0001 14.617 .006 72.634 
Depression measures excluding Geriatric Depression Scale & Center 
for Epidemiologic Studies Depression Scale* 
6 1449 -.202 -.313--.085 .0008 22.218 <.001 77.496 
Distress at NPS symptoms 10 1645 -.319 -.388--.246 <.0001 21.052 .012 57.248 
Burden or stress 23 4207 -.328 -.406--.246 <.0001 176.692 <.001 87.549 
Zarit Burden Interview 18 3275 -.343 -.433--.246 <.0001 148.656 <.001 88.564 
Burden or stress measures excluding Zarit Burden Interview 6 1003 -.280 -.428--.118 .0009 29.333 <.001 82.954 
Poorer mental health (GHQ)* 6 715 -.242 -.311--.170 <.0001 3.990 .551 0 
Carer quality of life (self-rated) 7 1409 .315 .201-.421 <.0001 27.700 <.001 78.339 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20c: Factors associated with informant ratings of quality of life for the person with dementia made by health care professionals only – factors 
pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 18 3966 -.050 -.103-.005 .0726 43.490 <.001 60.910 
Female gender 18 4155 .021 -.019-.062 .3022 25.920 .076 34.413 
Higher level of education 5 928 -.008 -.116-.101 .8868 9.172 .057 56.388 
More advanced dementia 13 3043 -.333 -.427--.231 <.0001 99.998 <.001 88.000 
Clinical Dementia Rating 5 2053 -.327 -.487--.146 .0006 71.904 <.001 94.437 
Advanced dementia measures excluding Clinical Dementia Rating 8 990 -.338 -.448--.217 <.0001 28.062 <.001 75.055 
Higher scores on cognitive screening measures 25 3237 .244 .180-.306 <.0001 81.605 <.001 70.590 
Mini-Mental State Examination 25 3228 .247 .182-.309 <.0001 84.364 <.001 71.552 
Taking medication 11 3108 -.049 -.085--.012 .0085 10.092 .432 .908 
Acetylcholinesterase inhibitors 5 766 -.105 -.211-.003 .0556 8.699 .069 54.018 
Psychotropics 8 2503 -.051 -.109-.007 .0852 12.423 .087 43.655 
Antidepressants 5 1076 -.126 -.244--.004 .0432 11.384 .023 64.864 
Longer duration of care home stay 10 1804 -.088 -.150--.025 .0062 14.138 .117 36.344 
Degree to which residential care is person-centred 6 1814 .154 .049-.256 .0042 13.718 .018 63.551 
Special dementia unit (vs. other residential facility) 5 2372 .120 .071-.168 <.0001 5.528 .237 27.641 
Better functional ability 29 6176 .368 .277-.452 <.0001 406 <.001 93.109 
Basic activities of daily living 25 4654 .363 .268-.451 <.0001 297.994 <.001 91.946 
Barthel Index 12 2329 .425 .264-.563 <.0001 207.202 <.001 94.691 
Katz Index of Independence in Activities of Daily Living 5 474 .371 .290-.447 <.0001 2.532 .639 0 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
7 1345 .280 .166-.386 <.0001 27.152 <.001 77.903 
Depression 19 3176 -.310 -.400--.214 <.0001 133.102 <.001 86.476 
Cornell Scale for Depression in Dementia 11 2506 -.262 -.350--.168 <.0001 52.375 <.001 80.907 
Neuropsychiatric Inventory-Depression 7 489 -.304 -.457--.133 .0006 20.521 .002 70.762 
Anxiety 9 761 -.215 -.314--.110 <.0001 14.794 .063 45.923 
Neuropsychiatric Inventory-Anxiety 7 489 -.199 -.336--.053 .0078 13.914 .031 56.877 
Neuropsychiatric symptoms/BPSD 24 3714 -.331 -.402--.255 <.0001 131.451 <.001 82.503 
Cohen-Mansfield Agitation Inventory 6 776 -.201 -.284--.115 <.0001 6.847 .232 26.980 
Neuropsychiatric Inventory 12 1794 -.311 -.404--.211 <.0001 43.189 <.001 74.531 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
9 1472 -.371 -.497--.230 <.0001 69.911 <.001 88.557 
Pain 9 2443 -.255 -.403--.095 .0021 115.216 <.001 93.057 
Presence of co-morbid conditions 8 1781 -.099 -.152--.046 .0003 8.528 .288 17.914 
Being married 5 917 .055 -.037-.146 .2428 6.578 .160 39.188 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data.  
 
  
 71 
 
Supplementary Table 20d: Factors associated with informant ratings of quality of life for the person with dementia made by mixed groups of informants including 
both family carers and health care professionals – factors pertaining to the person with dementia 
 
Factor  Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 5 1719 -.039 .014--.092 .1493 4.829 .305 17.170 
Higher scores on cognitive screening measures 5 1246 .225 .016-.414 .0350 52.030 <.001 92.312 
Better functional ability 9 2515 .339 .272-.403 <.0001 26.525 .001 69.840 
Basic activities of daily living* 8 2324 .330 .258-.399 <.0001 24.499 .001 71.427 
Neuropsychiatric symptoms/BPSD 5 1345 -.157 -.301--.006 .0415 29.669 <.001 86.518 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 20e: Factors associated with informant ratings of quality of life for the person with dementia made using the Quality of Life-Alzheimer’s 
Disease (QoL-AD) - factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 31 6501 -.011 -.047-.025 .5574 57.365 .002 47.703 
Female gender 25 5286 -.034 -.082-.014 .1658 65.922 <.001 63.593 
Higher level of education 19 3371 .061 .027-.095 .0004 17.493 .489 0 
Longer disease duration 6 1137 -.063 -.132-.006 .0754 6.184 .289 19.145 
More advanced dementia 18 3466 -.249 -.308-.188 <.0001 55.453 <.001 69.344 
Clinical Dementia Rating 12 2555 -.210 -.285-.134 <.0001 39.043 <.001 71.826 
Advanced dementia measures excluding Clinical Dementia Rating 6 911 -.330 -.387-.270 <.0001 4.064 .540 0 
Higher scores on cognitive screening measures 43 8818 .165 .120-.210 <.0001 164.917 <.001 74.533 
Mini-Mental State Examination 38 8113 .164 .116-.210 <.0001 142.608 <.001 74.055 
Cognitive screening measures excluding Dementia Rating Scale & 
Mini-Mental State Examination 
8 3165 .127 .017-.235 .0242 30.856 <.001 77.314 
Taking medication 11 4033 -.047 -.079--.016 .0033 10.179 .425 1.754 
Acetylcholinesterase inhibitors 5 1116 -.054 -.135-.028 .1947 6.465 .167 38.125 
Polypharmacy 6 1509 -.072 -.129--.014 .0148 6.109 .296 18.148 
Psychotropics 5 2437 -.032 -.072-.008 .1128 1.317 .859 0 
Better functional ability 44 9961 .303 .255-.349 <.0001 248.081 <.001 82.667 
Basic activities of daily living 27 7002 .317 .255-.376 <.0001 169.842 <.001 84.692 
Barthel Index 10 1885 .395 .326-.461 <.0001 22.776 .007 60.485 
Katz Index of Independence in Activities of Daily Living 9 2023 .286 .196-.370 <.0001 31.683 <.001 74.750 
Instrumental activities of daily living 15 1997 .320 .212-.421 <.0001 85.817 <.001 83.686 
Lawton’s Instrumental Activities of Daily Living 10 1567 .295 .158-.421 <.0001 66.351 <.001 86.436 
Instrumental activities of daily living measures excluding 
Lawton’s Instrumental Activities of Daily Living 
6 540 .412 .319-.498 <.0001 7.164 .209 30.203 
Better self-rated memory functioning 5 442 .213 .020-.390 .0308 16.079 .003 75.122 
Depression 43 9336 -.301 -.353--.248 <.0001 296.306 <.001 85.825 
Cornell Scale for Depression in Dementia 20 5720 -.339 -.399--.275 <.0001 118.105 <.001 83.913 
Geriatric Depression Scale (all versions) 12 1475 -.280 -.383--.170 <.0001 48.505 <.001 77.322 
Geriatric Depression Scale-30 8 983 -.314 -.453--.161 .0001 37.641 <.001 81.403 
Neuropsychiatric Inventory-Depression 8 1881 -.257 -.431--.064 .0096 107.576 <.001 93.493 
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Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
10 956 -.301 -.372--.226 <.0001 13.416 .145 32.914 
Anxiety 14 2884 -.183 -.254--.111 <.0001 41.720 <.001 68.840 
Anxiety measures excluding Neuropsychiatric Inventory-Anxiety 7 1188 -.196 -.305--.082 .0008 20.326 .002 70.481 
Neuropsychiatric symptoms/BPSD 41 9369 -.332 -.392--.268 <.0001 405.962 <.001 90.147 
Neuropsychiatric Inventory 32 8095 -.330 -.400--.257 <.0001 353.242 <.001 91.224 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
9 1126 -.401 -.513--.275 <.0001 44.122 <.001 81.869 
Pain 6 2764 -.049 -.086--.012 .0100 2.694 .747 0 
Presence of co-morbid conditions 13 2489 -.118 -.167--.068 <.0001 16.284 .179 26.310 
Cared for by spouse (vs. other carer type) 7 1835 .115 .021-.206 .0162 21.684 .001 72.330 
Being married 10 2020 .132 .082-.182 <.0001 11.222 .261 19.797 
Living alone 7 1657 -.158 -.240--.073 .0003 15.874 .014 62.202 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 20f: Factors associated with informant ratings of quality of life for the person with dementia made using the Quality of Life-Alzheimer’s 
Disease (QoL-AD) - factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 9 1845 -.014 -.115-.088 .7905 32.842 <.001 75.641 
Female gender 12 2282 .045 -.012-.101 .1206 17.642 .090 37.650 
Higher level of education 8 1357 .072 .001-.142 .0461 10.469 .164 33.136 
Depression 10 2003 -.254 -.338--.166 <.0001 34.194 <.001 73.680 
Distress at NPS symptoms 8 1097 -.302 -.373--.227 <.0001 11.291 .126 38.003 
Burden or stress 19 3544 -.327 -.427--.220 <.0001 208.780 <.001 91.379 
Zarit Burden Interview 14 2592 -.341 -.450--.223 <.0001 132.637 <.001 90.199 
Burden or stress measures excluding Zarit Burden Interview 5 952 -.286 -.529-.001 .0506 72.363 <.001 94.472 
Poorer mental health (GHQ) 6 742 -.286 -.392--.172 <.0001 8.442 .133 40.774 
Carer quality of life (self-rated) 7 1408 .323 .212-.427 <.0001 26.792 <.001 77.605 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 20g: Factors associated with informant ratings of quality of life for the person with dementia made using the Alzheimer's Disease Related 
Quality of Life (ADRQL) – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 12 2495 -.049 -.097--.001 .0443 14.699 .197 25.164 
Female gender 8 2085 .057 .014-.100 .0096 6.141 .523 0 
More advanced dementia 9 1596 -.383 -.487--.267 <.0001 46.370 <.001 82.747 
Higher scores on cognitive screening measures 14 2508 .295 .223-.363 <.0001 43.364 <.001 70.021 
Mini-Mental State Examination 14 2510 .295 .223-.365 <.0001 45.213 <.001 71.247 
Taking medication 6 1190 -.027 -.086-.032 .3690 5.295 .381 5.569 
Better functional ability 14 4069 .342 .233-.442 <.0001 161.125 <.001 91.932 
Basic activities of daily living 9 1339 .361 .267-.448 <.0001 26.861 .001 70.217 
Katz Index of Independence in Activities of Daily Living 7 989 .344 .274-.410 <.0001 8.170 .226 26.558 
Depression 10 1320 -.328 -.441--.204 <.0001 50.806 <.001 82.285 
Cornell Scale for Depression in Dementia 9 1186 -.353 -.470--.225 <.0001 44.614 <.001 82.068 
Neuropsychiatric symptoms/BPSD 14 2618 -.379 -.473--.276 <.0001 110.040 <.001 88.186 
Neuropsychiatric Inventory 8 1589 -.421 -.536--.291 <.0001 59.180 <.001 88.172 
Presence of co-morbid conditions 7 929 -.006 -.071-.059 .8511 6.011 .422 .185 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 20h: Factors associated with informant ratings of quality of life for the person with dementia made using the EQ-5D – factors pertaining to 
the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 7 2051 .018 -.065-.101 .6721 19.691 .003 69.529 
Female gender 6 1902 -.057 -.101-.011 .0140 2.363 .797 0 
Higher scores on cognitive screening measures 14 2839 .196 .100-.289 .0001 79.568 <.001 83.662 
Mini-Mental State Examination 13 2429 .215 .119-.308 <.0001 63.367 <.001 81.063 
Better functional ability 18 3551 .531 .409-.634 <.0001 342.597 <.001 95.038 
Basic activities of daily living 11 1981 .613 .481-.718 <.0001 152.400 <.001 93.438 
Barthel Index 6 1448 .723 .646-.785 <.0001 25.778 <.001 80.603 
Instrumental activities of daily living 5 636 .459 .330-.572 <.0001 11.179 .025 64.220 
Depression 8 2074 -.167 -.260--.070 .0007 29.949 <.001 76.627 
Neuropsychiatric symptoms/BPSD 8 1624 -.293 -.420--.154 .0001 54.199 <.001 87.085 
Neuropsychiatric Inventory* 8 1624 -.293 -.420--.154 .0001 54.199 <.001 87.085 
Presence of co-morbid conditions 6 1677 -.116 -.209--.021 .0164 15.527 .008 67.798 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20i: Factors associated with informant ratings of quality of life for the person with dementia made using the EQ-5D Visual Analogue Scale – 
factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 1689 -.020 -.118-.078 .6867 16.603 .005 69.884 
Female gender 5 1211 -.056 -.137-.027 .1878 6.622 .157 39.600 
Higher scores on cognitive screening measures 7 1763 .111 -.029-.246 .1204 46.034 <.001 86.966 
Mini-Mental State Examination 6 1356 .135 -.037-.300 .1233 43.564 <.001 88.523 
Better functional ability 6 1857 .285 .201-.365 <.0001 16.183 .006 69.104 
Depression 6 1740 -.178 -.279--.074 .0009 20.593 .001 75.720 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 20j: Factors associated with informant ratings of quality of life for the person with dementia made using the Quality of Life in Late Stage 
Dementia Scale (QUALID) – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 1765 -.022 -.094-.050 .5496 9.849 .080 49.234 
Female gender 7 2057 -.011 -.054-.033 .6271 5.064 .536 0 
More advanced dementia 5 1537 -.245 -.348--.135 <.0001 15.096 .005 73.504 
Higher scores on cognitive screening measures 6 1213 .091 -.084-.261 .3093 40.592 <.001 87.682 
Mini-Mental State Examination* 6 1213 .091 -.084-.261 .3093 40.592 <.001 87.682 
Taking medication 5 1319 -.087 -.169--.004 .0392 7.165 .127 44.176 
Better functional ability 9 2355 .203 .011-.381 .0388 165.249 <.001 95.159 
Basic activities of daily living* 9 2355 .203 .011-.381 .0388 165.249 <.001 95.159 
Depression 6 1058 -.526 -.664--.352 <.0001 48.065 <.001 89.597 
Neuropsychiatric symptoms/BPSD 8 1651 -.395 -.535--.234 <.0001 77.089 <.001 90.920 
Neuropsychiatric Inventory 5 1063 -.352 -.514--.165 .0003 27.454 <.001 85.430 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20k: Factors associated with informant ratings of quality of life for the person with dementia made using the Health Utility Index (HUI) 2 
and/or 3 – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Higher scores on cognitive screening measures 6 3336 .208 .025-.378 .0264 89.599 <.001 94.420 
Mini-Mental State Examination 5 2920 .240 -.032-.479 .0834 112.324 <.001 96.439 
Better functional ability 6 3338 .375 .158-.558 .0010 145.386 <.001 96.561 
Basic activities of daily living 5 2917 .385 .111-.604 .0070 126.927 <.001 96.849 
Presence of co-morbid conditions 5 1337 -.135 -.209--.060 .0005 7.097 .131 43.637 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 20l: Factors associated with informant ratings of quality of life for the person with dementia made using dementia-specific quality of life 
measures – factors pertaining to the person with dementia  
 
Factor   Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 49 10112 -.029 -.057--.001 .0428 85.287 .001 43.719 
Female gender 37 8320 .000 -.036-.036 .9987 88.710 <.001 59.418 
White ethnicity 5 906 .066 .000-.131 .0490 2.029 .730 0 
Higher level of education 24 3930 .042 .007-.077 .0187 26.544 .276 13.350 
Underweight* 5 1755 -.065 -.129--.002 .0447 7.119 .130 43.809 
Alzheimer’s (vs. other dementia subtypes) 8 2624 .067 -.010-.143 .0885 23.568 .001 70.298 
Longer disease duration 8 1356 -.070 -.123--.016 .0107 6.674 .464 0 
More advanced dementia 33 6532 -.281 -.336--.225 <.0001 176.330 <.001 81.852 
Clinical Dementia Rating 19 4715 -.261 -.337--.180 <.0001 142.262 <.001 87.347 
Global Deterioration Scale 6 898 -.283 -.379--.182 <.0001 12.740 .026 60.755 
Advanced dementia measures excluding Clinical Dementia Rating & 
Global Deterioration Scale 
8 919 -.337 -.429--.238 <.0001 17.240 .016 59.396 
Higher scores on cognitive screening measures 68 12491 .190 .152-.228 <.0001 285.747 <.001 76.553 
Mini-Mental State Examination 59 10906 .183 .143-.222 <.0001 227.086 <.001 74.459 
Cognitive screening measures excluding Dementia Rating Scale & 
Mini-Mental State Examination 
17 5004 .211 .120-.299 <.0001 132.416 <.001 87.917 
Taking medication 19 5737 -.057 -.086--.028 .0001 20.097 .327 10.434 
Acetylcholinesterase inhibitors 9 1684 -.093 -.165--.020 .0122 16.171 .040 50.527 
Polypharmacy 8 1776 -.058 -.104--.011 .0154 6.564 .476 0 
Psychotropics 12 4043 -.066 -.112--.018 .0064 19.261 .057 42.889 
Antipsychotics* 5 1244 -.171 -.290--.047 .0069 15.322 .004 73.893 
Antidepressants* 6 1221 -.098 -.195--.000 .0492 11.134 .049 55.092 
Anxiolytics * 7 1617 -.056 -.149-.038 .2459 17.494 .008 65.702 
Longer duration of care home stay 11 2217 -.103 -.164--.041 .0011 18.521 .047 46.008 
Degree to which residential care is person-centred* 6 1814 .155 .049-.257 .0042 13.729 .017 63.581 
Special dementia unit (vs. other residential facility)* 5 2366 .114 .069-.158 <.0001 4.753 .314 15.838 
Better functional ability 70 16702 .283 .246-.320 <.0001 414.271 <.001 83.344 
Alzheimer's Disease Co-operative Study-Activities of Daily 
Living Inventory 
6 1176 .354 .225-.470 <.0001 22.915 <.001 78.181 
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Disability Assessment for Dementia 5 3172 .214 .067-.353 .0047 43.709 <.001 90.849 
Basic activities of daily living 48 11109 .294 .255-.333 <.0001 206.491 <.001 77.239 
Barthel Index 13 2424 .331 .251-.406 <.0001 50.285 <.001 76.136 
Dependence Scale 5 2967 .217 .068-.356 .0045 36.368 <.001 89.001 
Katz Index of Independence in Activities of Daily Living 14 2840 .295 .239-.348 <.0001 29.224 .006 55.515 
Physical Self-Maintenance Scale 10 1716 .321 .237-.399 <.0001 25.638 .002 64.896 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
10 1777 .292 .195-.384 <.0001 38.905 <.001 76.867 
Instrumental activities of daily living 18 2610 .337 .244-.423 <.0001 103.639 <.001 83.597 
Lawton’s Instrumental Activities of Daily Living 12 2089 .303 .190-.409 <.0001 77.671 <.001 85.838 
Instrumental activities of daily living measures excluding 
Lawton’s Instrumental Activities of Daily Living 
7 63 .433 .347-.511 <.0001 8.967 .175 33.091 
More awareness* 5 557 .275 .037-.484 .0241 31.084 <.001 87.132 
Better self-rated memory functioning 7 710 .170 .030-.304 .0177 20.382 .002 70.562 
Depression 59 11196 -.321 -.369--.271 <.0001 442.334 <.001 86.888 
Cornell Scale for Depression in Dementia 27 6439 -.358 -.415--.299 <.0001 165.413 <.001 84.282 
Geriatric Depression Scale (all versions) 13 1509 -.284 -.383--.179 <.0001 49.013 <.001 75.517 
Geriatric Depression Scale-30 8 983 -.314 -.453--.161 <.0001 37.641 <.001 81.403 
Neuropsychiatric Inventory-Depression 11 2087 -.259 -.404--.102 .0015 113.249 <.001 91.170 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
17 1998 -.314 -.408--.213 <.0001 88.394 <.001 81.899 
Anxiety 17 3090 -.178 -.243--.112 <.0001 44.849 <.001 64.324 
Neuropsychiatric Inventory-Anxiety 11 2087 -.150 -.211--.088 <.0001 15.735 .107 36.447 
Anxiety measures excluding Neuropsychiatric Inventory-Anxiety 7 1188 -.219 -.316--.118 <.0001 16.338 .012 63.275 
Neuropsychiatric symptoms/BPSD 66 13851 -.335 -.383--.285 <.0001 625.716 <.001 89.612 
Cohen-Mansfield Agitation Inventory 9 1332 -.150 -.213--.085 <.0001 10.839 .211 26.191 
Neuropsychiatric Inventory 43 10216 -.348 -.409--.283 <.0001 495.411 <.001 91.522 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
20 3079 -.353 -.425-.276 <.0001 103.081 <.001 81.568 
Pain* 13 4048 -.203 -.307--.095 .0003 124.860 <.001 90.389 
Presence of co-morbid conditions 21 3888 -.072 -.111--.034 .0002 26.380 .154 24.185 
Cared for by spouse (vs. other carer type) 9 2068 .121 .046-.194 .0016 20.652 .008 62.263 
Being married 13 2407 .122 .076-.168 <.0001 14.966 .243 19.821 
Living alone 10 2066 -.141 -.206--.074 <.0001 18.676 .028 51.811 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20m: Factors associated with informant ratings of quality of life for the person with dementia made using dementia-specific quality of life 
measures – factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 13 2318 -.013 -.088-.061 .7257 33.985 .001 64.691 
Female gender 14 3066 .054 .006-.102 .0283 21.214 .090 35.689 
Higher level of education 11 2231 .087 .035-.138 .0010 13.164 .215 24.034 
More time spent caring (community only)* 5 681 -.137 -.267--.002 .0462 11.630 .020 65.606 
Depression 12 2215 -.266 -.342--.187 <.0001 37.599 <.001 70.744 
Center for Epidemiologic Studies Depression Scale 5 865 -.274 -.439--.091 .0037 26.446 <.001 84.875 
Depression measures excluding Geriatric Depression Scale & Center 
for Epidemiologic Studies Depression Scale 
5 1041 -.236 -.293--.178 <.0001 1.918 .751 0 
Distress at NPS symptoms 7 1027 -.331 -.419--.236 <.0001 14.753 .022 59.330 
Burden or stress 22 3827 -.336 -.425--.239 <.0001 211.743 <.001 90.082 
Zarit Burden Interview 17 2875 -.351 -.445--.250 <.0001 135.079 <.001 88.155 
Poorer mental health (GHQ)* 6 742 -.286 -.392--.172 <.0001 8.442 .133 40.774 
Carer quality of life (self-rated) 8 1508 .317 .217-.410 <.0001 26.916 <.001 73.993 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 20n: Factors associated with informant ratings of quality of life for the person with dementia made using dementia-specific quality of life 
measures by family carers – factors pertaining to the person with dementia factors 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 33 5786 -.030 -.064-.004 .0789 48.532 .031 34.064 
Female gender 26 5059 -.025 -.072-.023 .3037 63.531 <.001 60.649 
Higher level of education 22 3679 .052 .019-.084 .0018 18.091 .643 0 
Longer disease duration 6 1133 -.068 -.135-.001 .0520 5.966 .310 16.194 
More advanced dementia 18 2754 -.263 -.327--.196 <.0001 55.213 <.001 69.210 
Clinical Dementia Rating 10 1632 -.225 -.322--.124 <.0001 36.719 <.001 75.490 
Global Deterioration Scale 5 767 -.288 -.388--.181 <.0001 9.593 .048 58.301 
Higher scores on cognitive screening measures 46 8976 .161 .117-.204 <.0001 163.119 <.001 72.413 
Mini-Mental State Examination 39 7896 .160 .112-.206 <.0001 140.566 <.001 72.966 
Cognitive screening measures excluding Dementia Rating Scale & 
Mini-Mental State Examination 
12 987 .171 .069-.269 .0010 73.164 <.001 84.965 
Taking medication 12 3320 -.062 -.096--.028 .0003 10.969 .446 0 
Acetylcholinesterase inhibitors 6 1109 -.070 -.150-.011 .0904 7.653 .176 34.667 
Polypharmacy 7 1594 -.066 -.122--.009 .0232 7.360 .289 18.476 
Psychotropics 6 1731 -.093 -.163--.022 .0099 6.640 .249 24.696 
Better functional ability 44 9500 .275 .222-.327 <.0001 283.292 <.001 84.821 
Alzheimer's Disease Co-operative Study-Activities of Daily 
Living Inventory 
5 1179 .344 .213-.462 <.0001 22.319 <.001 82.078 
Disability Assessment for Dementia 5 3172 .214 .067-.353 .0047 43.709 <.001 90.849 
Basic activities of daily living 25 5531 .292 .229-.353 <.0001 113.668 <.001 78.886 
Barthel Index 6 587 .388 .296-.472 <.0001 7.489 .187 33.233 
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Katz Index of Independence in Activities of Daily Living 7 1434 .289 .191-.382 <.0001 20.106 .003 70.158 
Physical Self-Maintenance Scale 7 844 .296 .172-.411 <.0001 20.564 .002 70.823 
Basic activities of daily living measures excluding Barthel Index, 
Katz Index of Independence in Activities of Daily Living & 
Physical Self-Maintenance Scale 
5 543 .271 .135-.397 .0001 9.632 .047 58.472 
Instrumental activities of daily living 18 2610 .335 .242-.422 <.0001 103.328 <.001 83.548 
Lawton’s Instrumental Activities of Daily Living* 12 2089 .282 .171-.387 <.0001 73.362 <.001 85.006 
Instrumental activities of daily living measures excluding 
Lawton’s Instrumental Activities of Daily Living 
7 632 .426 .335-.510 <.0001 9.893 .129 39.351 
More awareness* 5 557 .275 .037-.484 .0241 31.084 <.001 87.132 
Better self-rated memory functioning* 6 515 .177 -.000-.343 .0503 19.765 .001 74.703 
Depression 40 7346 -.319 -.377--.258 <.0001 282.918 <.001 86.215 
Cornell Scale for Depression in Dementia 15 3371 -.394 -.468--.314 <.0001 80.048 <.001 82.511 
Geriatric Depression Scale (all versions) 12 1475 -.278 -.381--.168 <.0001 47.937 <.001 77.053 
Geriatric Depression Scale-30 8 983 -.320 -.458--.166 <.0001 37.958 <.001 81.558 
Neuropsychiatric Inventory-Depression 6 1669 -.267 -.473--.033 .0258 105.110 <.001 95.243 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
12 1240 -.289 -.366--.208 <.0001 23.239 .016 52.665 
Anxiety 12 2621 -.183 -.260--.104 <.0001 39.398 <.001 72.080 
Neuropsychiatric Inventory-Anxiety 7 1836 -.168 -.237--.097 <.0001 11.997 .062 49.986 
Anxiety measures excluding Neuropsychiatric Inventory-Anxiety 6 964 -.190 -.318--.055 .0061 18.114 .003 72.397 
Neuropsychiatric symptoms/BPSD 42 9113 -.368 -.430--.304 <.0001 443.809 <.001 90.762 
Neuropsychiatric Inventory 31 7638 -.383 -.456--.304 <.0001 403.246 <.001 92.560 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory 
13 1692 -.350 -.435--.258 <.0001 48.078 <.001 78.041 
Presence of co-morbid conditions 13 2208 -.097 -.149--.044 .0003 16.661 .163 27.974 
Cared for by spouse (vs. other carer type)* 9 2068 .121 .046-.194 .0016 20.652 .008 62.263 
Being married 11 2162 .126 .071-.181 <.0001 15.335 .120 34.789 
Living alone 9 1944 -.125 -.190--.060 .0002 15.001 .059 46.670 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20o: Factors associated with informant ratings of quality of life for the person with dementia made using dementia-specific quality of life 
measures by family carers only – factors pertaining to the carer factors 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 10 1976 -.037 -.121-.047 .3861 27.028 .001 66.701 
Female gender 13 2443 .037 -.019-.093 .1896 20.272 .062 40.806 
Higher level of education 10 1608 .080 .018-.142 .0120 12.749 .147 29.404 
More time spent caring (community only)* 5 681 -.137 -.267--.002 .0462 11.630 .020 65.606 
Depression* 12 2215 -.266 -.342--.187 <.0001 37.599 <.001 70.744 
Center for Epidemiologic Studies Depression Scale* 5 865 -.274 -.439--.091 .0037 26.446 <.001 84.875 
Depression measures excluding Geriatric Depression Scale & Center 
for Epidemiologic Studies Depression Scale* 
5 1041 -.236 -.293--.178 <.0001 1.918 .751 0 
Distress at NPS symptoms 7 1007 -.330 -.434--.216 <.0001 20.691 .002 71.002 
Burden or stress 20 3574 -.341 -.437--.238 <.0001 206.746 <.001 90.810 
Zarit Burden Interview 17 2866 -.349 -.443--.247 <.0001 135.117 <.001 88.158 
Poorer mental health (GHQ)* 6 742 -.286 -.392--.172 <.0001 8.442 .133 40.774 
Carer quality of life (self-rated) 7 1408 .318 .207-.421 <.0001 26.485 <.001 77.346 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20p: Factors associated with informant ratings of quality of life for the person with dementia made using dementia-specific quality of life 
measures by health care professionals only – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 14 3205 -.062 -.111--.012 .0152 22.767 .045 42.900 
Female gender 14 3394 .027 -.018-.072 .2415 20.523 .083 36.657 
More advanced dementia 13 3043 -.333 -.427--.231 <.0001 99.998 <.001 88.000 
Clinical Dementia Rating 5 2053 -.327 -.487--.146 .0006 71.904 <.001 94.437 
Advanced dementia measures excluding Clinical Dementia Rating 8 990 -.338 -.448--.217 <.0001 28.062 <.001 75.055 
Higher scores on cognitive screening measures 23 3047 .239 .172-.305 <.0001 78.324 <.001 71.912 
Mini-Mental State Examination 23 3038 .242 .173-.309 <.0001 81.160 <.001 72.893 
Taking medication 11 3108 -.049 -.085--.012 .0085 10.092 .432 .908 
Acetylcholinesterase inhibitors 5 766 -.105 -.211-.003 .0556 8.699 .069 54.018 
Psychotropics 8 2503 -.051 -.109-.007 .0852 12.423 .087 43.655 
Antidepressants 5 1076 -.126 -.244--.004 .0432 11.384 .023 64.864 
Longer duration of care home stay 9 1709 -.085 -.153--.016 .0152 13.936 .083 42.596 
Degree to which residential care is person-centred* 6 1814 .154 .049-.256 .0042 13.718 .018 63.551 
Special dementia unit (vs. other residential facility)* 5 2372 .120 .071-.168 <.0001 5.528 .237 27.641 
Better functional ability 23 5328 .292 .234-.349 <.0001 97.626 <.001 77.465 
Basic activities of daily living 21 3894 .303 .252-.353 <.0001 54.478 <.001 63.288 
Barthel Index 10 1759 .336 .258-.410 <.0001 27.120 .001 66.814 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
6 1249 .249 .137-.354 <.0001 19.768 <.001 74.707 
Depression 18 3135 -.315 -.407--.216 <.0001 132.695 <.001 87.189 
Cornell Scale for Depression in Dementia 11 2506 -.262 -.350--.168 <.0001 52.375 <.001 80.907 
Neuropsychiatric Inventory-Depression 5 424 -.318 -.508--.099 .0049 20.146 <.001 80.145 
Anxiety 8 720 -.213 -.322--.098 .0003 14.760 .039 52.575 
Neuropsychiatric Inventory-Anxiety 6 448 -.194 -.350--.026 .0236 13.790 .017 63.743 
Neuropsychiatric symptoms/BPSD 23 3673 -.326 -.399--.249 <.0001 130.165 <.001 83.098 
Neuropsychiatric Inventory 11 1753 -.300 -.398--.196 <.0001 41.346 <.001 75.814 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
14 2288 -.327 -.426--.221 <.0001 93.038 <.001 86.027 
Pain* 9 2443 -.255 -.403--.095 .0021 115.216 <.001 93.057 
Presence of co-morbid conditions 6 987 -.065 -.129-.000 .0508 5.193 .393 3.723 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
  
 81 
 
Supplementary Table 20q: Factors associated with informant ratings of quality of life for the person with dementia made using dementia-specific quality of life 
measures by mixed groups of carers including both family carers and health care professionals – factors pertaining to the person with dementia  
 
Factor  Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 5 1717 .040 -.013-.092 .1369 4.748 .314 15.746 
Better functional ability 9 2513 .311 .224-.394 <.0001 43.255 <.001 81.505 
Basic activities of daily living* 8 2322 .298 .206-.385 <.0001 38.411 <.001 81.776 
Neuropsychiatric symptoms/BPSD 6 1536 -.209 -.362--.046 .0126 51.817 <.001 90.351 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 20r: Factors associated with informant ratings of quality of life for the person with dementia made using health-related quality of life 
measures – factors pertaining to the person with dementia  
 
Factor   Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 13 3160 -.050 -.118-.019 .1538 38.056 <.001 68.468 
Female gender 11 2533 -.031 -.080-.018 .2195 13.666 .189 26.826 
Higher level of education 5 1764 .024 -.023-.071 .3165 1.726 .786 0 
More advanced dementia 8 2257 -.424 -.624.--171 .0015 284.268 <.001 97.538 
Clinical Dementia Rating 7 1849 -.375 -.608--.083 .0131 237.791 <.001 97.477 
Higher scores on cognitive screening measures 22 5828 .154 .078-.228 <.0001 135.888 <.001 84.546 
Mini-Mental State Examination 21 5438 .151 .060-.239 .0011 172.057 <.001 88.376 
Better functional ability 23 6347 .452 .331-.558 <.0001 601.300 <.001 96.341 
Basic activities of daily living 15 4710 .517 .345-.655 <.0001 572.421 <.001 97.554 
Barthel Index 7 1475 .664 .546-.756 <.0001 53.911 <.001 88.871 
Instrumental activities of daily living 6 711 .353 .164-.516 .0004 28.980 <.001 82.747 
Depression 13 2715 -.240 -.320--.157 <.0001 50.222 <.001 76.106 
Geriatric Depression Scale (all versions) 7 795 -.228 -.361--.086 .0018 18.927 .004 68.299 
Geriatric Depression Scale-30 5 589 -.306 -.481--.107 .0030 15.260 .004 73.788 
Neuropsychiatric symptoms/BPSD 12 4688 -.320 -.422--.209 <.0001 137.811 <.001 92.018 
Neuropsychiatric Inventory 10 4234 -.290 -.400--.172 <.0001 106.540 <.001 91.552 
Presence of co-morbid conditions 8 2393 -.114 -.189--.038 .0035 21.962 .003 68.127 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 20s: Factors associated with informant ratings of quality of life for the person with dementia made using health-related quality of life 
measures – factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Burden or stress 5 1515 -.267 -.402--.121 .0004 32.132 <.001 87.551 
 
 
Supplementary Table 20t: Factors associated with informant ratings of quality of life for the person with dementia made using health-related quality of life 
measures by family carers only – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 11 2157 -.060 -.142-.023 .1596 31.177 .001 67.925 
Female gender 9 1530 -.005 -.065-.055 .8692 9.930 .270 19.434 
More advanced dementia 7 2030 -.469 -.664--.215 .0006 237.789 <.001 97.477 
Clinical Dementia Rating 6 1622 -.422 -.657--.112 .0090 202.966 <.001 97.537 
Higher scores on cognitive screening measures 21 5300 .162 .081-.240 <.0001 128.786 <.001 84.470 
Mini-Mental State Examination 20 4909 .158 .060-.253 .0016 168.151 <.001 88.701 
Better functional ability 23 6347 .452 .331-.558 <.0001 601.300 <.001 96.341 
Basic activities of daily living 13 3692 .475 .300-.619 <.0001 298.154 <.001 95.975 
Barthel Index 7 1475 .664 .546-.756 <.0001 53.911 <.001 88.871 
Instrumental activities of daily living* 6 711 .353 .164-.516 .0004 28.980 <.001 82.747 
Depression 12 2190 -.267 -.343--.187 <.0001 34.677 <.001 68.278 
Geriatric Depression Scale (all versions) 7 795 -.228 -.361--.086 .0018 18.927 .004 68.299 
Geriatric Depression Scale-30 5 589 -.306 -.481--.107 .0030 15.260 .004 73.788 
Neuropsychiatric symptoms/BPSD 12 4688 -.315 -.418--.204 <.0001 136.816 <.001 91.960 
Neuropsychiatric Inventory 10 4234 -.285 -.394--.167 <.0001 105.366 <.001 91.458 
Presence of co-morbid conditions 5 1074 -.139 -.228--.047 .0032 7.514 .111 46.769 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20u: Factors associated with informant ratings of quality of life for the person with dementia made using health-related quality of life 
measures by family carers only – factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Burden or stress* 5 1515 -.267 -.402--.121 .0004 32.132 <.001 87.551 
Note: those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 20v: Factors associated with informant ratings of quality of life for the person with dementia made using generic quality of life measures – 
factors pertaining to the person with dementia  
 
Factor   Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Higher scores on cognitive screening measures 8 1045 .214 .019-.393 .0316 61.342 <.001 88.589 
Mini-Mental State Examination 6 476 .204 .027-.368 .0240 17.476 .004 71.389 
Better functional ability 6 818 .462 .252-.630 .0001 46.481 <.001 89.243 
Depression 5 625 -.168 -.328-.002 .0529 11.694 .020 65.795 
Geriatric Depression Scale (all versions) 5 625 -.288 -.477--.074 .0090 19.971 .001 79.971 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 20w: Factors associated with informant ratings of quality of life for the person with dementia made using generic quality of life measures by 
family carers only – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Higher scores on cognitive screening measures 7 950 .186 -.031-.386 .0922 56.747 <.001 89.427 
Mini-Mental State Examination 5 381 .157 -.053-.353 .1423 14.947 .005 73.238 
Better functional ability 5 709 .360 .187-.512 .0001 17.072 .002 76.570 
Depression* 5 625 -.168 -.328-.002 .0529 11.694 .020 65.795 
Geriatric Depression Scale (all versions)* 5 625 -.288 -.477--.074 .0090 19.971 .001 79.971 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20x: Factors associated with informant ratings of quality of life for people with dementia diagnosed with Alzheimer’s disease – factors 
pertaining to the person with dementia  
 
Factor   Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 20 3202 -.013 -.067-.041 .6383 38.724 .005 50.935 
Female gender 15 2646 -.005 -.076-.066 .8896 40.263 <.001 65.229 
Higher level of education 15 2364 .013 -.028-.053 .5462 6.844 .941 0 
More advanced dementia 9 1325 -.217 -.328--.099 .0003 37.128 <.001 78.453 
Clinical Dementia Rating 7 1073 -.195 -.326--.057 .0058 32.036 <.001 81.271 
Higher scores on cognitive screening measures 31 6659 .157 .102-.211 <.0001 117.522 <.001 74.473 
Mini-Mental State Examination 26 5640 .130 .073-.185 <.0001 80.492 <.001 68.941 
Cognitive screening measures excluding Dementia Rating Scale & 
Mini-Mental State Examination 
8 3416 .231 .105-.350 .0004 59.180 <.001 88.172 
Taking medication 8 1401 -.087 -.149--.025 .0063 8.752 .271 20.019 
Acetylcholinesterase inhibitors 5 1083 -.055 -.138-.028 .1909 6.409 .171 37.587 
Better functional ability 28 6218 .289 .221-.354 <.0001 172.427 <.001 84.341 
Basic activities of daily living 18 4845 .294 .214-.369 <.0001 107.216 <.001 84.144 
Dependence Scale 6 3374 .263 .108-.407 .0011 71.667 <.001 93.023 
Katz Index of Independence in Activities of Daily Living 5 877 .272 .138-.397 .0001 12.267 .015 67.391 
Physical Self-Maintenance Scale 5 441 .343 .238-.441 <.0001 5.561 .234 28.069 
Instrumental activities of daily living 11 1420 .334 .200-.456 <.0001 64.787 <.001 84.565 
Lawton’s Instrumental Activities of Daily Living 8 1157 .317 .151-.466 .0003 51.773 <.001 86.479 
Depression 26 3464 -.274 -.328--.218 <.0001 66.994 <.001 62.683 
Cornell Scale for Depression in Dementia 7 826 -.414 -.532--.279 <.0001 26.831 <.001 77.638 
Geriatric Depression Scale (all versions) 12 1539 -.237 -.338--.129 <.0001 46.065 <.001 76.121 
Geriatric Depression Scale-30 7 949 -.245 -.396--.081 .0037 34.026 <.001 82.366 
Neuropsychiatric Inventory-Depression 6 953 -.332 -.471--.177 .0001 22.630 <.001 77.905 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
8 931 -.249 -.309--.187 <.0001 3.701 .813 0 
Anxiety 9 1126 -.170 -.261--.076 .0004 14.112 .079 43.312 
Neuropsychiatric Inventory-Anxiety 6 858 -.218 -.354--.074 .0033 12.607 .027 60.340 
Neuropsychiatric symptoms/BPSD 32 6928 -.339 -.408--.267 <.0001 285.405 <.001 89.138 
Neuropsychiatric Inventory 22 5643 -.344 -.432--.251 <.0001 252.974 <.001 91.699 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
8 999 -.343 -.404--.279 <.0001 8.369 .301 16.359 
Presence of co-morbid conditions 8 1456 -.073 -.124--.021 .0056 2.547 .924 0 
Being married 8 1595 .101 .052-.149 <.0001 5.600 .587 0 
Living alone 5 1017 -.100 -.191--.007 .0349 7.193 .126 44.389 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 20y: Factors associated with informant ratings of quality of life for people with dementia diagnosed with Alzheimer’s disease – factors 
pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 5 807 -.119 -.187--.050 .0008 1.386 .847 0 
Female gender 7 1018 -.012 -.074-.050 .7102 3.032 .805 0 
Depression 7 1343 -.205 -.316--.088 .0007 23.207 .001 74.146 
Burden or stress 13 2464 -.258 -.357--.153 <.0001 80.475 <.001 85.089 
Zarit Burden Interview 10 2149 -.288 -.399--.170 <.0001 68.951 <.001 86.947 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 20z: Factors associated with informant ratings of quality of life for people with dementia diagnosed with Alzheimer’s disease made by family 
carers only – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 19 3094 -.013 -.070-.044 .6540 38.623 .003 53.395 
Female gender 15 2646 -.006 -.077-.066 .8724 40.543 <.001 65.468 
Higher level of education 15 2356 .010 -.031-.051 .6370 5.733 .973 0 
More advanced dementia 6 953 -.207 -.366--.038 .0169 35.737 <.001 86.009 
Clinical Dementia Rating 5 732 -.175 -.360-.023 .0833 29.546 <.001 86.463 
Higher scores on cognitive screening measures 32 6719 .163 .109-.217 <.0001 123.055 <.001 74.808 
Mini-Mental State Examination  27 5700 .138 .081-.194 <.0001 87.152 <.001 70.167 
Cognitive screening measures excluding Dementia Rating Scale & 
Mini-Mental State Examination 
8 3416 .231 .105-.350 .0004 59.180 <.001 88.172 
Taking medication 8 1401 -.087 -.148--.024 .0067 8.775 .269 20.228 
Acetylcholinesterase inhibitors 5 1083 -.055 -.138-.028 .1909 6.409 .171 37.587 
Better functional ability 25 5907 .288 .216-.358 <.0001 171.226 <.001 85.983 
Instrumental activities of daily living 11 1420 .331 .197-.453 <.0001 64.186 <.001 84.420 
Lawton’s Instrumental Activities of Daily Living* 8 1157 .317 .151-.466 .0003 51.773 <.001 86.479 
Basic activities of daily living 15 4462 .297 .207-.382 <.0001 101.437 <.001 86.198 
Katz Index of Independence in Activities of Daily Living* 5 877 .272 .138-.397 .0001 12.267 .015 67.391 
Depression 22 3142 -.272 -.332--.210 <.0001 63.114 <.001 66.727 
Cornell Scale for Depression in Dementia 6 630 -.427 -.572--.256 <.0001 27.013 <.001 81.490 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
7 850 -.256 -.319--.191 <.0001 3.217 .781 0 
Geriatric Depression Scale (all versions) 11 1505 -.223 -.328--.113 .0001 43.658 <.001 77.094 
Geriatric Depression Scale-30 7 949 -.245 -.396--.081 .0037 34.026 <.001 82.366 
Anxiety 7 1131 -.171 -.265--.073 .0007 13.331 .038 54.992 
Neuropsychiatric symptoms/BPSD 26 6228 -.348 -.425--.266 <.0001 262.972 <.001 90.493 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
7 849 -.359 -.418--.297 <.0001 6.142 .407 2.316 
Neuropsychiatric Inventory 19 5379 -.340 -.434--.239 <.0001 239.349 <.001 92.480 
Presence of co-morbid conditions* 8 1456 -.073 -.124--.021 .0056 2.547 .924 0 
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Being married 8 1595 .107 .057-.158 <.0001 7.302 .398 4.132 
Living alone* 5 1017 -.100 -.191--.007 .0349 7.193 .126 44.389 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 20aa: Factors associated with informant ratings of quality of life for people with dementia diagnosed with Alzheimer’s disease made by 
family carers only – factors pertaining to the carer 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age* 5 807 -.119 -.187--.050 .0008 1.386 .847 0 
Female gender 7 1018 -.019 -.081-.043 .5396 4.215 .648 0 
Depression* 7 1343 -.205 -.316--.088 .0007 23.207 .001 74.146 
Burden or stress 13 2455 -.250 -.350--.145 <.0001 81.036 <.001 85.192 
Zarit Burden Interview 10 2140 -.279 -.391--.159 <.0001 70.006 <.001 87.144 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 20ab: Factors associated with informant ratings of quality of life for the person with dementia, excluding studies that focused specifically on 
people diagnosed with Alzheimer’s disease – factors pertaining to the person with dementia  
 
Factor   Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 39 8815 -.032 -.065-.001 .0561 82.818 <.001 54.116 
Female gender 34 7669 -.005 -.039-.029 .7701 65.909 .001 49.931 
White ethnicity* 5 906 .066 .000-.131 .0490 2.029 .730 0 
Higher level of education 16 3253 .061 .023-.100 .0017 17.403 .295 13.807 
Alzheimer’s (vs. other dementia subtypes)* 9 2719 .050 -.027-.126 .2054 27.443 .001 70.849 
Longer disease duration 8 983 -.053 -.116-.010 .1016 1.605 .978 0 
More advanced dementia 31 6769 -.318 -.405--.225 <.0001 485.325 <.001 93.819 
Clinical Dementia Rating 18 4796 -.293 -.413--.163 <.0001 361.339 <.001 95.295 
Global Deterioration Scale 5 677 -.265 -.382--.141 <.0001 11.376 .023 64.839 
Advanced dementia measures excluding Global Deterioration Scale 
& Clinical Dementia Rating 
8 1296 -.403 -.555--.224 <.0001 84.093 <.001 91.676 
Higher scores on cognitive screening measures 55 7858 .195 .147-.242 <.0001 240.569 <.001 77.553 
Mini-Mental State Examination  50 7152 .192 .142-.240 <.0001 211.931 <.001 76.879 
Cognitive screening measures excluding Dementia Rating Scale & 
Mini-Mental State Examination 
9 1033 .124 .011-.234 .0319 21.125 .007 62.131 
Taking medication 13 4602 -.046 -.075--.016 .0023 11.196 .512 0 
Acetylcholinesterase inhibitors 5 809 -.109 -.215--.000 .0498 9.371 .052 57.314 
Psychotropics 9 3769 -.050 -.096--.004 .0314 12.960 .113 38.270 
Antidepressants 5 1119 -.074 -.171-.025 .1416 7.923 .094 49.513 
Anxiolytics  6 1515 -.064 -.168-.042 .2363 17.125 .004 70.802 
Longer duration of care home stay* 12 2312 -.105 -.162--.047 .0004 18.574 .069 40.778 
Degree to which residential care is person-centred* 6 1814 .155 .049-.257 .0042 13.729 .017 63.581 
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Special dementia unit (vs. other residential facility)* 5 2372 .120 .071-.168 <.0001 5.528 .237 27.641 
Better functional ability 59 12394 .360 .303-.413 <.0001 669.188 <.001 91.333 
Basic activities of daily living 41 8103 .394 .327-.457 <.0001 455.482 <.001 91.218 
Barthel Index 18 3327 .498 .384-.596 <.0001 259.016 <.001 93.437 
Katz Index of Independence in Activities of Daily Living 11 2114 .310 .256-.363 <.0001 16.416 .088 39.082 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
10 1808 .287 .193-.376 <.0001 37.609 <.001 76.070 
Instrumental activities of daily living 13 1814 .348 .243-.445 <.0001 60.784 <.001 80.258 
Lawton’s Instrumental Activities of Daily Living 7 1149 .261 .166-.351 <.0001 15.567 .016 61.456 
Instrumental activities of daily living measures excluding 
Lawton’s Instrumental Activities of Daily Living 
7 776 .517 .462-.567 <.0001 5.640 .465 0 
Depression 42 8856 -.318 -.379--.256 <.0001 388.227 <.001 89.439 
Cornell Scale for Depression in Dementia 21 5844 -.318 -.382--.250 <.0001 140.453 <.001 85.760 
Geriatric Depression Scale (all versions) 7 414 -.307 -.455--.144 .0003 16.548 .011 63.742 
Neuropsychiatric Inventory-Depression 6 1270 -.192 -.408-.043 .1084 73.543 <.001 93.201 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
11 1572 -.346 -.468--.211 <.0001 79.163 <.001 87.368 
Anxiety 9 2018 -.143 -.186--.100 <.0001 6.214 .623 0 
Neuropsychiatric Inventory-Anxiety 6 1270 -.122 -.176--.067 <.0001 2.888 .717 0 
Neuropsychiatric symptoms/BPSD 44 8430 -.322 -.377--.265 <.0001 332.965 <.001 87.086 
Cohen-Mansfield Agitation Inventory 6 1015 -.141 -.201--.080 <.0001 3.448 .631 0 
Neuropsychiatric Inventory 29 5570 -.333 -.403--.260 <.0001 226.724 <.001 87.650 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
14 2517 -.322 -.398--.242 <.0001 59.110 <.001 78.007 
Pain* 13 4048 -.203 -.307-.095 .0003 124.860 <.001 90.389 
Presence of co-morbid conditions 196 3893 -.101 -.148--.053 <.0001 36.917 .005 51.242 
Cared for by spouse (vs. other carer type) 7 1453 .129 .066-.191 <.0001 8.234 .221 27.130 
Being married 6 1303 .115 .033-.197 .0064 10.267 .068 51.298 
Living alone 8 1379 -.161 -.220--.101 <.0001 8.540 .287 18.033 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20ac: Factors associated with informant ratings of quality of life for the person with dementia, excluding studies that focused specifically on 
people diagnosed with Alzheimer’s disease – factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 10 1693 -.004 -.062-.070 .9088 15.187 .086 40.737 
Female gender 8 2071 .098 .049-.147 .0001 8.376 .301 16.424 
Higher level of education 9 2094 .098 .043-.152 .0005 11.342 .183 29.463 
More time spent caring (residential care only) 5 605 -.166 -.284--.043 .0082 9.436 .051 57.609 
Depression 7 1350 -.290 -.376--.199 <.0001 17.128 .009 64.970 
Distress at NPS symptoms 5 878 -.331 -.436--.216 <.0001 12.111 .017 66.973 
Burden or stress 12 1996 -.373 -.477--.260 <.0001 82.666 <.001 86.693 
Zarit Burden Interview 8 1135 -.385 -.538--.206 <.0001 73.232 <.001 90.441 
Poorer mental health (GHQ)* 6 715 -.242 -.311--.170 <.0001 3.990 .551 0 
Carer quality of life (self-rated) 6 1228 .330 .209-.441 <.0001 22.844 <.001 78.112 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 20ad: Factors associated with informant ratings of quality of life for the person with dementia made by family carers only, excluding studies 
that focused specifically on people diagnosed with Alzheimer’s disease – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 22 4007 -.045 -.086--.004 .0326 33.375 .042 37.078 
Female gender 21 3819 -.034 -.079-.011 .1336 34.792 .021 42.516 
Higher level of education 13 2485 .082 .043-.121 <.0001 7.481 .824 0 
Longer disease duration 6 756 -.059 -.131-.013 .1074 1.194 .945 0 
More advanced dementia 19 3510 -.322 -.453--.178 <.0001 361.331 <.001 95.018 
Clinical Dementia Rating 11 2202 -.286 -.481--.064 .0120 265.365 <.001 96.232 
Higher scores on cognitive screening measures 34 4456 .154 .093-.214 <.0001 127.116 <.001 74.040 
Mini-Mental State Examination 30 4109 .161 .093-.227 <.0001 127.011 <.001 77.167 
Cognitive screening measures excluding Dementia Rating Scale & 
Mini-Mental State Examination 
6 869 .120 -.025-.260 .1036 18.060 .003 72.315 
Taking medication 6 2185 -.050 -.092--.008 .0207 2.569 .766 0 
Better functional ability 35 5176 .358 .284-.427 <.0001 267.710 <.001 87.300 
Basic activities of daily living 19 2319 .423 .313-.521 <.0001 153.424 <.001 88.268 
Barthel Index 9 919 .550 .408-.666 <.0001 50.258 <.001 84.082 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
5 560 .238 .130-.341 <.0001 6.437 .169 37.861 
Instrumental activities of daily living* 13 1814 .348 .243-.445 <.0001 60.784 <.001 80.258 
Lawton’s Instrumental Activities of Daily Living 7 1149 .261 .166-.351 <.0001 15.567 .016 61.456 
Instrumental activities of daily living measures excluding 
Lawton’s Instrumental Activities of Daily Living* 
7 776 .517 .462-.567 <.0001 5.640 .465 0 
Depression 27 5327 -.320 -.396--.240 <.0001 226.800 <.001 88.536 
Cornell Scale for Depression in Dementia 10 2972 -.336 -.419--.247 <.0001 50.641 <.001 82.228 
Geriatric Depression Scale (all versions) 7 414 -.315 -.462--.151 .0003 16.856 .010 64.404 
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Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
8 1062 -.300 -.404--.188 <.0001 22.755 .002 69.237 
Anxiety 6 1544 -.137 -.185--.087 <.0001 1.810 .875 0 
Neuropsychiatric symptoms/BPSD 26 4321 -.357 -.421--.289 <.0001 140.919 <.001 82.259 
Neuropsychiatric Inventory 20 3256 -.384 -.457--.306 <.0001 109.702 <.001 82.680 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
8 1360 -.358 -.467--.239 <.0001 36.806 <.001 80.981 
Presence of co-morbid conditions 9 1417 -.152 -.232--.070 .0003 17.530 .025 54.363 
Cared for by spouse (vs. other carer type)* 7 1453 .129 .066-.191 <.0001 8.234 .221 27.130 
Being married* 6 1303 .115 .033-.197 .0064 10.267 .068 51.298 
Living alone 7 1254 -.139 -.204--.073 <.0001 7.783 .254 22.906 
 Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 20ae: Factors associated with informant ratings of quality of life for the person with dementia made by family carers only, excluding studies 
that focused specifically on people diagnosed with Alzheimer’s disease – factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 7 1351 -.026 -.093-.040 .4394 8.258 .220 27.341 
Female gender 7 1448 .088 .025-.151 .0066 8.198 .224 26.813 
Higher level of education 8 1457 .095 .026-.164 .0074 11.161 .132 37.281 
More time spent caring (residential care only)* 5 605 -.166 -.284--.043 .0082 9.436 .051 57.609 
Depression* 7 1350 -.290 -.376--.199 <.0001 17.128 .009 64.970 
Distress at NPS symptoms 5 858 -.322 -.446--.186 <.0001 16.515 .002 75.780 
Burden or stress 10 1752 -.401 -.511--.277 <.0001 71.985 <.001 87.497 
Zarit Burden Interview 8 1135 -.392 -.542--.218 <.0001 70.434 <.001 90.062 
Poorer mental health (GHQ)* 6 715 -.242 -.311--.170 <.0001 3.990 .551 0 
Carer quality of life (self-rated) 5 1128 .335 .194-.462 <.0001 22.438 <.001 82.173 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20af: Factors associated with informant ratings of quality of life for the person with dementia made by health care professionals only, 
excluding studies that focused specifically on people diagnosed with Alzheimer’s disease – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 17 3858 -.052 -.108-.005 .0713 43.123 <.001 62.897 
Female gender 17 4053 .025 -.017-.066 .2393 25.050 .069 36.127 
More advanced dementia 12 3012 -.338 -.435--.234 <.0001 99.396 <.001 88.933 
Clinical Dementia Rating 5 2053 -.327 -.487--.146 .0006 71.904 <.001 94.437 
Advanced dementia measures excluding Clinical Dementia Rating 7 959 -.347 -.463--.219 <.0001 27.406 <.001 78.107 
Higher scores on cognitive screening measures 21 2965 .242 .176-.305 <.0001 67.722 <.001 70.468 
Mini-Mental State Examination 21 2956 .245 .177-.310 <.0001 70.495 <.001 71.629 
Taking medication 10 3006 -.050 .010-.090 .0136 10.069 .345 10.619 
Psychotropics 7 2401 -.050 -.113-.014 .1281 12.273 .056 51.112 
Anxiolytics 5 1370 -.104 -.240-.036 .1449 21.632 <.001 81.509 
Longer duration of care home stay* 10 1804 -.088 -.150--.025 .0062 14.138 .117 36.344 
Degree to which residential care is person-centred* 6 1814 .154 .049-.256 .0042 13.718 .018 63.551 
Special dementia unit (vs. other residential facility)* 5 2372 .120 .071-.168 <.0001 5.528 .237 27.641 
Better functional ability 26 6008 .367 .271-.456 <.0001 403.300 <.001 93.801 
Basic activities of daily living 23 4510 .372 .272-.463 <.0001 294.753 <.001 92.536 
Barthel Index 11 2227 .443 .276-.583 <.0001 197.598 <.001 94.939 
Katz Index of Independence in Activities of Daily Living 5 474 .371 .290-.447 <.0001 2.532 .639 0 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
7 1345 .280 .166-.386 <.0001 27.152 <.001 77.903 
Depression 15 2897 -.283 -.387--.172 <.0001 123.916 <.001 88.702 
Cornell Scale for Depression in Dementia 10 2398 -.244 -.337--.147 <.0001 47.726 <.001 81.142 
Anxiety 5 563 -.165 -.264--.061 .0019 5.630 .229 28.950 
Neuropsychiatric symptoms/BPSD 19 3466 -.330 -.411--.245 <.0001 127.793 <.001 85.915 
Neuropsychiatric Inventory 9 1619 -.320 -.431--.199 <.0001 41.768 <.001 80.847 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
8 1303 -.318 -.419--.209 <.0001 30.289 <.001 76.889 
Pain* 9 2443 -.255 -.403--.095 .0021 115.216 <.001 93.057 
Presence of co-morbid conditions 8 1781 -.099 -.152--.046 .0003 8.528 .288 17.914 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20ag: Factors associated with informant ratings of quality of life for the person with dementia made by mixed groups of informants including 
family carers and health care professionals, excluding studies that focused specifically on people diagnosed with Alzheimer’s disease – factors pertaining to the 
person with dementia   
 
Factor  Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 5 1719 -.039 -.092-.014 .1493 4.829 .305 17.170 
Better functional ability 6 1983 .341 .257-.420 <.0001 20.398 .001 75.488 
Basic activities of daily living* 6 1983 .341 .257-.420 <.0001 20.398 .001 75.488 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
Supplementary Table 20ah: Factors associated with informant ratings of quality of life for people with dementia living in the community – factors pertaining to the 
person with dementia  
 
Factor   Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 27 4932 -.020 -.067-.027 .4077 63.551 <.001 59.088 
Female gender 20 3894 .015 -.041-.070 .6052 49.788 <.001 61.838 
Higher level of education 19 3597 .043 .011-.076 .0097 13.919 .734 0 
Longer disease duration 5 1067 -.088 -.148--.028 .0041 2.156 .707 0 
More advanced dementia 10 1681 -.232 -.333--.125 <.0001 43.127 <.001 79.131 
Clinical Dementia Rating 6 1122 -.220 -.372--.055 .0091 35.013 <.001 85.719 
Higher scores on cognitive screening measures 40 8097 .148 .098-.196 <.0001 158.260 <.001 75.357 
Mini-Mental State Examination  34 6956 .127 .074-.179 <.0001 122.962 <.001 73.976 
Cognitive screening measures excluding Dementia Rating Scale & 
Mini-Mental State Examination 
14 3868 .165 .074-.253 .0004 61.744 <.001 78.945 
Taking medication 9 2377 -.040 -.080-.001 .0545 7.754 .458 0 
Acetylcholinesterase inhibitors 5 1077 -.012 -.072-.048 .6899 2.037 .729 0 
Polypharmacy 5 1115 -.068 -.145-.010 .0855 5.905 .206 32.264 
Psychotropics 5 1226 -.104 -.202--.004 .0425 8.195 .085 51.192 
Better functional ability 34 7799 .339 .272-.402 <.0001 288.900 <.001 88.577 
Bristol Activities of Daily Living Scale 5 769 .419 .322-.507 <.0001 6.973 .137 42.637 
Disability Assessment for Dementia 5 3042 .208 .071-.337 .0030 29.842 <.001 86.596 
Basic activities of daily living 17 5108 .329 .223-.428 <.0001 217.392 <.001 92.640 
Katz Index of Independence in Activities of Daily Living 6 1059 .335 .226-.436 <.0001 15.098 .010 66.883 
Instrumental activities of daily living 15 2215 .402 .291-.503 <.0001 108.271 <.001 87.070 
Lawton’s Instrumental Activities of Daily Living 7 1356 .343 .182-.487 .0001 54.793 <.001 89.050 
Instrumental activities of daily living measures excluding 
Lawton’s Instrumental Activities of Daily Living 
9 970 .491 .431-.547 <.0001 9.859 .275 18.860 
Depression 31 5694 -.321 -.369--.272 <.0001 103.915 <.001 71.130 
Cornell Scale for Depression in Dementia 9 2823 -.362 -.438--.282 <.0001 36.031 <.001 77.797 
Geriatric Depression Scale (all versions) 12 1262 -.270 -.389--.142 .0001 52.200 <.001 78.927 
Geriatric Depression Scale-30 8 912 -.281 -.433--.113 .0012 39.036 <.001 82.068 
Neuropsychiatric Inventory-Depression 6 1083 -.351 -.481--.205 <.0001 26.160 <.001 80.887 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression 
8 888 -.297 -.382--.207 <.0001 12.997 .072 46.143 
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Anxiety 10 1821 -.159 -.221--.096 <.0001 14.064 .120 36.007 
Neuropsychiatric Inventory-Anxiety 6 1083 -.201 -.304--.095 .0003 12.322 .031 59.424 
Neuropsychiatric symptoms/BPSD 33 7104 -.371 -.438--.301 <.0001 300.843 <.001 89.363 
Neuropsychiatric Inventory 25 6113 -.374 -.455--.288 <.0001 283.585 <.001 91.537 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
8 1018 -.402 -.478--.320 <.0001 14.457 .044 51.579 
Presence of co-morbid conditions 9 1746 -.105 -.176--.032 .0046 15.523 .050 48.463 
Cared for by spouse (vs. other carer type) 6 1761 .116 .041-.191 .0027 11.823 .037 57.709 
Being married 12 2575 .111 .066-.155 <.0001 13.808 .244 20.338 
Living alone 10 2030 -.126 -.190--.061 .0002 16.828 .051 46.519 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 20ai: Factors associated with informant ratings of quality of life for people with dementia living in the community - factors pertaining to the 
carer 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 9 1750 -.048 -.101-.005 .0785 9.216 .324 13.193 
Female gender 9 1584 .029 -.023-.081 .2783 8.470 .289 5.550 
Higher level of education 6 1316 .090 .000-.179 .0495 12.327 .031 59.439 
More time spent caring (community only)* 5 681 -.137 -.267--.002 .0462 11.630 .020 65.606 
Depression 9 2050 -.237 -.340--.130 <.0001 45.312 <.001 82.345 
Center for Epidemiologic Studies Depression Scale 5 854 -.273 -.446--.081 .0059 28.229 <.001 85.830 
Distress at NPS symptoms 5 925 -.364 -.442--.281 <.0001 6.681 .143 41.697 
Burden or stress 17 3469 -.358 -.440--.270 <.0001 124.683 <.001 87.167 
Zarit Burden Interview 12 2575 -.397 -.494--.291 <.0001 96.649 <.001 88.619 
Burden or stress measures excluding Zarit Burden Interview 5 894 -.255 -.427--.066 .0086 27.271 <.001 85.332 
Carer quality of life (self-rated) 5 1108 .306 .176-.425 <.0001 17.771 .001 77.492 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20aj: Factors associated with informant ratings of quality of life for people with dementia living in the community made by family carers 
only – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 25 4724 -.020 -.070-.029 .4200 63.230 <.001 62.043 
Female gender 20 3894 .014 -.042-.070 .6186 50.065 <.001 62.049 
Higher level of education 18 3489 .043 .010-.077 .0112 12.856 .746 0 
More advanced dementia* 10 1681 -.232 -.333--.125 <.0001 43.127 <.001 79.131 
Clinical Dementia Rating* 6 1122 -.220 -.372--.055 .0091 35.013 <.001 85.719 
Higher scores on cognitive screening measures 38 7912 .147 .096-.197 <.0001 154.127 <.001 75.994 
Mini-Mental State Examination 30 6671 .129 .073-.184 <.0001 117.460 <.001 75.311 
Cognitive screening measures excluding Dementia Rating Scale & 
Mini-Mental State Examination* 
14 3868 .165 .074-.253 .0004 61.744 <.001 78.945 
Taking medication 8 1586 -.053 -.102--.003 .0372 6.905 .439 0 
Acetylcholinesterase inhibitors 5 1077 -.012 -.072-.048 .6899 2.037 .729 0 
Polypharmacy* 5 1115 -.068 -.145-.010 .0855 5.905 .206 32.264 
Better functional ability 32 7631 .337 .268-.402 <.0001 284.355 <.001 89.098 
Disability Assessment for Dementia* 5 3042 .208 .071-.337 .0030 29.842 <.001 86.596 
Basic activities of daily living 16 5008 .334 .222-.436 <.0001 217.457 <.001 93.102 
Katz Index of Independence in Activities of Daily Living 5 959 .345 .214-.464 <.0001 15.089 .005 73.491 
Instrumental activities of daily living 15 2215 .400 .288-.501 <.0001 108.533 <.001 87.101 
Lawton’s Instrumental Activities of Daily Living* 7 1356 .343 .182-.487 .0001 54.793 <.001 89.050 
Instrumental activities of daily living measures excluding 
Lawton’s Instrumental Activities of Daily Living 
9 970 .482 .415-.544 <.0001 11.367 .182 29.619 
Depression 30 5588 -.328 -.377--.277 <.0001 103.831 <.001 72.070 
Cornell Scale for Depression in Dementia 8 2717 -.380 -.459--.296 <.0001 34.170 <.001 79.514 
Geriatric Depression Scale (all versions)* 8 912 -.281 -.433--.113 .0012 39.036 <.001 82.068 
Geriatric Depression Scale-30* 8 888 -.297 -.382--.207 <.0001 12.997 .072 46.143 
Neuropsychiatric Inventory-Depression 6 1083 -.368 -.500--.220 <.0001 28.020 <.001 82.156 
Depression measures excluding Geriatric Depression Scale, Cornell 
Scale for Depression in Dementia & Neuropsychiatric Inventory-
Depression* 
8 888 -.297 -.382--.207 <.0001 12.997 .072 46.143 
Anxiety 10 1821 -.155 -.213--.096 <.0001 12.508 .186 28.044 
Neuropsychiatric Inventory-Anxiety 6 1083 -.194 -.290--.094 .0002 10.851 .054 53.923 
Neuropsychiatric symptoms/BPSD 32 7004 -.378 -.446--.305 <.0001 306.693 <.001 89.892 
Neuropsychiatric Inventory 24 6013 -.380 -.462--.291 <.0001 282.294 <.001 91.852 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
8 1018 -.414 -.500--.319 <.0001 19.533 .007 64.162 
Presence of co-morbid conditions* 9 1746 -.105 -.176--.032 .0046 15.523 .050 48.463 
Cared for by spouse (vs. other carer type)* 6 1761 .116 .041-.191 .0027 11.823 .037 57.709 
Being married 11 2464 .118 .068-.168 <.0001 15.003 .132 33.344 
Living alone* 10 2030 -.126 -.190--.061 .0002 16.828 .051 46.519 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20ak: Factors associated with informant ratings of quality of life for people with dementia living in the community made by family carers 
only – factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 8 1650 -.052 -.112-.007 .0863 8.978 .254 22.034 
Female gender 9 1584 .022 -.038-.083 .4646 10.292 .245 22.273 
Higher level of education* 6 1316 .090 .000-.179 .0495 12.327 .031 59.439 
More time spent caring (community only)* 5 681 -.137 -.267--.002 .0462 11.630 .020 65.606 
Depression* 9 2050 -.237 -.340--.130 <.0001 45.312 <.001 82.345 
Center for Epidemiologic Studies Depression Scale* 5 854 -.273 -.446--.081 .0059 28.229 <.001 85.830 
Distress at NPS symptoms 5 925 -.372 -.454--.283 <.0001 7.747 .101 48.368 
Burden or stress 16 3349 -.355 -.442--.261 <.0001 126.936 <.001 88.183 
Zarit Burden Interview 12 2566 -.390 -.489--.282 <.0001 99.191 <.001 88.910 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 20al: Factors associated with informant ratings of quality of life for people with dementia living in the community made by health care 
professionals only – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Higher scores on cognitive screening measures 5 489 .132 -.031-.288 .1129 13.060 .011 69.373 
Mini-Mental State Examination* 5 489 .132 -.031-.288 .1129 13.060 .011 69.373 
Better functional ability 5 438 .380 .243-.502 <.0001 9.983 .041 59.933 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20am: Factors associated with informant ratings of quality of life for people with dementia living in residential care settings – factors 
pertaining to the person with dementia  
 
Factor   Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 18 4208 -.026 -.074-.023 .2967 37.041 .003 54.105 
Female gender 17 4120 -.006 -.049-.038 .7906 27.808 .033 42.462 
Higher level of education 5 1672 .012 -.081-.104 .8077 13.001 .011 69.234 
More advanced dementia 14 2948 -.288 -.358--.214 <.0001 50.995 <.001 74.507 
Clinical Dementia Rating 6 1971 -.250 -.340--.155 <.0001 20.781 .001 78.939 
Advanced dementia measures excluding Global Deterioration Scale 8 979 -.321 -.426--.208 <.0001 23.752 .001 70.529 
Higher scores on cognitive screening measures 19 3313 .239 .169-.306 <.0001 75.494 <.001 76.157 
Mini-Mental State Examination 18 3118 .246 .171-.319 <.0001 78.566 <.001 78.362 
Taking medication 9 3007 -.062 -.098--.025 .0009 7.993 .434 0 
Psychotropics 6 2423 -.065 -.132-.003 .0609 9.789 .081 48.920 
Longer duration of care home stay* 12 2312 -.105 -.162--.047 .0004 18.574 .069 40.778 
Better functional ability 25 5927 .399 .300-.490 <.0001 411.991 <.001 94.175 
Basic activities of daily living 24 4562 .419 .325-.506 <.0001 294.635 <.001 92.194 
Barthel Index 14 2790 .504 .371-.616 <.0001 226.725 <.001 94.266 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
12 2067 .322 .251-.390 <.0001 28.818 .002 61.829 
Depression 18 3738 -.309 -.406--.206 <.0001 176.913 <.001 90.391 
Cornell Scale for Depression in Dementia 11 2957 -.287 -.394--.172 <.0001 99.990 <.001 89.999 
Anxiety 5 546 -.158 -.257--.056 .0025 5.284 .259 24.293 
Neuropsychiatric symptoms/BPSD 20 3777 -.303 -.381--.221 <.0001 130.068 <.001 85.392 
Cohen-Mansfield Agitation Inventory 8 1243 -.149 -.219--.077 .0001 10.594 .157 33.928 
Neuropsychiatric Inventory 7 1483 -.338 -.447--.218 <.0001 28.326 <.001 78.818 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
10 1684 -.317 -.442--.181 <.0001 79.560 <.001 88.688 
Pain 9 2199 -.268 -.422--.099 .0021 114.141 <.001 92.991 
Presence of co-morbid conditions 8 1763 -.044 -.110-.021 .1846 11.657 .112 39.950 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 20an: Factors associated with informant ratings of quality of life for people with dementia living in residential care settings made by family 
carers only – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 1153 -.032 -.090-.027 .2868 2.273 .810 0 
Female gender 6 1182 -.063 -.120--.006 .0309 2.801 .731 0 
Better functional ability 7 523 .464 .237-.643 .0002 46.736 <.001 87.162 
Basic activities of daily living 7 523 .487 .248-.670 .0002 53.503 <.001 88.786 
Barthel Index 5 382 .614 .395-.767 <.0001 26.443 <.001 84.873 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 20zo: Factors associated with informant ratings of quality of life for people with dementia living in residential care settings made by health 
care professionals only – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 14 3040 -.033 -.094-.028 .2889 32.792 .002 60.356 
Female gender 14 3049 .010 -.037-.057 .6787 20.158 .091 35.510 
More advanced dementia 12 2420 -.309 -.389--.225 <.0001 48.344 <.001 77.246 
Higher scores on cognitive screening measures 16 2543 .253 .181-.323 <.0001 53.642 <.001 72.037 
Mini-Mental State Examination 16 2534 .257 .183-.328 <.0001 56.286 <.001 73.350 
Taking medication 8 1821 -.075 -.123--.028 .0019 6.916 .438 0 
Psychotropics 5 1216 -.080 -.177-.019 .1140 9.203 .056 56.538 
Longer duration of care home stay* 10 1804 -.088 -.150--.025 .0062 14.138 .117 36.344 
Special dementia unit (vs. other residential facility)* 5 2372 .120 .071-.168 <.0001 5.528 .237 27.641 
Better functional ability 20 5178 .365 .249-.471 <.0001 373.509 <.001 94.913 
Basic activities of daily living 19 3812 .386 .275-.488 <.0001 258.544 <.001 93.038 
Barthel Index 9 2075 .455 .266-.610 <.0001 192.570 <.001 95.846 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of 
Daily Living & Physical Self-Maintenance Scale 
11 1934 .328 .256-.397 <.0001 25.263 <.001 60.417 
Depression 14 2785 -.305 -.413--.189 <.0001 122.925 <.001 89.424 
Cornell Scale for Depression in Dementia 9 2298 -.251 -.349--.146 <.0001 47.214 <.001 83.056 
Anxiety* 5 546 -.158 -.257--.056 .0025 5.284 .259 24.293 
Neuropsychiatric symptoms/BPSD 16 3056 -.331 -.419--.238 <.0001 109.008 <.001 86.240 
Neuropsychiatric Inventory 5 1230 -.353 -.509--.175 <.0001 31.678 <.001 87.373 
Neuropsychiatric symptom measures excluding Neuropsychiatric 
Inventory & Cohen-Mansfield Agitation Inventory 
8 1368 -.348 -.484--.195 <.0001 64.515 <.001 89.150 
Cohen-Mansfield Agitation Inventory 6 776 -.201 -.284--.115 <.0001 6.847 .232 26.980 
Pain 8 2049 -.271 -.443--.081 .0057 114.980 <.001 93.912 
Presence of co-morbid conditions 6 1068 -.074 -.150-.002 .0577 6.961 .224 28.176 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 21a: Factors associated with proxy ratings of quality of life for the person with dementia made by family carers only – factors pertaining to 
the person with dementia 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 8 865 .059 -.061-.177 .3383 20.802 .004 66.349 
Female gender 5 428 .061 -.035-.156 .2148 1.637 .802 0 
Higher scores on cognitive screening measures 10 1145 .002 -.066-.071 .9452 11.337 .253 20.614 
Mini-Mental State Examination* 10 1145 .002 -.066-.071 .9452 11.337 .253 20.614 
Better functional ability 8 1124 .139 .009-.265 .0361 32.947 <.001 78.754 
Basic activities of daily living 5 699 .114 -.038-.261 .1423 15.249 .004 73.768 
Depression 7 761 -.362 -.494--.215 <.0001 26.611 <.001 77.453 
Geriatric Depression Scale (all versions)* 5 466 -.446 -.608--.248 <.0001 20.722 <.001 80.697 
Neuropsychiatric symptoms/BPSD 10 1267 -.356 -.437--.270 <.0001 23.112 .006 61.060 
Neuropsychiatric Inventory 8 1033 -.349 -.444--.247 <.0001 20.217 .005 65.376 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
Supplementary Table 21b: Factors associated with proxy ratings of quality of life for the person with dementia made by family carers only – factors pertaining to 
the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age* 5 412 -.017 -.160-.126 .8173 7.963 .093 49.768 
Note: those asterisked are unchanged from previous analyses. 
 
Supplementary Table 21c: Factors associated with proxy ratings of quality of life for the person with dementia made by health care professionals only – factors 
pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 5 989 -.095 -.290-.107 .3569 34.171 <.001 88.294 
Female gender 5 1166 .027 -.031-.084 .3682 1.430 .839 0 
Taking medication 5 886 -.120 -.207--.030 .0088 6.916 .140 42.161 
Better functional ability 6 862 .082 .008-.156 .0300 5.544 .353 9.808 
Basic activities of daily living 6 862 .082 .008-.156 .0300 5.544 .353 9.808 
Depression 5 583 -.347 -.417--.272 <.0001 3.665 .453 0 
Neuropsychiatric symptoms/BPSD 5 1005 -.295 -.382--.203 <.0001 8.874 .064 54.926 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
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Supplementary Table 21d: Factors associated with proxy ratings of quality of life for the person with dementia made using the Dementia Quality of Life 
Questionnaire (DEMQOL) – factors pertaining to the person with dementia  
 
Factor Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 826 .094 -.042-.227 .1753 18.263 .003 72.622 
Higher scores on cognitive screening measures 8 875 .003 -.086-.091 .9553 11.111 .134 36.997 
Mini-Mental State Examination* 8 875 .003 -.086-.091 .9553 11.111 .134 36.997 
Better functional ability 8 1134 .097 -.030-.220 .1334 28.953 <.001 75.823 
Basic activities of daily living 5 727 .041 -.033-.114 .2753 2.655 .617 0 
Depression 5 487 -.386 -.577--.155 .0015 26.266 <.001 84.771 
Neuropsychiatric symptoms/BPSD 7 898 -.404 -.491--.311 <.0001 13.860 .031 56.711 
Neuropsychiatric Inventory* 7 898 -.404 -.491--.311 <.0001 13.860 .031 56.711 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 21e: Factors associated with proxy ratings of quality of life for the person with dementia made using dementia-specific quality of life 
measures – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 14 2243 -.016 -.118-.087 .7643 71.886 <.001 81.916 
Female gender 11 1832 .037 -.009-.083 .1184 3.351 .972 0 
More advanced dementia 7 1381 -.307 -.425--.179 <.0001 35.663 <.001 83.176 
Higher scores on cognitive screening measures 15 1903 .112 .022-.199 .0144 49.267 <.001 71.584 
Mini-Mental State Examination 12 1482 .068 -.030-.165 .1718 35.146 <.001 68.702 
Taking medication* 7 1160 -.099 -.170--.026 .0076 8.884 .180 32.465 
Better functional ability 15 2284 .139 .051-.224 .0019 56.667 <.001 75.294 
Basic activities of daily living 12 1878 .124 .039-.208 .0042 33.337 <.001 67.004 
Basic activities of daily living measures excluding 
Barthel Index & Katz Index of Independence in 
Activities of Daily Living 
8 1251 .141 .039-.240 .0066 19.852 .006 64.739 
Depression* 13 1651 -.317 -.409--.219 <.0001 47.495 <.001 74.734 
Geriatric Depression Scale (all versions)* 5 466 -.446 -.608--.248 <.0001 20.722 <.001 80.697 
Cornell Scale for Depression in Dementia* 5 811 -.200 -.361--.027 .0235 19.089 .001 79.046 
Neuropsychiatric symptoms/BPSD 16 2484 -.321 -.377--.263 <.0001 34.096 .003 26.007 
Neuropsychiatric Inventory 12 1609 -.333 -.404--.257 <.0001 27.782 .003 60.406 
Neuropsychiatric measures excluding Neuropsychiatric 
Inventory 
5 1080 -.297 -.372--.219 <.0001 6.800 .147 41.175 
Presence of co-morbid conditions* 6 873 -.121 -.186--.054 .0004 3.383 .641 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 21f: Factors associated with proxy ratings of quality of life for the person with dementia made by family carers only using dementia-specific 
quality of life measures – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 7 825 .064 -.066-.192 .3364 20.696 .002 71.008 
Higher scores on cognitive screening measures 9 1069 .005 -.069-.080 .8879 11.186 .191 28.483 
Mini-Mental State Examination* 9 1069 .005 -.069-.080 .8879 11.186 .191 28.483 
Better functional ability 8 1108 .121 -.009-.247 .0685 32.214 <.001 78.270 
Basic activities of daily living 5 701 .074 -.032-.178 .1721 7.379 .117 45.792 
Depression* 7 761 -.362 -.494--.215 <.0001 26.611 <.001 77.453 
Geriatric Depression Scale (all versions)* 5 466 -.446 -.608--.248 <.0001 20.722 <.001 80.697 
Neuropsychiatric symptoms/BPSD 9 1191 -.366 -.441--.285 <.0001 17.687 .024 54.770 
Neuropsychiatric Inventory 8 997 -.376 -.463--.282 <.0001 17.110 .017 59.088 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 21g: Factors associated with proxy ratings of quality of life for the person with dementia made by health care professionals only using 
dementia-specific quality of life measures – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 5 989 -.095 -.290-.107 .3569 34.171 <.001 88.294 
Female gender 5 1015 .037 -.025-.099 .2417 1.664 .797 0 
Taking medication* 5 886 -.120 -.207--.030 .0088 6.916 .140 42.161 
Better functional ability 6 862 .082 .008-.156 .0300 5.544 .353 16.522 
Basic activities of daily living* 6 862 .082 .008-.156 .0300 5.544 .353 16.522 
Depression* 5 583 -.347 -.417--.272 <.0001 3.665 .453 0 
Neuropsychiatric symptoms/BPSD 5 1005 -.295 -.382--.203 <.0001 8.874 .064 54.926 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 21h: Factors associated with proxy ratings of quality of life for people with Alzheimer’s disease made using dementia-specific quality of life 
measures – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Higher scores on cognitive screening measures 6 669 .041 -.036-.118 .3003 4.481 .482 0 
Mini-Mental State Examination* 6 669 .041 -.036-.118 .3003 4.481 .482 0 
Better functional ability 5 745 .224 .052-.382 .0110 22.280 <.001 82.047 
Neuropsychiatric symptoms/BPSD 8 974 -.361 -.464--.249 <.0001 22.197 .002 68.465 
Neuropsychiatric Inventory 7 934 -.341 -.448--.225 <.0001 19.313 .004 68.932 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 21i: Factors associated with proxy ratings of quality of life for people with Alzheimer’s disease – factors pertaining to the family carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Higher scores on cognitive screening measures* 6 669 .041 -.036-.118 .3003 4.481 .482 0 
Mini-Mental State Examination* 6 669 .041 -.036-.118 .3003 4.481 .482 0 
Better functional ability* 5 745 .224 .052-.382 .0110 22.280 <.001 82.047 
Neuropsychiatric symptoms/BPSD* 8 974 -.361 -.464--.249 <.0001 22.197 .002 68.465 
Neuropsychiatric Inventory* 7 934 -.341 -.448--.225 <.0001 19.313 .004 68.932 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 21j: Factors associated with proxy ratings of quality of life for the person with dementia, excluding studies that focused specifically on people 
diagnosed with Alzheimer’s disease – factors pertaining to the person with dementia factors 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 11 1893 -.007 -.133-.120 .9182 71.381 <.001 85.991 
Female gender 9 1637 .029 -.020-.078 .2455 1.889 .984 0 
More advanced dementia 6 1266 -.306 -.438--.161 <.0001 34.496 <.001 85.506 
Higher scores on cognitive screening measures 10 1310 .127 .005-.245 .0412 41.275 <.001 78.195 
Mini-Mental State Examination 7 889 .062 -.098-.218 .4491 30.517 <.001 80.339 
Taking medication 6 1080 -.098 -.179--.017 .0181 8.829 .116 43.367 
Better functional ability 10 1556 .110 .010-.207 .0318 30.559 <.001 70.549 
Basic activities of daily living* 10 1556 .110 .010-.207 .0318 30.559 <.001 70.549 
Basic activities of daily living measures excluding 
Barthel Index & Katz Index of Independence in 
Activities of Daily Living 
7 1009 .144 .021-.263 .0220 19.591 .003 69.373 
Depression 9 1277 -.323 -.428--.209 <.0001 32.990 <.001 75.750 
Neuropsychiatric symptoms/BPSD 9 1586 -.290 -.354--.223 <.0001 14.887 .061 46.262 
Neuropsychiatric Inventory 5 711 -.284 -.385--.177 <.0001 8.768 .067 54.378 
Neuropsychiatric symptom measures excluding 
Neuropsychiatric Inventory 
5 1080 -.297 -.372--.219 <.0001 6.800 .147 41.175 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 21k: Factors associated with proxy ratings of quality of life for the person with dementia, excluding studies that focused specifically on people 
diagnosed with Alzheimer’s disease made by health care professionals only – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 5 989 -.095 -.290-.107 .3569 34.171 <.001 88.294 
Female gender 5 1015 .037 -.025-.099 .2417 1.664 .797 0 
Taking medication 5 886 -.120 -.207--.030 .0088 6.916 .140 42.161 
Better functional ability 6 862 .082 .008-.156 .0300 5.544 .353 16.522 
Basic activities of daily living* 6 862 .082 .008-.156 .0300 5.544 .353 16.522 
Depression 5 583 -.347 -.417--.272 <.0001 3.665 .453 0 
Neuropsychiatric symptoms/BPSD 5 1005 -.295 -.382--.203 <.0001 8.874 .064 54.926 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 21l: Factors associated with proxy ratings of quality of life for people with dementia living in the community – factors pertaining to the 
person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 7 710 .068 -.073-.207 .3436 20.293 .002 70.433 
Female gender 5 428 .061 -.035-.156 .2148 1.637 .802 0 
Higher scores on cognitive screening measures 8 712 .006 -.093-.105 .9103 11.279 .127 37.940 
Mini-Mental State Examination* 8 712 .006 -.093-.105 .9103 11.279 .127 37.940 
Better functional ability 5 574 .163 -.063-.373 .1570 28.959 <.001 86.187 
Depression 7 625 -.376 -.489--.251 <.0001 16.538 .011 63.720 
Geriatric Depression Scale (all versions) 5 466 -.446 -.608--.248 <.0001 20.722 <.001 80.697 
Neuropsychiatric symptoms/BPSD 7 609 -.419 -.519--.308 <.0001 13.330 .038 54.990 
Neuropsychiatric Inventory 5 375 -.429 -.550--.291 <.0001 8.769 .067 54.384 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 21m: Factors associated with proxy ratings of quality of life for people with dementia living in the community made by family carers only – 
factors pertaining to the person with dementia   
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age* 7 710 .068 -.073-.207 .3436 20.293 .002 70.433 
Female gender* 5 428 .061 -.035-.156 .2148 1.637 .802 0 
Higher scores on cognitive screening measures* 8 712 .006 -.093-.105 .9103 11.279 .127 37.940 
Mini-Mental State Examination* 8 712 .006 -.093-.105 .9103 11.279 .127 37.940 
Better functional ability* 5 574 .163 -.063-.373 .1570 28.959 <.001 86.187 
Depression 6 548 -.406 -.521--.277 <.0001 13.161 .022 62.010 
Geriatric Depression Scale (all versions)* 5 466 -.446 -.608--.248 <.0001 20.722 <.001 80.697 
Neuropsychiatric symptoms/BPSD* 7 609 -.419 -.519--.308 <.0001 13.330 .038 54.990 
Neuropsychiatric Inventory* 5 375 -.429 -.550--.291 <.0001 8.769 .067 54.384 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 21n: Factors associated with proxy ratings of quality of life for people with dementia living in residential care settings – factors pertaining to 
the person with dementia   
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 1418 -.093 -.227-.045 .1875 36.520 <.001 83.571 
Female gender 7 1444 .032 -.020-.084 .2246 1.759 .941 0 
More advanced dementia* 6 1266 -.306 -.438--.161 <.0001 34.496 <.001 85.506 
Taking medication 5 886 -.120 -.207--.030 .0088 6.916 .140 42.161 
Higher scores on cognitive screening measures 6 834 .260 .176-.341 <.0001 7.532 .184 33.617 
Better functional ability 7 1177 .161 .037-.281 .0115 23.078 .001 74.001 
Basic activities of daily living* 7 1177 .161 .037-.281 .0115 23.078 .001 74.001 
Basic activities of daily living measures excluding 
Barthel Index & Katz Index of Independence in 
Activities of Daily Living 
5 790 .182 .043-.314 .0107 13.498 .009 70.367 
Depression 6 891 -.267 -.400--.124 .0003 19.642 .001 74.544 
Neuropsychiatric symptoms/BPSD 7 1293 -.271 -.350--.188 <.0001 13.079 .042 54.126 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 21o: Factors associated with proxy ratings of quality of life for people with dementia living in residential care settings made by health care 
professionals only – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 5 989 -.095 -.290-.107 .3569 34.171 <.001 88.294 
Female gender 5 1015 .037 -.025-.099 .2417 1.664 .797 0 
Taking medication* 5 886 -.120 -.207--.030 .0088 6.916 .140 42.161 
Depression 5 583 -.347 -.417--.272 <.0001 3.665 .453 0 
Neuropsychiatric symptoms/BPSD 5 1005 -.295 -.382--.203 <.0001 8.874 .064 54.926 
Note: those asterisked are unchanged from previous analyses. 
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Supplementary Table 22a: Factors associated with the difference between self-ratings and informant ratings made by family carers only of the quality of life of the 
person with dementia – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 9 1543 -.046 -.069-.046 .0716 .632 1.000 0 
Female gender 9 1606 .075 .026-.124 .0028 5.137 .743 0 
Higher level of education* 7 1212 .027 -.056-.110 .5198 10.832 .094 44.606 
Higher scores on cognitive screening measures 18 2415 .126 .069-.183 <.0001 30.397 .024 44.074 
Mini-Mental State Examination 16 2186 .124 .060-.186 .0001 28.605 .018 47.561 
Better functional ability 14 1944 .211 .130-.290 <.0001 37.453 <.001 65.290 
Basic activities of daily living 8 1206 .261 .133-.381 <.0001 27.266 <.001 74.327 
Instrumental activities of daily living* 7 1019 .099 .037-.160 .0018 1.227 .976 0 
Lawton’s Instrumental Activities of Daily Living* 7 1019 .099 .037-.160 .0018 1.227 .976 0 
Depression 8 709 -.325 -.470--.163 .0001 32.779 <.001 78.645 
Geriatric Depression Scale (all versions) 6 422 -.422 -.599--.206 .0003 26.203 <.001 80.918 
Neuropsychiatric symptoms/BPSD 12 1614 -.227 -.296--.156 <.0001 20.396 .040 46.067 
Neuropsychiatric Inventory 11 1494 -.221 -.295--.145 <.0001 19.188 .038 47.883 
Being married* 6 668 .075 -.002-.151 .0559 2.727 .742 0 
Living alone 7 1399 -.061 -.114--.009 .0223 5.883 .436 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 22b: Factors associated with the difference between self-ratings and informant ratings made by family carers only of the quality of life of the 
person with dementia – factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age* 7 1397 -.038 -.090-.015 .1629 3.621 .728 0 
Female gender* 8 1538 .072 .022-.122 .0050 6.524 .480 0 
Burden or stress 9 1672 -.229 -.296--.160 <.0001 15.501 .050 48.392 
Zarit Burden Interview 7 1262 -.258 -.342--.171 <.0001 14.043 .029 57.273 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 22c: Factors associated with the difference between self-ratings and informant ratings of the quality of life of the person with dementia made 
using the Quality of Life-Alzheimer’s Disease (QoL-AD) – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 7 1144 -.037 -.095-.022 .2172 1.239 .975 0 
Female gender 5 987 .063 .000-.125 .0498 3.222 .521 0 
Higher level of education* 6 1068 .016 -.079-.110 .7457 10.078 .073 50.389 
Higher scores on cognitive screening measures 14 1695 .086 .036-.135 .0007 13.477 .412 3.540 
Mini-Mental State Examination 13 1576 .091 .035-.145 .0014 13.463 .336 10.866 
Better functional ability 12 1429 .254 .153-.350 <.0001 34.572 <.001 68.182 
Basic activities of daily living 5 731 .263 .101-.411 .0017 10.803 .029 62.972 
Instrumental activities of daily living* 5 818 .105 .036-.173 .0028 .760 .944 0 
Lawton’s Instrumental Activities of Daily Living* 5 818 .105 .036-.173 .0028 .760 .944 0 
Depression 6 511 -.402 -.584--.182 .0006 31.243 <.001 83.996 
Neuropsychiatric symptoms/BPSD 11 1475 -.234 -.309--.155 <.0001 20.272 .027 50.670 
Neuropsychiatric Inventory 10 1355 -.227 -.309--.142 <.0001 19.115 .024 52.917 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 22d: Factors associated with the difference between self-ratings and informant ratings of the quality of life of the person with dementia made 
using the Quality of Life-Alzheimer’s Disease (QoL-AD) – factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Female gender* 6 1128 .080 .012-.147 .0217 6.093 .297 17.940 
Older age* 5 987 .018 -.045-.081 .5771 3.457 .484 0 
Burden or stress 7 1262 -.258 -.342--.171 <.0001 14.043 .029 57.273 
Zarit Burden Interview 8 1353 -.248 -.319--.174 <.0001 12.557 .084 44.253 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 22e: Factors associated with the difference between self-ratings and informant ratings of the quality of life of the person with dementia made 
using dementia-specific quality of life measures – factors pertaining to the person with dementia   
 
Factor   Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 8 1235 -.046 -.102-.011 .1122 1.043 .994 0 
Female gender 6 1078 .058 -.002-.118 .0584 2.758 .737 0 
Higher level of education 5 1068 .018 -.078-.113 .7203 10.263 .068 51.280 
Higher scores on cognitive screening measures 17 1867 .085 .039-.131 .0003 13.756 .617 0 
Mini-Mental State Examination 16 1748 .086 .039-.133 .0004 13.740 .545 0 
Better functional ability 13 1520 .239 .144-.330 <.0001 35.835 <.001 66.513 
Basic activities of daily living 6 822 .218 .082-.346 .0019 12.141 .033 58.819 
Instrumental activities of daily living 6 909 .106 .041-.170 .0015 .767 .979 0 
Lawton’s Instrumental Activities of Daily Living* 6 909 .106 .041-.170 .0015 .767 .979 0 
Depression 9 683 -.293 -.443--.127 .0007 35.850 <.001 77.685 
Geriatric Depression Scale (all versions) 7 396 -.374 -.572--.135 .0027 33.819 <.001 82.259 
Neuropsychiatric symptoms/BPSD 13 1556 -.232 -.303--.158 <.0001 22.021 .037 45.507 
Neuropsychiatric Inventory 12 1436 -.226 -.302--.147 <.0001 20.896 .034 47.357 
Being married* 6 668 .075 -.002-.151 .0559 2.727 .742 0 
Living alone 5 1014 -.032 -.094-.030 .3118 .078 .999 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 22f: Factors associated with the difference between self-ratings and informant ratings of the quality of life of the person with dementia made 
using dementia-specific quality of life measures – factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 1078 -.038 -.098-.022 .2160 3.621 .605 0 
Female gender 7 1219 .066 .008-.124 .0269 6.255 .395 4.077 
Burden or stress 10 1434 -.259 -.341--.174 <.0001 21.812 .009 58.738 
Zarit Burden Interview* 10 1434 -.259 -.341--.174 <.0001 21.812 .009 58.738 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 22g: Factors associated with the difference between self-ratings and informant ratings of the quality of life of the person with dementia made 
using health-related quality of life measures – factors pertaining to the person with dementia  
 
Factor   Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Higher scores on cognitive screening measures 5 1192 .208 .077-.332 .0020 17.420 .002 77.038 
 
 
Supplementary Table 22h: Factors associated with the difference between self-ratings and informant ratings of the quality of life of people with Alzheimer’s disease 
– factors pertaining to the person with dementia  
 
Factor   Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 5 903 -.040 -.105-.026 .2324 .150 .997 0 
Higher level of education 5 903 .060 -.006-.125 .0734 .798 .939 0 
Higher scores on cognitive screening measures 13 1496 .086 .042-.144 .0004 8.458 .748 0 
Mini-Mental State Examination 12 1386 .082 .029-.135 .0026 6.163 .862 0 
Better functional ability 8 1150 .161 .067-.253 .0008 14.404 .044 51.401 
Instrumental activities of daily living 6 928 .097 .032-.161 .0033 1.203 .945 0 
Lawton’s Instrumental Activities of Daily Living* 6 928 .097 .032-.161 .0033 1.203 .945 0 
Depression 7 508 -.326 -.483--.149 .0004 23.464 .001 74.429 
Geriatric Depression Scale (all versions) 6 386 -.375 -.552--.166 .0007 21.049 .001 76.246 
Neuropsychiatric symptoms/BPSD 10 1241 -.243 -.335--.147 <.0001 21.567 .010 58.270 
Neuropsychiatric Inventory 9 1121 -.238 -.340--.131 <.0001 20.327 .009 60.644 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 22i: Factors associated with the difference between self-ratings and informant ratings of the quality of life of people with Alzheimer’s disease 
– factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Female gender 5 963 .078 -.006-.162 .0703 5.897 .207 32.166 
Burden or stress 7 1059 -.287 -.402--.164 <.0001 20.777 .002 71.122 
Zarit Burden Interview* 7 1059 -.287 -.402--.164 <.0001 20.777 .002 71.122 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 22j: Factors associated with the difference between self-ratings and informant ratings of the quality of life of people with dementia, excluding 
studies that focused specifically on people diagnosed with Alzheimer’s disease – factors pertaining to the person with dementia  
 
Factor   Number of 
studies  
Number of 
participants  
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 1346 -.043 -.096-.011 .1191 2.099 .910 0 
Female gender 7 1415 .085 .033-.137 .0015 2.083 .912 0 
Higher scores on cognitive screening measures 10 1707 .159 .071-.244 .0004 25.360 .003 64.512 
Mini-Mental State Examination 9 1588 .170 .073-.263 .0006 24.883 .002 67.850 
Better functional ability 9 930 .283 .172-.387 <.0001 21.198 .007 62.260 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 22k: Factors associated with the difference between self-ratings and informant ratings of the quality of life of people with dementia living in 
the community – factors pertaining to the person with dementia  
 
Factor   Number of 
studies  
Number of 
participants  
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 1275 -.044 -.099-.011 .1204 .366 .996 0 
Female gender 6 1275 .051 -.004-.106 .0676 1.145 .950 0 
Higher scores on cognitive screening measures 11 1722 .114 .034-.192 .0053 23.729 .008 57.858 
Mini-Mental State Examination 9 1493 .106 .013-.198 .0259 21.590 .006 62.946 
Better functional ability 6 1305 .146 .085-.206 <.0001 5.928 .313 15.650 
Depression 5 447 -.167 -.323--.003 .0459 10.887 .028 63.260 
Neuropsychiatric symptoms/BPSD 6 986 -.211 -.270--.150 <.0001 3.932 .559 0 
Neuropsychiatric Inventory 5 866 -.198 -.262--.133 <.0001 2.711 .607 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 22l: Factors associated with the difference between self-ratings and informant ratings of the quality of life of people with dementia living in 
the community – factors pertaining to the carer Factors associated with the difference between self- and informant-rated quality of life of person with dementia 
quality of life: community living only studies: carer factors 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 1275 -.041 -.096-.014 .1466 3.460 .629 0 
Female gender 6 1275 .053 -.003-.107 .0623 1.405 .924 0 
Burden or stress 8 1355 -.205 -.289--.118 <.0001 15.132 .034 53.739 
Zarit Burden Interview 7 1036 -.227 -.327--.122 <.0001 13.748 .033 56.358 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data.  
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Supplementary Table 23a: Baseline factors associated with self-ratings of quality of life for the person with dementia made by the person with dementia at follow-
up in longitudinal studies – factors pertaining to the person with dementia 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
More advanced dementia 5 383 -.078 -.179-.025 .1376 .521 .971 0 
Clinical Dementia Rating* 5 383 -.078 -.179-.025 .1376 .521 .971 0 
Higher scores on cognitive screening measures 6 572 .050 -.034-.132 .2431 1.683 .891 0 
Mini-Mental State Examination 6 572 .051 -.032-.134 .2266 1.617 .899 0 
Better functional ability 5 371 .053 -.069-.173 .3941 5.239 .264 23.643 
Neuropsychiatric symptoms/BPSD 6 572 -.111 -.198--.022 .0147 5.547 .353 9.869 
Quality of life rating at baseline 9 1040 .243 -.000-.459 .0503 113.798 <.001 92.970 
Quality of Life-Alzheimer’s Disease rating at baseline 7 859 .211 -.099-.484 .1806 107.747 <.001 94.431 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 23b: Baseline factors associated with informant ratings of quality of life for the person with dementia made by the family carer at follow-up 
in longitudinal studies – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Quality of life rating at baseline 6 949 .157 -.159-.444 .3296 106.253 <.001 95.294 
Quality of Life-Alzheimer’s Disease rating at baseline 5 812 .097 -.307-.472 .6458 118.082 <.001 96.613 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 23c: Baseline factors associated with informant ratings of quality of life for the person with dementia made by health care professionals at 
follow-up in longitudinal studies – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Quality of life rating at baseline 5 429 .405 .249-.541 <.0001 10.235 .037 60.918 
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Supplementary Table 23d: Baseline factors associated with ratings of quality of life for the person with dementia made using the Quality of Life-Alzheimer’s 
Disease (QoL-AD) at follow-up in longitudinal studies – factors pertaining to the person with dementia  
 
Factor Number of 
studies  
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 6 497 -.079 -.170-.013 .0912 2.901 .715 0 
Female gender 5 480 .112 .016-.206 .0221 4.152 .386 3.659 
More advanced dementia* 6 561 -.062 -.147-.024 .1600 .879 .972 0 
Clinical Dementia Rating* 5 439 -.078 -.175-.021 .1227 .459 .977 0 
Higher scores on cognitive screening measures 6 628 .064 -.017-.144 .1228 2.891 .717 0 
Mini-Mental State Examination 6 628 .065 -.016-.146 .1132 2.798 .731 0 
Better functional ability* 5 371 .115 .012-.216 .0287 2.867 .580 0 
Neuropsychiatric symptoms/BPSD 6 572 -.112 -.193--.029 .0082 3.792 .580 0 
Quality of life rating at baseline* 10 1352 .233 .022-.425 .0309 125.859 <.001 92.849 
Quality of Life-Alzheimer’s Disease rating at baseline* 10 1352 .233 .022-.425 .0309 125.859 <.001 92.849 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 23e: Baseline factors associated with ratings of quality of life for the person with dementia made using dementia-specific quality of life 
measures at follow-up in longitudinal studies – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age* 7 544 -.079 -.166-.009 .0771 2.901 .821 0 
Female gender* 6 527 .112 .023-.199 .0138 4.176 .524 0 
More advanced dementia* 6 561 -.062 -.147-.024 .1600 .879 .972 0 
Clinical Dementia Rating* 5 439 -.078 -.175-.021 .1227 .459 .977 0 
Higher scores on cognitive screening measures 8 770 .138 .024-.248 .0180 15.596 .029 55.116 
Mini-Mental State Examination 7 675 .121 -.003-.242 .0554 13.562 .035 55.758 
Better functional ability* 5 371 .115 .012-.216 .0287 2.867 .580 0 
Depression* 5 447 -.144 -.255--.029 .0144 5.052 .282 20.826 
Neuropsychiatric symptoms/BPSD* 7 619 -.120 -.199--.041 .0031 4.361 .628 0 
Quality of life rating at baseline 14 1672 .296 .140-.437 .0003 129.614 <.001 89.970 
Quality of Life-Alzheimer’s Disease rating at baseline* 10 1352 .233 .022-.425 .0309 125.859 <.001 92.849 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 23f: Baseline factors associated with self-ratings of quality of life for the person with dementia made using dementia-specific quality of life 
measures at follow-up in longitudinal studies – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
More advanced dementia* 6 561 -.062 -.147-.024 .1600 .879 .972 0 
Clinical Dementia Rating* 5 439 -.078 -.175-.021 .1227 .459 .977 0 
Higher scores on cognitive screening measures 6 572 .050 -.034-.132 .2431 1.683 .891 0 
Mini-Mental State Examination 6 572 .051 -.032-.134 .2266 1.167 .899 0 
Better functional ability* 5 371 .053 -.069-.173 .3941 5.239 .264 23.643 
Neuropsychiatric symptoms/BPSD* 6 572 -.111 -.198--.022 .0147 5.547 .353 9.869 
Quality of life rating at baseline 8 929 .239 -.034-.478 .0849 107.995 <.001 93.518 
Quality of Life-Alzheimer’s Disease rating at baseline* 7 859 .211 -.099-.484 .1806 107.747 <.001 94.431 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 23g: Baseline factors associated with informant ratings of quality of life for the person with dementia made by family carers using dementia-
specific quality of life measures at follow-up in longitudinal studies – factors pertaining to the person with dementia   
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Quality of life rating at baseline 6 951 .194 -.151-.497 .2691 128.606 <.001 96.112 
Quality of Life-Alzheimer’s Disease rating at baseline* 5 812 .097 -.307-.472 .6458 118.082 <.001 96.613 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 23h: Baseline factors associated with ratings of quality of life for people with dementia, excluding studies that focused specifically on people 
diagnosed with Alzheimer’s disease at follow-up in longitudinal studies – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Female gender* 6 527 .112 .023-.199 .0138 4.176 .524 0 
More advanced dementia* 6 561 -.062 -.147-.024 .1600 .879 .972 0 
Clinical Dementia Rating* 5 439 -.078 -.175-.021 .1227 .459 .977 0 
Higher scores on cognitive screening measures 7 694 .147 .008-.282 .0390 17.798 .007 66.289 
Mini-Mental State Examination 7 694 .148 .009-.282 .0367 17.580 .007 65.870 
Depression* 5 447 -.144 -.255--.029 .0144 5.052 .282 20.826 
Neuropsychiatric symptoms/BPSD 5 401 -.115 -.212--.015 .0238 2.023 .732 0 
Quality of life rating at baseline 12 1455 .314 .202-.418 <.0001 47.617 <.001 76.899 
Quality of Life-Alzheimer’s Disease rating at baseline 8 1128 .307 .142-.455 .0004 48.904 <.001 85.686 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 23i: Baseline factors associated with self-ratings of quality of life for people with dementia, excluding studies that focused specifically on 
people diagnosed with Alzheimer’s disease at follow-up in longitudinal studies – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Quality of life rating at baseline 7 849 .168 -.148-.453 .2977 109.614 <.001 94.526 
Quality of Life-Alzheimer’s Disease rating at baseline 6 737 .165 -.210-.498 .3895 106.404 <.001 95.301 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. 
 
 
Supplementary Table 23j: Baseline factors associated with ratings of quality of life for people with dementia living in residential care settings at follow-up in 
longitudinal studies – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Quality of life rating at baseline 6 965 .286 .103-.450 .0025 35.782 <.001 86.026 
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Supplementary Table 24a: Moderating effect of age on the association between self-ratings of quality of life and factors pertaining to the person with dementia  
 
Factor Number of studies Point estimate Standard error 95% CI Z p 
Depression 67 -.00325 .00532 -.01368 to .00719 -.60974 .54203 
 
 
Supplementary Table 24b: Moderating effect of MMSE score on the association between self-ratings of quality of life and factors pertaining to the person with 
dementia  
 
Factor Number of studies Point estimate Standard error 95% CI Z p 
Depression 57 -.00306 .00583 -.01448 to .00836 -.52495 .59962 
 
 
Supplementary Table 25a: Moderating effect of age on the association between informant ratings of quality of life and factors pertaining to the person with 
dementia  
Factor Number of studies Point estimate Standard error 95% CI Z p 
Functional ability 87 -.00491 .00574 -.01616 to .00634 -.85482 .39265 
Neuropsychiatric symptoms/BPSD 76 -.01372 .00591 -.02530 to -.00213 -2.32040 .02032 
Global Deterioration indices 14 -.01558 .01869 -.05222 to .02106 -.83361 .40450 
Depression 67 -.00325 .00532 -.01368 to .00719 -.60974 .54203 
 
 
Supplementary Table 25b: Moderating effect of age on the association between informant ratings of quality of life and factors pertaining to the carer  
 
Factor Number of studies Point estimate Standard error 95% CI Z p 
Burden/stress 25 -.01874 .01312 -.04446 to -.00698 -1.42792 .15332 
Distress (Neuropsychiatric Inventory) 10 .00074 .01080 -.02043 to .02191 .06820 .94563 
 
 
Supplementary Table 25c: Moderating effect of MMSE score on the association between informant ratings of quality of life and factors pertaining to the person 
with dementia  
Factor Number of studies Point estimate Standard error 95% CI Z p 
Functional ability 67 -.00631 .00477 -.01565 to .00304 -1.32300 .18583 
Neuropsychiatric symptoms/BPSD 61 -.00084 .00597 -.01253 to .01085 -.14098 .88789 
Global Deterioration indices* 6      
Depression 57 -.00306 .00583 -.01448 to .00836 -.52495 .59962 
Note: those asterisked are where moderator analysis was not conducted as there were data available for less than 10 studies 
 
 
Supplementary Table 25d: Moderating effect of MMSE score on the association between informant ratings of quality of life and factors pertaining to the carer  
 
Factor Number of studies Point estimate Standard error 95% CI Z p 
Burden/stress 18 .00319 .01440 -.02502 to .03141 .22185 .82443 
Distress (Neuropsychiatric Inventory)* 8      
Note: those asterisked are where moderator analysis was not conducted as there were data available for less than 10 studies 
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Supplementary Table 26a: Sensitivity analyses removing the inserted correlation of zero for non-significant p values. Factors associated with self-ratings of quality 
of life by the person with dementia: factors pertaining to the person with dementia 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 52 7671 -.024 .005--.053 .1042 74.548 .017 31.588 
Female gender 39 5709 .009 -.022-.039 .5813 49.031 .108 22.498 
White ethnicity 10 1562 .199 .137-.259 <.0001 13.734 .132 34.471 
Higher income 7 1002 .166 -.008-.331 .0620 45.738 <.001 86.882 
Higher level of education 40 4841 .068 .030-.106 .0005 63.786 .007 38.858 
Underweight 7 1052 -.004 .125--.133 .9542 25.777 <.001 76.724 
Alzheimer’s (vs. other dementia subtypes) 9 1552 .148 -.030-.316 .1028 96.047 <.001 91.671 
Longer disease duration 9 1470 -.008 .066--.083 .8246 13.668 .091 41.469 
More advanced dementia 24 3541 -.098 -.048--.148 .0001 48.246 .002 52.328 
Global Deterioration Scale* 6 886 -.103 -.177--.029 .0067 5.897 .316 15.207 
Clinical Dementia Rating 15 2177 -.091 -.016--.165 .0180 40.310 <.001 65.270 
Higher scores on cognitive screening measures 88 13102 .096 .065-.127 <.0001 229.036 <.001 62.015 
Mini-Mental State Examination 80 11698 .090 .057-.123 <.0001 211.413 <.001 62.632 
Alzheimer's Disease Assessment Scale-Cognitive Subscale* 5 3095 .066 .030-.100 .0003 3.239 .519 0 
Taking medication 19 4606 -.142 -.192--.092 <.0001 42.001 .001 57.143 
Acetylcholinesterase inhibitors 5 968 -.135 -.207--.061 .0004 4.714 .318 15.138 
Polypharmacy  8 1396 -.151 -.203--.099 <.0001 1.392 .986 0 
Psychotropic drugs 9 2519 -.159 -.251--.064 .0011 27.124 .001 70.506 
Longer duration of care home stay 7 665 -.102 -.026--.178 .0091 5.420 .491 0 
Better functional ability 76 12784 .182 .148-.216 <.0001 252.425 <.001 70.288 
Alzheimer's Disease Co-operative Study-Activities of Daily Living Inventory 3 581 .152 -.069-.235 .2773 22.156 <.001 81.946 
Disability Assessment for Dementia  3 581 .152 -.132-.414 .2936 20.451 <.001 90.221 
Basic activities of daily living 48 8431 .228 .183-.272 <.0001 173.193 <.001 72.863 
Barthel Index 16 2365 .210 .105-.311 .0001 95.399 <.001 84.277 
Katz Index of Independence in Activities of Daily Living  11 1338 .225 .127-.319 <.0001 26.257 .003 61.915 
Physical Self-Maintenance Scale* 6 703 .216 .132-.297 <.0001 6.403 .269 21.917 
Basic activities of daily living measures excluding Barthel Index, Katz Index 
of Independence in Activities of Daily Living & Physical Self-Maintenance 
Scale 
18 4353 .233 .165-.298 <.0001 58.459 <.001 70.920 
Instrumental activities of daily living* 25 3330 .148 .087-.208 <.0001 65.771 <.001 63.510 
Functional Activities Questionnaire* 5 398 .176 .077-.271 .0005 2.319 .678 0 
Lawton’s Instrumental Activities of Daily Living* 13 1660 .115 .059-.170 <.0001 14.161 .291 15.259 
Instrumental activities of daily living measures excluding Lawton’s 
Instrumental Activities of Daily Living & Functional Activities Questionnaire* 
8 1372 .208 .059-.349 .0066 50.192 <.001 86.054 
Presence of unmet needs* 5 838 -.204 -.305--.100 .0002 9.273 .055 56.866 
More awareness* 10 1285 .145 .090-.198 <.0001 7.769 .558 0 
Better self-rated memory functioning 8 1320 .035 -.019-.089 .2084 6.239 .512 0 
Depression 79 11394 -.321 -.280--.361 <.0001 386.517 <.001 79.820 
Cornell Scale for Depression in Dementia* 27 5537 -.245 -.300--.189 <.0001 102.956 <.001 74.746 
Geriatric Depression Scale (all versions) 27 2787 -.455 -.359--.541 <.0001 218.578 <.001 88.105 
Geriatric Depression Scale-15 15 1605 -.524 -.392--.635 <.0001 150.171 <.001 90.677 
Geriatric Depression Scale-30* 11 1079 -.320 -.397--.240 <.0001 15.873 .103 36.999 
Neuropsychiatric Inventory-Depression* 12 1855 -.262 -.363--.154 <.0001 55.863 <.001 80.309 
Depression measures excluding Geriatric Depression Scale, Cornell Scale for 
Depression in Dementia & Neuropsychiatric Inventory-Depression* 
28 2802 -.332 -.401--.259 <.0001 109.001 <.001 75.229 
Anxiety 20 2479 -.255 -.174--.333 <.0001 76.351 <.001 75.115 
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Neuropsychiatric Inventory-Anxiety 8 970 -.094 -.031--.157 .0037 6.022 .537 0 
Rating of Anxiety in Dementia* 6 925 -.328 -.462--.180 <.0001 21.077 .001 76.278 
Anxiety measures excluding Rating of Anxiety in Dementia & 
Neuropsychiatric Inventory-Anxiety* 
8 872 -.351 -.482--.204 <.0001 35.812 <.001 80.453 
Neuropsychiatric symptoms/BPSD 53 9200 -.119 -.097--.141 <.0001 55.255 .353 5.892 
Neuropsychiatric Inventory 39 7681 -.118 -.092--.144 <.0001 42.768 .274 11.149 
Neuropsychiatric symptom measures excluding Neuropsychiatric Inventory 16 1605 -.131 -.082--.180 <.0001 12.231 .661 0 
Pain* 10 2720 -.157 -.236--.077 .0001 24.305 .004 62.971 
Better self-rated health 11 1702 .269 .167-.366 <.0001 44.359 <.001 77.457 
Presence of co-morbid conditions 29 3573 -.228 -.173--.282 <.0001 73.744 <.001 62.031 
Better quality of relationship with carer* 6 802 .384 .148-.579 .0019 62.659 <.001 92.020 
Cared for by spouse (vs. other carer type) 7 1629 .137 .072-.201 <.0001 9.840 .132 39.025 
Being married 19 3216 .099 .065-.134 <.0001 14.866 .671 0 
Living alone 7 1449 -.160 -.012--.301 .0342 45.751 <.001 86.885 
Greater social engagement* 11 1035 .314 .121-.483 .0017 94.157 <.001 89.379 
Presence of religious beliefs/spirituality* 8 641 .352 .120-.547 .0035 60.621 <.001 88.453 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 26b: Sensitivity analyses removing the inserted correlation of zero for non-significant p values. Factors associated with self-ratings of quality 
of life by the person with dementia: factors pertaining to the carer 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 9 1662 -.067 -.002--.133 .0441 11.922 .155 32.899 
Female gender 10 1562 .021 -.049-.090 .5631 15.283 .083 41.113 
Higher level of education 10 1621 .097 .036-.158 .0020 12.622 .180 28.697 
Depression  9 1008 -.148 -.021--.270 .0227 31.182 <.001 74.344 
Center for Epidemiologic Studies Depression Scale* 5 564 -.118 -.244-.011 .0738 9.181 .057 56.432 
Distress at NPS symptoms* 9 1089 -.140 -.202--.078 .0001 8.536 .383 6.284 
Burden or stress  19 2713 -.153 -.091--.214 <.0001 41.462 .001 56.587 
Zarit Burden Interview 14 1691 -.141 -.055--.226 .0015 35.267 .001 63.138 
Burden or stress measures excluding Zarit Burden Interview* 5 1032 -.166 -.225--.105 <.0001 3.010 .556 0 
Poorer mental health (GHQ)* 5 702 -.156 -.275--.034 .0126 6.753 .150 40.767 
Carer quality of life (self-rated) 6 667 .277 .114-.424 .0010 21.397 .001 76.632 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 27a: Sensitivity analyses removing the inserted correlation of zero for non-significant p values. Factors associated with informant ratings of 
quality of life: factors pertaining to the person with dementia 
 
Factor   Number of 
studies  
Number of 
participants  
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 51 10314 -.030 .002--.063 .0626 119.267 <.001 58.077 
Female gender 51 10743 .030 -.001-.061 .0616 119.932 <.001 57.476 
White ethnicity* 7 1486 .101 .042-.159 .0008 7.612 .268 21.180 
Higher level of education 27 4964 .045 .016-.074 .0024 27.401 .389 5.112 
Underweight 4 1229 -.120 -.196--.042 .0025 5.634 .131 46.756 
Alzheimer’s (vs. other dementia subtypes) 7 2214 .069 -.031-.167 .1774 26.825 <.001 77.633 
Longer disease duration 10 1530 -.076 -.026--.126 .0032 7.018 .635 0 
More advanced dementia 39 7949 -.307 -.228--.381 <.0001 518.263 <.001 92.668 
Clinical Dementia Rating 24 5735 -.278 -.172--.378 <.0001 394.685 <.001 94.173 
Global Deterioration Scale 6 887 -.303 -.218--.384 <.0001 9.145 .103 45.328 
Advanced dementia measures excluding Clinical Dementia Rating & Global 
Deterioration Scale* 
9 1327 -.388 -.535--.216 <.0001 86.493 <.001 90.751 
Higher scores on cognitive screening measures 81 14207 .193 .157-.230 <.0001 358.994 <.001 77.716 
Dementia Rating Scale 4 527 .351 .173-.507 .0002 14.162 .003 78.817 
Mini-Mental State Examination  72 12533 .182 .143-.221 <.0001 315.903 <.001 77.525 
Cognitive screening measures excluding Dementia Rating Scale & Mini-Mental 
State Examination 
12 4547 .216 .128-.300 <.0001 75.165 <.001 85.366 
Taking medication 19 5401 .101 .058-.143 <.0001 36.547 .006 50.748 
Acetylcholinesterase inhibitors 6 895 .161 .096-.225 <.0001 4.749 .447 0 
Polypharmacy* 9 1834 -.060 -.105--.014 .0112 6.754 .563 0 
Psychotropic drugs 11 3649 .128 .057-.198 .0004 35.279 <.001 71.655 
Antipsychotic 5 1244 .191 .085-.293 .0005 11.304 .023 64.615 
Antidepressants 5 1060 .125 .005-.241 .0414 10.512 .033 61.949 
Anxiolytics  4 960 .105 -.067-.271 .2317 13.673 .003 78.060 
Longer duration of care home stay 11 2178 -.114 -.054--.173 .0002 16.974 .075 41.085 
Degree to which residential care is person-centred 6 1815 .167 .063-.266 .0016 13.219 .021 62.176 
Community dwelling (vs. residential care)* 5 1011 .123 .062-.184 .0001 3.398 .494 0 
Special dementia unit (vs. other residential facility)* 5 2366 .114 .069-.158 <.0001 4.753 .314 15.838 
Better functional ability* 87 18707 .337 .292-.380 <.0001 893.737 <.001 90.377 
Alzheimer's Disease Co-operative Study-Activities of Daily Living Inventory* 6 1264 .346 .223-.458 <.0001 25.967 <.001 80.745 
Bristol Activities of Daily Living Scale* 5 859 .450 .393-.504 <.0001 4.094 .393 2.296 
Disability Assessment for Dementia* 6 3206 .249 .110-.378 .0005 45.745 <.001 89.070 
Basic activities of daily living* 61 13149 .371 .317-.423 <.0001 695.854 <.001 91.378 
Barthel Index* 19 3429 .484 .372-.583 <.0001 268.501 <.001 93.296 
Dependence Scale* 7 3523 .328 .154-.483 .0003 123.388 <.001 95.137 
Katz Index of Independence in Activities of Daily Living* 16 2991 .300 .247-.354 <.0001 31.816 .007 52.854 
Physical Self-Maintenance Scale* 9 1494 .333 .265-.398 <.0001 13.285 .102 39.780 
Basic activities of daily living measures excluding Barthel Index, 
Dependence Scale, Katz Index of Independence in Activities of Daily Living 
& Physical Self-Maintenance Scale* 
11 1859 .300 .208-.386 <.0001 40.364 <.001 75.225 
Instrumental activities of daily living* 24 3234 .351 .270-.428 <.0001 134.793 <.001 82.937 
Lawton’s Instrumental Activities of Daily Living* 15 2306 .303 .210-.390 <.0001 72.120 <.001 80.588 
Instrumental activities of daily living measures excluding Lawton’s 
Instrumental Activities of Daily Living* 
10 1039 .458 .382-.528 <.0001 16.148 .064 44.267 
More awareness* 5 557 .275 .037-.484 .0241 31.084 <.001 87.132 
Better self-rated memory functioning* 8 1185 .213 .054-.363 .0092 47.334 <.001 85.211 
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Depression  68 12382 -.307 -.262--.351 <.0001 456.872 <.001 85.335 
Cornell Scale for Depression in Dementia* 28 6671 -.339 -.396--.280 <.0001 171.626 <.001 84.268 
Geriatric Depression Scale (all versions) 18 1919 -.268 -.180--.352 <.0001 62.428 <.001 72.769 
Geriatric Depression Scale-30* 10 1082 -.289 -.414--.154 <.0001 40.764 <.001 77.922 
Geriatric Depression Scale-15 7 803 -.229 -.104--.347 .0004 18.424 .005 67.434 
Neuropsychiatric Inventory-Depression* 12 2223 -.263 -.396--.118 .0004 117.702 <.001 90.654 
Other depression measures excluding Geriatric Depression Scale, Cornell Scale 
for Depression in Dementia & Neuropsychiatric Inventory-Depression* 
19 2503 -.309 -.392--.221 <.0001 93.689 <.001 80.787 
Anxiety* 18 3143 -.148 -.189--.107 <.0001 20.328 .258 16.371 
Neuropsychiatric Inventory-Anxiety* 12 2128 -.151 -.209--.092 <.0001 16.069 .139 31.545 
Anxiety measures excluding Neuropsychiatric Inventory-Anxiety* 7 1201 -.163 -.235--.089 <.0001 8.765 .187 31.546 
Neuropsychiatric symptoms/BPSD  74 14595 -.339 -.295--.381 <.0001 564.243 <.001 87.062 
Cohen-Mansfield Agitation Inventory* 9 1332 -.150 -.213--.085 <.0001 10.839 .211 26.191 
Neuropsychiatric Inventory 48 10355 -.352 -.296--.406 <.0001 427.307 <.001 89.001 
Neuropsychiatric symptom measures excluding Neuropsychiatric Inventory & 
Cohen-Mansfield Agitation Inventory* 
23 3685 -.353 -.417--.286 <.0001 107.094 <.001 79.457 
Pain* 13 4048 -.203 -.307--.095 .0003 124.860 <.001 90.389 
Better self-rated health* 8 1826 .198 .131-.263 <.0001 12.123 .097 42.260 
Presence of co-morbid conditions 26 5188 -.104 -.064--.143 <.0001 45.393 .008 44.925 
Cared for by spouse (vs. other carer type) 9 1613 .137 .081-.193 <.0001 9.920 .271 19.351 
Being married 17 3552 .105 .060-.149 <.0001 26.545 .047 39.724 
Living alone 11 1709 -.170 -.123--.216 <.0001 6.506 .771 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 27b: Sensitivity analyses removing the inserted correlation of zero for non-significant p values. Factors associated with informant ratings of 
quality of life: factors pertaining to the carer 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 13 2239 -.043 .022--.108 .1933 23.940 .021 49.874 
Female gender 12 2364 .055 -.005-.116 .0743 20.183 .043 45.497 
Higher level of education* 12 2313 .084 .035-.132 .0007 13.597 .256 19.098 
More time spent caring (residential care only)* 6 772 -.159 -.253--.061 .0016 9.538 .089 47.578 
More time spent caring (community only) 4 520 -.179 -.016--.332 .0317 9.410 .024 68.119 
Depression* 14 2694 -.255 -.338--.169 <.0001 64.440 <.001 79.826 
Center for Epidemiologic Studies Depression Scale* 6 905 -.299 -.458--.122 .0012 32.272 <.001 84.507 
Geriatric Depression Scale (all versions)* 5 591 -.362 -.496--.211 <.0001 14.617 .006 72.634 
Depression measures excluding Geriatric Depression Scale & Center for 
Epidemiologic Studies Depression Scale* 
6 1449 -.202 -.313--.085 .0008 22.218 <.001 77.496 
Burden or stress* 25 4460 -.324 -.398--.247 <.0001 180.102 <.001 86.674 
Zarit Burden Interview* 18 3284 -.345 -.435--.248 <.0001 148.814 <.001 88.576 
Burden or stress measures excluding Zarit Burden Interview* 8 1247 -.276 -.391--.152 <.0001 32.129 <.001 78.213 
Distress at NPS symptoms* 10 1665 -.320 -.379--.258 <.0001 15.219 .085 40.863 
Poorer mental health (GHQ)* 6 715 -.242 -.311--.170 <.0001 3.990 .551 0 
Carer quality of life (self-rated)* 8 1509 .314 .212-.410 <.0001 28.246 <.001 75.218 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses.  
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Supplementary Table 28a: Sensitivity analyses removing the inserted correlation of zero for non-significant p values. Factors associated with proxy ratings of 
quality of life: factors pertaining to the person with dementia 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 13 1934 -.017 .099--.132 .7735 70.895 <.001 83.073 
Female gender 10 1378 -.004 -.058-.049 .8731 6.380 .701 0 
More advanced dementia* 8 1421 -.302 -.413--.183 <.0001 35.674 <.001 80.378 
Higher scores on cognitive screening measures 15 1788 .116 .023-.207 .0147 48.959 <.001 71.405 
Mini-Mental State Examination 12 1367 .072 -.033-.175 .1784 35.776 <.001 69.253 
Taking medication 6 966 -.142 -.067--.215 .0002 6.745 .240 25.866 
Better functional ability  13 1975 .186 .089-.279 .0002 52.252 <.001 77.035 
Basic activities of daily living 11 1699 .167 .067-.264 .0012 38.486 <.001 74.017 
Basic activities of daily living measures excluding Barthel Index & Katz 
Index of Independence in Activities of Daily Living 
8 1135 .228 .126-.325 <.0001 18.565 .010 62.269 
Depression* 13 1651 -.317 -.409--.219 <.0001 47.495 <.001 74.734 
Cornell Scale for Depression in Dementia* 5 811 -.200 -.361--.027 .0235 19.089 .001 79.046 
Geriatric Depression Scale* 5 466 -.446 -.608--.248 <.0001 20.722 <.001 80.697 
Neuropsychiatric symptoms/BPSD* 17 2559 -.316 -.373--.257 <.0001 37.956 .002 57.845 
Neuropsychiatric Inventory* 12 1645 -.315 -.387--.238 <.0001 28.633 .003 61.582 
Neuropsychiatric symptom measures excluding Neuropsychiatric Inventory* 6 1120 -.315 -.396--.228 <.0001 10.134 .072 50.659 
Presence of co-morbid conditions* 6 873 -.121 -.186--.054 .0004 3.383 .641 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 28b: Sensitivity analyses removing the inserted correlation of zero for non-significant p values. Factors associated with proxy ratings of 
quality of life: factors pertaining to the carer 
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 5 412 -.017 -.160-.126 .8173 7.963 .093 49.768 
  
 120 
 
Supplementary Table 29a: Sensitivity analyses removing the inserted correlation of zero for non-significant p values. Factors associated with the difference between 
self-ratings and informant-ratings of the quality of life of the person with dementia – factors pertaining to the person with dementia   
 
Factor   Number of 
studies  
Number of 
participants  
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age* 12 2249 -.042 -.083--.000 .0497 2.254 .997 0 
Female gender* 11 2237 .007 -.052-.066 .8093 16.622 .083 39.840 
Higher level of education* 7 1212 .027 -.056-.110 .5198 10.832 .094 44.606 
Higher scores on cognitive screening measures* 23 3203 .128 .079-.175 <.0001 35.229 .037 37.552 
Mini-Mental State Examination* 21 2974 .126 .074-.177 <.0001 33.508 .030 40.312 
Better functional ability* 17 2080 .221 .147-.292 <.0001 40.001 .001 60.011 
Basic activities of daily living* 8 1207 .204 .115-.291 <.0001 12.960 .073 45.988 
Instrumental activities of daily living* 7 1019 .099 .037-.160 .0018 1.227 .976 0 
Lawton’s Instrumental Activities of Daily Living* 7 1019 .099 .037-.160 .0018 1.227 .976 0 
Depression* 11 1354 -.277 -.397--.148 <.0001 46.807 <.001 78.635 
Geriatric Depression Scale (all versions)* 9 1067 -.337 -.486--.168 .0002 47.848 <.001 83.281 
Neuropsychiatric symptoms/BPSD* 14 1700 -.224 -.289--.157 <.0001 22.251 .052 41.576 
Neuropsychiatric Inventory* 13 1580 -.218 -.287--.147 <.0001 21.047 .050 42.984 
Presence of co-morbid conditions* 5 467 -.131 -.311-.058 .1739 15.201 .004 73.686 
Being married* 6 668 .075 -.002-.151 .0559 2.727 .742 0 
Living alone* 7 1402 -.061 -.113--.008 .0234 5.335 .502 0 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 29b: Sensitivity analyses removing the inserted correlation of zero for non-significant p values. Factors associated with the difference 
between self-ratings and informant-ratings of the quality of life of the person with dementia – factors pertaining to the carer  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age* 7 1397 -.038 -.090-.015 .1629 3.621 .728 0 
Female gender* 8 1538 .034 -.036-.104 .3398 11.970 .102 41.519 
Burden or stress* 11 1753 -.242 -.317--.163 <.0001 25.123 .005 60.196 
Zarit Burden Interview* 10 1434 -.259 -.341--.174 <.0001 21.812 .009 58.738 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
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Supplementary Table 30: Sensitivity analyses removing the inserted correlation of zero for non-significant p values. Baseline factors associated with ratings of 
quality of life for the person with dementia at follow-up in longitudinal studies – factors pertaining to the person with dementia  
 
Factor  Number of 
studies 
Number of 
participants 
r 95% CI p Cochran’s Q  p value 
(Cochran’s Q) 
I2 
Older age 5 390 -.096 .005--.195 .0616 2.913 .573 0 
Female gender 6 457 -.157 -.316-.012 .0682 13.744 .017 63.621 
More advanced dementia 5 529 -.066 -.154-.023 .1480 .760 .944 0 
Clinical Dementia Rating 4 407 -.084 -.184-.019 .1088 .270 .966 0 
Higher scores on cognitive screening measures 8 853 .171 .056-.281 .0037 18.486 .010 62.134 
Mini-Mental State Examination 8 853 .172 .058-.281 .0033 18.222 .011 61.586 
Better functional ability  4 339 .126 .018-.230 .0225 2.443 .486 0 
Depression* 5 447 -.144 -.255--.029 .0144 5.052 .282 20.826 
Neuropsychiatric symptoms/BPSD  6 587 -.127 -.045--.206 .0024 3.914 .564 0 
Quality of life rating at baseline 15 1782 .265 .112-.406 .0008 141.101 <.001 90.078 
Quality of Life-Alzheimer’s Disease rating at baseline 10 1352 .210 -.021-.420 .0743 149.171 <.001 93.967 
Note: where enough data existed individual measures were analysed separately. This analysis is included indented under the relevant factor label. The overall factor includes 
this and other relevant data. Those asterisked are unchanged from previous analyses. 
 
 
Supplementary Table 31: Effect sizes after poor quality articles were removed from the analysis for self-ratings of quality of life by the person with dementia – 
factors pertaining to the person with dementia  
 
Factor  Number of studies Number of participants r 95% CI p Cochran’s Q  p value (Cochran’s Q) I2 
Depression  78 11200 .315 .275-.355 <.0001 362.847 <.001 78.779 
Anxiety  20 2956 .211 .135-.285 <.0001 76.021 <.001 75.007 
Functional ability  78 12848 .172 .138-.206 <.0001 262.571 <.001 70.675 
Neuropsychiatric symptoms/BPSD  55 9250 .108 .084-.132 <.0001 63.012 .188 14.302 
Dementia diagnostic category 8 1233 .097 .029-.165 .0053 9.846 <.001 28.903 
Cognitive screening measures 92 13447 .081 .053-.108 <.0001 193.861 <.001 53.059 
Self-rated memory functioning 7 1141 .038 -.023-.098 .2204 6.225 .398 3.619 
Age 55 7900 .026 .004-.048 .0215 48.970 .668 0 
Disease duration 11 1739 .011 -.049-.071 .7169 13.827 .181 27.676 
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Supplementary Table 32a: Effect sizes after poor quality articles were removed from the analysis for informant ratings of quality of life for the person with 
dementia – factors pertaining to the person with dementia 
 
Factor   Number of studies  Number of participants r 95% CI p Cochran’s Q  p value (Cochran’s Q) I2 
Functional ability  86 17118 .348 .303-.391 <.0001 839.025 <.001 89.869 
Global Deterioration indices  13 2073 .322 .189-.443 <.0001 121.704 <.001 90.140 
Depression  66 12199 .302 .256-.347 <.0001 456.610 <.001 85.765 
Pain 12 3654 .208 .088-.323 .0008 123.733 <.001 91.110 
Cognitive screening measures 85 14518 .176 .141-.211 <.0001 346.654 <.001 75.768 
Length of care home stay 11 2221 .103 .041-.163 .0011 18.471 .048 45.860 
Co-morbidity 25 4895 .090 .051-.128 <.0001 39.714 .023 39.568 
Gender 47 9932 .067 .044-.090 <.0001 56.471 .139 18.542 
Medication 20 5609 .058 .030-.085 <.0001 19.736 .411 3.729 
Diet 4 1361 .047 -.055-.148 .3672 10.368 .016 71.066 
Age 58 11926 .025 -.003-.052 .0837 118.082 <.001 51.728 
 
 
Supplementary Table 32b: Effect sizes after poor quality articles were removed from the analysis for informant ratings of quality of life for the person with 
dementia – factors pertaining to the carer  
 
Factor  Number of studies Number of participants r 95% CI p Cochran’s Q  p value (Cochran’s Q) I2 
Burden/stress 25 4465 .328 .250-.401 <.0001 179.696 <.001 86.644 
Depression 14 2698 .261 .174-.344 <.0001 65.084 <.001 80.026 
 
 
Supplementary Table 33: Effect sizes after poor quality articles were removed from the analysis for proxy ratings of quality of life for the person with dementia – 
factors pertaining to the person with dementia  
 
Factor  Number of studies Number of participants r 95% CI p Cochran’s Q  p value (Cochran’s Q) I2 
Cognitive screening measures 15 1845 .085 .000-.169 .0497 41.897 <.001 66.584 
 
 
Supplementary Table 34: Effect sizes after poor quality articles were removed from the analysis for baseline factors associated with ratings of quality of life at 
follow-up in longitudinal studies – factors pertaining to the person with dementia 
  
Factor  Number of studies Number of participants r 95% CI p Cochran’s Q  p value (Cochran’s Q) I2 
Baseline quality of life 15 1801 .328 .200-.445 <.0001 106.472 <.001 86.851 
Cognitive screening measures 8 853 .171 .056-.281 .0037 18.486 .010 62.134 
Neuropsychiatric symptoms/BPSD  6 587 .127 .045-.206 .0024 3.914 .562 0 
Functional ability  4 339 .126 .018-.230 .0225 2.443 .486 0 
Gender 5 495 .102 .010-.192 .0299 3.397 .494 0 
Clinical Dementia Rating 4 446 .085 -.009-.177 .0768 .345 .651 0 
Age 6 516 .076 -.014-.165 .0958 3.634 .603 0 
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